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INTRODUCTION 
1. INTRODUCTION 
 
1.1 ISOINDOLINES 
In the nomenclature, the isoindolines are related to the heterocycle 1H-indole (1) 
(benzopyrrole), a fused ring system composed of a 5- and a 6-membered ring. As its 
dihydrogenated derivative is the 2,3-dihydro-1H-indole or indoline (2), the dihydrogenated 
heterocycle possessing the nitrogen in the 2-position is called 2,3-dihydro-1H-isoindole or 
isoindoline (3) (Figure 1). 
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Figure 1: Nomenclature for the nitrogen heterocycles with a 5,6-fused ring system  
 
1.1.1 STRUCTURE AND BIOLOGICAL ACTIVITY OF ISOINDOLINES 
Several patents described the biological activity of N-substituted 2,3-dihydro-1H-isoindoles. 
For example the quinoline-containing compound 4 is a potent modulator of dopamine D3 
receptors and could therefore act as an antipsychotic agent,1 whereas the N- and 5-substituted 
isoindoline 5 was recognised as a potent inhibitor of the amyloid protein aggregation (IC50 = 
1.1 µM) indicating an eventual capacity in the treatment of Alzheimer's disease (Figure 2).2
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Figure 2: N-substituted isoindolines with significant biological activity 
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The class of isoindolinones (2,3-dihydro-1H-isoindol-1-ones) has also attracted much 
attention since they represent the core unit of a wide range of naturally occurring and/or 
bioactive substances.3 More particularly, enantiopure isoindolinones substituted at C-3 
possess various biological properties. For example the thiazoloisoindolones 6 strongly inhibit 
the HIV-reverse transcriptase (IC50 = 16-300 nM),4 the pazinaclone (7) (DN-2327) is an 
anxiolytic drug candidate5 and both enantiomers of PD-172938 8 are antagonists of the 
dopamine D4 receptor6 (Figure 3). 
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Figure 3: Examples of biologically active 2,3-dihydro-1H-isoindol-1-ones 
 
The 1,3-substituted isoindolines, such as the pigment yellow 139 9, are mainly used in the 
industry of organic pigments due to their stability to oxidising and reducing agents, acids, 
bases and heat. They also display good resistance to light and weather and good migration 
behaviour.7 In addition, a patent of the Kodak® company described the isoindoline 10 as 
additive for a heat developable photoimaging process (Figure 4).8
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Figure 4: 1,3-Substituted isoindolines employed in industry 
 
To our knowledge only one 1,3-disubstituted isoindoline compound has been reported to be 
biologically active so far. In fact the cis- and trans-isomers of 11 are potent endothelin A 
(ETA) receptor antagonists (Figure 5).9  
The endothelins (ET), peptides consisting of 21 amino acids, are mainly released by vascular 
endothelial cells. There are three known subtypes, namely ET-1, ET-2, and ET-3, binding to 
at least two types of receptors, ETA and ETB. Elevated levels of ET-1 and of ETA receptors 
and down-regulation of ETB receptors were verified in diseases such as essential and 
pulmonary hypertension, congestive heart failure, and arteriosclerosis. Therefore, antagonism 
of the ETA receptor is expected to be an effective way for treating these disorders.10  
The indane dicarboxylic compound (S,R,S)-12 has been described as one of the most potent 
dual ETA/ETB receptor antagonist.11 Thus, P. J. Kukkola et al. envisioned that substitution of 
the indane ring system with an isoindoline bearing an acidic group attached to the nitrogen 
atom, should lead to a new class of endothelin antagonists with high affinity for both 
receptors. These disubstituted isoindolines, missing the chiral centre at the 2-position, should 
be synthetically more accessible than the indane 2-carboxylic acid analogues. Furthermore, 
introduction of a basic nitrogen to the backbone of the template might result in compounds 
with improved bioavailability. Surprisingly, all analogues of trans- and cis-11 were both 
identified as selective ETA receptor antagonists and both isomers of 11 were found to be the 
most potent (trans-11: ETA-IC50 = 5.4 nM; cis-11: ETA-IC50 = 4.1 nM) (Figure 5).9b
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Figure 5: Potent endothelin receptor antagonists trans-11 and (S,R,S)-12  
 
1.1.2 SYNTHESIS OF 1,3-DISUBSTITUTED ISOINDOLINES 
Although several syntheses of racemic 1,3-disubstituted isoindolines were reported12, to our 
knowledge only two diastereo- and enantioselective syntheses exist.13 Only one will be 
described, the other following the same strategy and differing only in the structure of the 
chiral auxiliary.  
In his goal to realise novel and interesting chiral systems using C2-symmetrical isoindolines, 
A. I. Meyers et al. reported the synthesis of the 1,3-dialkyl isoindolines (S,S)-18.13a The 
isoindoline 14 was obtained in moderate yield using the Délepine reaction with ortho-xylenyl 
dichloride 13 and hexamethylene tetramine after acidic and basic workup. After construction 
of the chiral compound (S)-16 by refluxing the isoindoline in toluene with the dimethylamino 
formamidine (S)-15, metalation of (S)-16 with n-butyllithium gave an anion which was cooled 
to −100 °C and treated with various electrophiles. After chromatography the monoalkylated 
isoindolines were remetalated in the same conditions to give (S,S,S)-17. Hydrazinolysis gave 
the free chiral C2-symmetric amines (S,S)-18 in good overall yields and very high 
enantioselectivity (Scheme 1). 
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Scheme 1: Asymmetric synthesis of 1,3-dialkyl isoindolines (S,S)-18 by A. I. Meyers et al.a
 
Two diastereoselective syntheses of 1,3-disubstituted isoindolines were also reported.9b,14 
P. J. Kukkola et al. described a regioselective route to highly functionalised 
dibenzoylbenzenes and a methodology for the stereoselective preparation of trans- and cis-
1,3-disubstituted isoindolines trans- and cis-11, two potent selective ETA receptor 
antagonists.9b Oxazoline directed ortho-lithiation of the disubstituted phenyl compound 19 
followed by condensation with 2-benzyloxy-4-methoxybenzaldehyde furnished the resulting 
hydroxyoxazoline intermediate 20. In situ hydrolysis gave the lactone 21 in 70% overall yield 
and subsequent Grignard reaction led to the formation of an unstable hemiketal 22. Oxidation 
by treatment with pyridinium chlorochromate (PCC) provided the desired dibenzoylbenzene 
23, which reacted with ammonium acetate and a catalytic amount of sodium ethoxide to 
afford the hydroxyisoindole derivatives 24 as a 1/1 mixture of regioisomers. This mixture was 
converted nearly quantitatively to the isoindolines 25 by in situ Zn-Cu reduction in the 
presence of glacial acetic acid. The compounds 25 were obtained exclusively as the trans-
isomers (Scheme 2).  
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Scheme 2: Synthesis of the endothelin A receptor antagonist trans-11 by P. J. Kukkola et al.9b 
 
N-alkylation of 25 with ethyl bromoacetate was followed by removal of the benzyl protecting 
group using catalytic hydrogenation to give the ortho-hydroxyaryl isoindolines. Finally, these 
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compounds were converted to the desired trans-dicarboxylic acid 11 in 63% overall yield by 
an alkylation and hydrolysis sequence (Scheme 2). 
The o-hydroxyaryl isoindolines trans-26, obtained previously, were converted quantitatively 
to the thermodynamically more stable cis-isomers 26 by heating trans-26 at 100 °C with a 
catalytic amount of tetra-n-butylammonium iodide. This reaction likely proceeded through a 
quinone-methide type intermediate 27 in which the benzylic carbon-nitrogen bond at the 
isoindoline C-3 had been cleaved. Cyclisation then led to the formation of the more stable cis-
26. Alkylation and hydrolysis under the previously described conditions afforded the cis-
dicarboxylic acid analogues 11. However, the authors stated that the trans- to cis-
isomerisation is limited to isoindoline derivatives possessing an o- or p-hydroxyaryl 
substituent either at C-1 or C-3 (Scheme 3). 
 
N
EtO
O
OMeO
O
EtO2C
27
N
EtO
O
OMeO
OH
EtO2C
n-Bu4NI, 100 °C
cis-26
N
EtO
O
OMeO
OH
EtO2C
trans-26
N
EtO
O
OMeO
O
HO2C
HO2C
cis-11
1. NaH, 
    BrCH2CO2Et
2. NaOH
100%
90%
 
Scheme 3: Synthesis of the endothelin A receptor antagonist cis-11 by P. J. Kukkola et al.b 
 
The nucleoside analogue 29 with the 2',3' double bond incorporated into a benzene ring has 
been synthesised as an analogue of d4T (28), a commercial anti-HIV nucleoside approved by 
the US FDA (Food and Drug Administration).15 Thanks to this modification the substrate 
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should be more resistant to the hydrolytic process that contributes to the short half-life of d4T 
in vivo. Furthermore, this system is very rigid and it has been speculated that the 
conformational restriction imposed by the double bond in d4T might be an important factor in 
its interaction with viral enzymes.16 Recently, C. Len et al. described the diastereoselective 
synthesis of the N-substituted 1,3-disubstituted isoindoline (S)-30.14 This azasaccharide mimic 
could provide an access to a new series of nucleoside analogues with potential as anti 
retroviral agents (anti-HIV) (Figure 6). 
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Figure 6: Commercial anti-HIV d4T (28) and nucleoside analogues 29 and (S)-30 
 
It is interesting to note that some diastereoselective syntheses of 1,1,3,3-tetrasubstituted 
isoindolines were also reported in the field of radical chemistry.17
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1.2 TETRAHYDRO-2-BENZAZEPINES 
In the nomenclature, the 2-benzazepines are related to the 1H-azepine (31), a nitrogen-
containing seven-membered unsaturated heterocycle. As the fused 6,7-ring system possessing 
the nitrogen in the 2-position is known as the 1H-2-benzazepine (32), its tetrahydrogenated 
derivative is called 2,3,4,5-tetrahydro-1H-2-benzazepine (33) (Figure 7).  
 
31
1H-azepine
NH
33
2,3,4,5-tetrahydro-1H-2-benzazepine
H
N N
32
1H-2-benzazepine
1 2
3
4
5
1 2
3
4
5
 
 
Figure 7: Nomenclature for the azepine and the fused 6,7-ring system of 2-benzazepines 
 
1.2.1 STRUCTURE AND BIOLOGICAL ACTIVITY OF TETRAHYDRO-2-BENZAZEPINES 
The tetrahydro-2-benzazepine skeleton is a common structural feature found in a variety of 
naturally occurring and synthetically produced bioactive compounds. For example the 
alkaloid from the Amaryllidaceae family, galanthamine (34),18 which contains a spiro-linked 
benzazepine structure, is currently the most effective experimental drug in the treatment of 
Alzheimer's disease due to its selective inhibiting activity on acetylcholinesterase (Figure 8). 
An evaluation in the year 2000 showed that the illness is not stopped but the symptoms are 
efficiently reduced when galanthamine was given to patients with mild to moderate 
Alzheimer's disease.19  
 
Examples are also found in the ribasine-type alkaloids, which possess a indanobenzazepine 
structure. Ribasine (35), isolated independently in 1983 by L. Castedo et al.20 and M. Shamma 
et al.21 from Sarcocapnos crassifolia and Coryladis claviculata, is the parent compound of 
this new class of alkaloids. Other members of this class are the hydroxy ribasines 
himalayamine (36) and ribasidine (37), and the N-demethyl congener norribasine (38) 
(Figure 8).22 Although this family of alkaloids is not known to possess any particular 
medicinal activity so far, the presence of the reactive 8,14-epoxy-indanobenzazepine ring may 
provide interesting biological responses.  
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Figure 8: Structure of galanthamine and of ribasine-type alkaloids  
 
Another biologically prominent example is the fused 2-amino 9-chloro-7-(2-fluorophenyl)-
5H-pyrimido[5,4-d][2]benzazepine or BBL22 (39), that exhibits very promising antitumour 
activity (Figure 9). In fact in 2000, N. L. Spector reported that 39 promotes apoptosis of 
prostate and certain breast cancer lines (Apoptosis or "programmed cellular death": 
mechanism responsible for the physiological suppression of the cells, indispensible for the 
equilibrium of the body. In some cancers, the cell accumulation promoting the tumours could 
be due to an insufficient apoptosis and not only to an increasing production).23 In addition, 
BBL22 exhibited selectivity in targeting tumour cells while sparing the growth and survival 
of normal cells. The in vivo antitumour activity was examined and 39 significantly reduced 
the growth of prostate tumours without provoking toxicity. The molecule and its analogues 
were patented one year later.24
 
Integrins are surface molecules found on the exterior of cells helping to bind whole cells 
together. In particular integrin αvβ3 has been shown to mediate adhesion of osteoclasts to the 
bone matrix. An osteoclast is a cell that actively reabsorbs old or fatigued bone so that new 
bone may be built up by cells which aid the growth and development of bones (osteoblasts). 
When osteoclasts reabsorb bone faster than the osteoblast cells are producing it, then 
osteroporosis (bone loss) occurs. Therefore, antagonists of integrin αvβ3 are expected to be of 
use in the treatment of several human diseases, including osteoporosis. Integrin αvβ3 is 
known to recognise the arginine-glycine-aspartic acid tripeptide sequence. Therefore W. H. 
Miller et al. investigated peptidomimetic approaches to identify αvβ3 antagonists. In their 
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structure-activity report, incorporation of the 6-(methyl-amino)pyridine as Arg mimetic has a 
significant impact on both biological activity and oral bioavailability. Among the new class of 
2-benzazepine Gly-Asp mimetics, 40 proved to be the more potent inhibitor of bone 
resorption in vitro and in vivo and was active in an animal model of osteoporosis (Figure 9).25  
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Figure 9: Pyrimido-2-benzazepine BBL22 and the Gly-Asp mimetic 2-benzazepine 40 
 
1.2.2 SYNTHESIS OF SUBSTITUTED TETRAHYDRO-2-BENZAZEPINES 
In the literature describing the synthesis of 2-benzazepine derivatives,26 two major approaches 
have been employed. One involves the intramolecular cyclisation of appropriately substituted 
aromatic substrates,27 and the other follows the expansion of smaller rings.27p,28 Concerning 
the 3,4-disubstituted tetrahydro-2-benzazepine derivatives, to our knowledge, only three 
asymmetric syntheses were reported.  
In their search of new podophyllotoxin derivatives, potentially efficient in the treatment of 
tumours, H. Laatsch et al. were interested in the formation of tetrahydro-2-benzazepines by 
hemisynthesis starting with natural podophyllotoxin (41).29 For example, after 
alcohol/chloride exchange with thionyl chloride and treatment with two equivalents of sodium 
azide, a diastereomeric mixture of the 9-azidopodophyllotoxin derivatives 42 was obtained in 
69% yield (Scheme 4). At short reaction times and low concentrations 92% of the dihydro-2-
benzazepine 43 could be obtained by photochemical ring expansion of the azides 42 in 
cyclohexene. Final hydrogenation with palladium on charcoal gave the 3,4,5-trisubstituted 
tetrahydro-2-benzazepine 44 in 92% yield.  
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Scheme 4: Hemisynthesis of tetrahydro-2-benzazepine 44 by H. Laatsch et al.  
 
In their strategy for the total synthesis of (−)-coccinine (50), S. M. Weinreb et al. proceeded 
via a diastereo- and enantiomerically pure 3,4,5-trisubstituted tetrahydro-2-benzazepine.30 The 
aldehyde functionality of the synthesised building block 45 was condensed with 
iminophosphorane 46 to form the corresponding imine 47 (Scheme 5). Upon heating to 
reflux, a stereospecific cyclisation occurred, that is believed to be a thermal imino ene 
reaction. After alkyne desilation, a single stereoisomer of the amino acetylene 48 was 
isolated. This pericyclic process can, in principle, proceed through two imine conformations, 
one of them shown in Scheme 5. However, both lead to the same stereoisomer of the 
cyclisation product. Alkyne 48 was then partially hydrogenated using Lindlar's catalyst to 
generate a terminal olefin. This bromoalkene cyclised under Heck's conditions to form the 
desired tetrahydro-2-benzazepine 49 bearing an exocyclic alkene. From 49 several steps were 
necessary to reach the natural product (−)-coccinine (50). 
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Scheme 5: Key steps in the total synthesis of (−)-coccinine (50) by S. M. Weinreb et al.  
 
Another example for the asymmetric synthesis of 3,4-disubstituted tetrahydro-2-benzazepine 
derivatives was realised by A. G. Griesbeck et al. using photochemistry (Scheme 6).31 After 
photochemical excitation of the phthaloyl leucine ester 51, the Norrish II abstraction of an 
hydrogen in γ-CH-position led to the intermediate 52. Yang cyclisation formed the azetidinol 
53 which opened in a retrotransannular manner to afford the dihydrobenzazepinedione 54. 
Again under photochemical excitation, Norrish II abstraction of an hydrogen in γ-CH-position 
led to the intermediate 55. Yang cyclisation led to the formation of 41% of a single tetrahydro-
2-benzazepinone enantiomer 56 whereas at the same time Norrish II cleavage led to the 
formation of 41% of the dihydrobenzazepinedione 57. 
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Scheme 6: Synthesis of tetrahydro-2-benzazepinone 56 by A. G. Griesbeck et al.  
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1.3 TETRAHYDROPALMATINE 
Tetrahydropalmatine belongs to the protoberberine family, a large class of naturally occurring 
alkaloids possessing antitumour, antimicrobial and other biological activities.32,33 The 
tetrahydroprotoberberines 58 are widespread, occurring in at least eight botanical families. 
They are present most frequently in the various genera of the Papaveraceae, but they also 
appear in the Berberaceae, Menispermaceae, Ranunculaceae, Rutaceae, and Annonaceae 
families.32 They are characterised by a tetracyclic skeleton and an isoquinoline core. Alkoxy 
or hydroxy substituents are always attached to the A- and D-rings. The protoberberines can 
have alkyl or hydroxy substitution at the C-13 position, and they all possess a stereogenic 
centre in C-14 (Figure 10).34
 
N
R1
R2
R6
R5
R4
H
R3
A
D
13
14
58
R1 = OH, OMe; R2 = OMe or R1 + R2 = OCH2O
R3 = H, OH, Me
R4 = H, OH, OMe; R5 = OMe or R4 + R5 = OCH2O
R6 = H, OH, OMe  
 
Figure 10: Structure of the tetrahydroprotoberberine alkaloids 
 
1.3.1 ISOLATION, STRUCTURE AND BIOLOGICAL ACTIVITY OF TETRAHYDROPALMATINE 
Both enantiomers of tetrahydropalmatine as well as the racemate are present in nature. 
Although (+)-tetrahydropalmatine seems to have been isolated as early as 1903,35 it was not 
before 1923 that the structure elucidation of this alkaloid was accomplished by E. Späth et al. 
after its isolation from tubers of Corydalis Cava (Figure 11).36  
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H
59  
 
Figure 11: The protoberberine alkaloid (S)-(−)-tetrahydropalmatine (59)  
 
In addition to the proof of the structure of tetrahydropalmatine by its oxidation to palmatine 
and reverse reduction,36 tetrahydropalmatine was also synthesised from tetrahydroberberine 
(also known as canadine; Figure 10; R1 + R2 = OCH2O; R3, R6 = H; R4, R5 = OMe).37 The 
racemic form was isolated in 1928 from tubers of Corydalis Ambigua38 and the (−)-
enantiomer was extracted in 1933 from Corydalis Aurea39 (Figure 12).  
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Figure 12: Examples of plants containing (S)-(−)-tetrahydropalmatine40
 
The absolute configuration of tetrahydropalmatine, also called corydalis B, gindarine, 
caseanine or rotundine,41 was established in 1956 by H. Corrodi and E. Hardegger.42 The 
absolute configuration of (−)-tetrahydropapaverine (61), a 3-phenyl substituted 
tetrahydroisoquinoline, could be deduced by its oxidation to the L-asparaginic acid derivative 
(−)-60, possessing a known configuration (Figure 13). After reaction of (−)-61 with two 
equivalents of methyl iodide and potassium hydroxide, the salt of 61 was found to be the 
antipode of the salt of (−)-laudanosine. It was concluded that the (−)-tetrahydropapaverine 
16 
INTRODUCTION 
(61) has the same configuration as the natural (+)-laudanosine (62). The absolute 
configuration of many protoberberine alkaloids was finally determined using the known 
relations with (+)-62. Since then, NMR-studies were undertaken to allow the full assignment 
in tetrahydropalmatine43 and the (S) absolute configuration attributed by X-ray analysis of 
(−)-tetrahydropalmatine monohydrate44 confirmed the one reported by H. Corrodi and E. 
Hardegger (Figure 11). 
 
HO2C
HO2C NH
HO2C
NH
MeO
MeO
MeO
MeO
N
MeO
MeO
MeO
MeO
Me
(−)-60
(−)-tetrahydropapaverine 61 (+)-laudanosine 62  
 
Figure 13: Substances used for the configuration determination of tetrahydropalmatine 
 
Among all biological activities attributed to tetrahydropalmatine (59), only three examples 
will be shortly detailed here. The racemic form of 59 was shown to possess an insecticidal 
activity against larvae (LD50 > 8.45 µmol/mL of diet) and adults (LD50 = 6.5 µg/adults) of 
Drosophila melanogaster.45 The (S) enantiomer might be valuable as anti-tumour promoter 
(inhibitory effect on Epstein-Barr virus).46
The (R) enantiomer was shown to be an inhibitor by 46% of the activity of GABA-T 
(γ-aminobutyric acid transaminase).47 GABA is a major inhibitory chemical neurotransmitter 
in the central nervous system of mammals. When the concentration of GABA in the brain 
falls below a certain level, various neurological disorders including epilepsy, seizures, 
convulsions and Parkinsonism may occur. The concentration of GABA in the brain is 
controlled by two enzymes, one of them being the GABA-T. Therefore, the irreversible 
inhibition of GABA-T is the basic action mechanism of drugs used in the treatment of 
convulsive disorders.  
 
1.3.2 ENANTIOSELECTIVE TOTAL SYNTHESES OF TETRAHYDROPALMATINE 
Although 13 syntheses of racemic tetrahydropalmatine have been reported,48 until now only 
three enantioselective syntheses exist.  
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S. G. Pyne et al. reported a total synthesis of (R)-(+)-tetrahydropalmatine (59) as illustration 
of their methodology based on addition of α-sulfinyl carbanions to imines (Scheme 7).49 After 
formation of the 6,7-dimethoxy-3,4-dihydroisoquinoline (64) by reaction of N-formyl 
homoveratrylamine 63 with phosphorous oxychloride, the addition of the lithium salt of 
(R)-(+) methyl p-tolyl sulfoxide led to a mixture of diastereoisomers (de = 84%) in which the 
thermodynamic (S,RS)-65 was favoured. This diastereoselectivity under equilibrium 
controlled conditions was in contradiction with their former observation of modest to good 
diastereoselectivities achieved under kinetic control by addition of lithium carbanions of 
racemic methyl phenyl sulfoxide and (R)-(+) methyl p-tolyl sulfoxide to aryl imines. 
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(S,S)-67
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p-tolyl sulfoxide, THF,
−78 °C to 0 °C
92%
(S,RS)-65
de = 84%
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2. 2,3-dimethoxy-
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    NaCNBH3, MeCN
87%
TFAA, CHCl3,
0 °C then 95 °C
82%
Ra-Ni, H2, EtOH, rt
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H H
 
Scheme 7: Total synthesis of (R)-(+)-tetrahydropalmatine (59) by S. G. Pyne et al. 
 
Separation of the diastereoisomers of tetrahydroisoquinoline 65 followed by reductive 
alkylation with 2,3-dimethoxy-benzaldehyde and sodium cyanoborohydride gave (S,RS)-66 in 
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87% yield. The tetracyclic sulfide (S,S)-67 was obtained as a single diastereoisomer in 82% 
yield by intra-molecular Pummerer reaction upon exposure to trifluoroacetic anhydride and 
subsequent heating. Reductive desulfurisation with Raney nickel furnished (R)-(+)-59 in 92% 
yield (Scheme 7). 
 
In his program towards the asymmetric synthesis of isoquinoline alkaloids A. I. Meyers et al. 
investigated the synthesis of (S)-(−)-tetrahydropalmatine (59).50 Due to the C-9 and C-10 D-
ring substitution pattern in 59 (see Figure 10), the use of the Pictet-Spengler reaction for the 
formation of the berberine bridge was excluded, although it had been successfully used for the 
construction of (−)-norcoralydine (ee = 98.5%) (Figure 10, R1, R2 = OMe, R3, R6 = H, R4, R5 
= OMe).51 Their strategy was based on an asymmetric alkylation of a tetrahydroisoquinoline 
where the nitrogen carried a chiral formamidine substituent. However, an ortho-substituted 
electrophile had to be used here to establish the D-ring substitution present in 
tetrahydropalmatine (59).  
The synthesis of the electrophile started from the commercially available veratric acid (68). 
After transformation of the carboxylic group into an amide functionality using oxalyl chloride 
and dimethyl amine, reduction with lithium aluminium hydride led to the benzylic amine 69 
in excellent yield. 69 was then subjected to directed lithiation using n-butyllithium and the 
resulting anion was treated with paraformaldehyde. The resulting primary alcohol was then 
protected to give the silyl ether in 65% over two steps. The substitution of the amine by a 
chloride using ethyl chloroformate furnished the benzyl chloride 70 in 87% yield (Scheme 8). 
 
OMe
OMe
OHO
68
OMe
OMe
NMe2
69
OMe
OMe
70
1. (COCl)2, DMF (cat.)
2. Me2NH
3. LiAlH4
1. n-BuLi, (CH2O)n 
2. TBSCl
3. K2CO3, ClCO2Et
97% 57%
OTBS
Cl
 
 
Scheme 8: Synthesis of the benzyl chloride electrophile 70 
 
The chiral formamidine (S)-73 was constructed from the tetrahydroisoquinoline 71 by 
formamidine exchange with the (S)-valinol derived chiral auxiliary (S)-72. Lithiation of 73 
was effected with tert-butyllithium at −78 °C. The solution was then cooled to −100 °C and 
treated with electrophile 70. Subsequent removal of the formamidine with hydrazine hydrate 
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gave the protected amino alcohol (S)-74 in 61% yield. The enantiomeric excess was found to 
be 88% after derivatisation with 1-naphtoylchloride. Final closure of the berberine bridge was 
accomplished with triphenylphosphine and bromine to give (S)-(−)-tetrahydropalmatine (59) 
in 65% yield (the ee was not determined) (Scheme 9). The disappointing low 
enantioselectivity, compared to those generally obtained in alkylations of chiral 
formamidines, was explained by a disruption in the formamidine chelate due to chelation of 
the oxygen lone pairs of the silyl ether. It should be noted that prior to 70 another electrophile 
was tested and that delivered a nearly racemic product. 
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VME = (S)-valinol methyl ether
(S)-74
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(by derivatisation)  
 
Scheme 9: Total synthesis of (S)-(−)-tetrahydropalmatine (59) by A. I. Meyers et al.  
 
In 2002, an enantioselective synthesis of (S)-(−)-tetrahydropalmatine, based on the strategy of 
A. I. Meyers et al. but using a silyl-directed Pictet-Spengler cyclisation for the formation of 
the berberine bridge, was described, but the natural product was obtained in only moderate 
enantioselectivity (ee = 55%) in 22% overall yield over 5 steps.52
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1.3.3 TANDEM 1,2-ADDITION/RING CLOSURE SEQUENCE 
An important entry to the isoquinoline heterocycles is the general concept of nucleophilic 
addition/cyclisation first outlined by D. B. McLean et al. in 1983, who obtained 13-hydroxy-
8-oxoprotoberberines from lithiated phthalide anions and 3,4-dihydroisoquinolines.53 In a 
related approach, R. D. Clark et al. pioneered a non-stereoselective tandem 
addition/cyclisation of lithiated 2-methyl-benzamides with imines to yield 3-substituted 
dihydro-2H-isoquinolin-1-ones with low to moderate yields.54 Since then, the lateral 
metalation methodology55 has been applied stereoselectively in moderate yields using 
enantiopure imines,56 or in low yields and good enantioselectivities using racemic imines and 
(−)-sparteine.57 Good overall yields and high enantioselectivities were obtained in a three step 
process using chiral sulfinimines.58 Later, these two concepts were combined and 8-
oxoprotoberberines were assembled upon condensation of ortho-toluamides incorporating 
chiral auxiliaries with 3,4-dihydroisoquinoline in moderate yields and high enantiomeric 
excesses.59 (−)-Sparteine has also been used instead of an auxiliary giving moderate yield and 
low to good enantioselectivity.60  
Recently, D. Enders and V. Braig reported on the first asymmetric synthesis of 3-aryl-
substituted 2,3-dihydro-1H-isoindol-1-ones by 1,2-addition of ortho-lithiated benzamides to 
aldehyde SAMP/RAMP hydrazones.61  
Later it was found that the asymmetric synthesis of the N-amino-substituted 3-phenyl-3,4-
dihydro-2H-isoquinolin-1-one (R,S)-77a was possible by nucleophilic addition of lithiated 
N,N-diethyl-2-methylbenzamide (75) to benzaldehyde SAMP-hydrazone (S)-76a.62 A first 
approach employed 3.5 equivalents of lithiated 75 and the addition to (S)-76a yielded 37% of 
(R,S)-77a (Scheme 10, Table 1, entry 1). The open-chain product resulting from a mere 1,2-
addition reaction could not be detected, indicating that the reaction took place in a tandem 
1,2-addition/ring closure process. As shown in Table 1, the reaction conditions were 
optimised varying the number of equivalents of 75, the metalation and addition temperatures 
and the additive. A large excess of lithiated ortho-toluamide 75 slightly improved the yield 
(entry 1 vs. 2). Various additives like BF3⋅OEt2, LiCl and LiI were examined, but none of 
them was found to have a significant effect on the reaction (entry 3 to 5). When the metalation 
and the addition were conducted at a temperature of −40 °C, the yield could be increased to 
52% (entry 6 vs. 2). By comparison with positive effects during nucleophilic 1,2-addition of 
organolithiums to enantiomerically pure N-sulfinyl ketimines,63 trimethylaluminium as Lewis 
acid was then envisaged. Its presence resulted in the best yield so far (70%, entry 7).  
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Scheme 10: Optimisation of the synthesis of (R,S)-77a by V. Braig  
 
Entry X (eq) Metalation temp. Additive Addition temp. Yield 
1 3.5 −78 °C - −78 °C to rt 37% 
2 10 −78 °C - −78 °C to rt 46% 
3 7 −78 °C BF3·OEt2 −78 °C to rt 21% 
4 5 −78 °C LiCl −78 °C to rt 43% 
5 5 −78 °C LiI −78 °C to rt 31% 
6 7 −40 °C - −40 °C 52%a
7 7 −40 °C AlMe3 −40 °C 70% 
a With RAMP as auxiliary 
 
Table 1: Variation of the conditions for the synthesis of (R,S)-77a by V. Braig  
 
Consequently, the 3,4-dihydro-2H-isoquinolin-1-ones (R,S)-77 were then synthesised under 
the optimised conditions employing the aromatic aldehyde SAMP-hydrazones (S)-76 
(Scheme 11). Moderate to good yields were obtained but the diastereoselectivity of this 
tandem process was always excellent. 
 
Methods for the N−N bond cleavage of the auxiliary were then investigated. The use of 
lithium or calcium in liquid ammonia led to the formation of 3,4-dihydroisoquinolines (R)-78 
(probably after reduction of the carbonyl group and subsequent dehydration) in moderate to 
good yields and in excellent enantiomeric excesses (ee ≥ 95%). In order to obtain 3-
substituted 3,4-dihydro-2H-isoquinolin-1-ones (R)-79, another cleavage method was 
employed that used either magnesium monoperoxyphthalate hexahydrate (MMPP·6H2O) or 
zinc in acetic acid after prior activation of the hydrazine with a methanolic solution of 
hydrochloric acid. The yields were moderate to good for (R)-79, although displaying high 
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enantioselectivity. Access to 3-substituted 1,2,3,4-tetrahydroisoquinolines (R)-80 was easily 
accomplished using an excess of the borane-tetrahydrofuran complex. Every hydrazine (R,S)-
77 was successfully cleaved in moderate to good yields without racemisation. The results are 
summarised in Scheme 12. 
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Scheme 11: Tandem 1,2-addition/ring closure providing the dihydroisoquinolinones (R,S)-77 
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Scheme 12: Conversion to isoquinoline derivatives (R)-78, (R)-79 and (R)-80 by V. Braig  
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2. OBJECTIVES 
 
The projects of the present work are based on three points. 
 
1. A straightforward asymmetric synthesis of 1,3-disubstituted 2,3-dihydro-1H-
isoindoles 81 should be undertaken (Figure 14). Due to their potential as bioactive 
substances, the preparation should allow flexibility in the different substitutions.  
 
NH
R
X
81
*
*
R = alkyl
X = electron-withdrawing group  
 
Figure 14: 1,3-disubstituted 2,3-dihydro-1H-isoindoles 81 
 
2. The first diastereo- and enantioselective synthesis of 3,4-disubstituted 2,3,4,5-
tetrahydro-1H-2-benzazepines 82 was to be performed (Figure 15). Our synthetic 
strategy should allow various 3- and 4-substitutions.  
 
NH
R2
R1
82
R1, R2 = alkyl  
 
Figure 15: 3,4-disubstituted 2,3,4,5-tetrahydro-1H-2-benzazepines 82 
 
The construction of both heterocycles was intended to base on a tandem 1,2-
addition/cyclisation process. This should permit to create the two stereogenic centres of the 
isoindolines 81 and the creation of the second chiral centre in the tetrahydro-2-benzazepines 
82 after formation of the first centre in a previous alkylation step. 
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3. Both enantiomers of the protoberberine alkaloid tetrahydropalmatine ((S)-(−)-59) and 
((R)-(+)-59) were meant to be prepared in enantiomerically pure form by asymmetric 
synthesis (Figure 16). The synthetic strategy should give access to the asymmetric 
total synthesis of most of the protoberberines. The formation of the stereogenic centre 
of the target molecule would proceed via the tandem 1,2-addition/ring closure 
methodology previously developed in our group.62 
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Figure 16: (S)-(−)-and (R)-(+)-tetrahydropalmatine (59) 
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3. RESULTS AND DISCUSSION 
 
3.1 ASYMMETRIC SYNTHESIS OF ISOINDOLINES 
 
3.1.1 RETROSYNTHETIC CONCEPT 
An efficient diastereo- and enantioselective access to isoindolines must be straightforward and 
substitution diversity should be permitted without changing the entire synthetic strategy. 
Taking into account these two parameters, the different diastereomeric 2,3-dihydro-1H-
isoindoles 81 are meant to be accessible in a tandem process from the hydrazones (S)-83. In 
the first step of this sequence the 1,2-addition of an organometallic reagent on the SAMP-
hydrazone would allow the introduction of the first stereogenic centre. A subsequent Michael-
addition of the formed anion onto an olefin, bearing an electron-withdrawing group, should 
promote the ring closure and the formation of the second stereogenic centre. A final N─N 
cleavage of the auxiliary would then lead to the isoindolines 81. The generation of the olefin 
of (S)-83 would be achieved from an aldehyde precursor using the Horner-Wadsworth-
Emmons (HWE) reaction. This will allow tuning either towards the (E)- or the (Z)-isomer to 
detect an eventual difference in behaviour and stereoselectivity. As the hydrazone 
functionality should also be installed on an aldehyde precursor the cheap and commercially 
available o-phthalic dicarboxaldehyde (84) will be used as starting material (Scheme 13). 
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Scheme 13: Retrosynthetic consideration for the asymmetric synthesis of the isoindolines 81 
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3.1.2 SYNTHESIS OF THE TANDEM ADDITION PRECURSOR  
3.1.2.1 FIRST APPROACH: OLEFIN FORMATION FIRST 
At the beginning, the combination of steps generating the Michael acceptor first and then 
introducting the SAMP-hydrazone was chosen for the synthesis of the compounds (S)-83. 
Indeed, the chiral auxiliary, more expensive than the phosphonate, should preferentially be 
employed as late as possible. 
In comparison with the Wittig reaction64 and the Horner reaction65, the Horner-Wadsworth-
Emmons reaction66 has several preparative advantages. First, the isolation of the product is 
facilitated by the water solubility of the phosphate by-product. Furthermore, reaction 
conditions are often available for the preparation of olefin mixtures enriched with either the 
(Z)-67 or (E)-isomers.68 The variety of possible products is large due to a stabilisation of the 
negative charge of the phosphonate carbanion by delocalisation on the P(O) group. In 
addition, the phosphonates react with a wide variety of aldehydes and ketones under mild 
conditions and are also less sensitive to the nature of the base or to atmospheric oxygen. 
Standard HWE-conditions (1.7 eq of the phosphonoacetate, 1.5 eq of NaH, 0 °C to rt) were 
first applied to the o-phthalic dicarboxaldehyde (84) as it was shown to yield ethyl cinnamate 
quantitatively and with complete (E)-selectivity when benzaldehyde and ethyl diethyl 
phosphonoacetate were employed.69 As anticipated, a mixture of monoolefin 85 and diolefin 
86 was obtained when we employed this method to the dialdehyde. However, to our surprise 
the disubstituted compound was the major product formed and the mixture proved to be very 
difficult to separate by column chromatography (Scheme 14, Table 2).  
 
H
O
CO2Et
CO2Et
CO2Et
H
O
H
O
8584 86
table
(EtO)2POCH2CO2Et
 
 
Scheme 14: Attemps for the synthesis of the monoolefin 85 by HWE reaction 
 
R. Neidlein et al. described the synthesis of the monosubstituted alkene 88 from 
diethylphosphono acetic acid ethyl ester and 1,3,5-cycloheptatriene-1,6-dicarbaldehyde (87) 
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(Scheme 15).70 They showed that lowering the temperature to −25 °C was the decisive factor 
for a successful monoolefination. They also stated that, when 0.9 equivalents of the 
phosphonate was used, the yield was reduced to 80% but the monoolefinated product was not 
contamined with the disubstituted product.  
 
CHO
CHO
CHO
CO2Et
(EtO)2POCH2CO2Et,
NaH, −25 °C, 1 h
88%
87 88  
 
Scheme 15: Monoolefination of cycloheptatriene dicarbaldehyde by R. Neidlein et al.  
 
When these conditions were applied to our system, an improvement in the ratio of the 
monoolefinated/diolefinated products in favour of the former was observed allowing a better 
separation. However, only small amounts of the desired product were obtained pure (19% 
yield) showing that the carbonyl groups of o-phthalic dicarboxaldehyde (84) were more 
reactive than in cycloheptatriene dicarbaldehyde 87 (Table 2). Lowering the temperature to 
−40 °C was also attempted to decrease the reactivity even further, but NMR analysis of the 
crude mixture showed no improvements in the ratio of the monoolefinated/diolefinated 
products. 
 
Conditions Results 
(EtO)2P(O)CH2CO2Et (1.7 eq), 
NaH (1.5 eq), THF, 0 °C to rt, 17 h inseparable mixture of 85/86 
(EtO)2P(O)CH2CO2Et (0.9 eq), 
NaH (1.0 eq), THF, −20 °C, 1 h 19% of 85 
 
Table 2: Attempts for the synthesis of the monoolefin 85 by HWE reaction 
 
Pursuing this strategy would only be possible with a protection of one aldehyde functionality 
prior to the HWE-reaction to ensure the formation of a monoolefin. A deprotection would then 
liberate the aldehyde suitable for the formation of the hydrazone (S)-83. However, in order to 
avoid a four step protocol alternative strategy was envisaged: the bromo ethyl cinnamate 91 
should be formed starting from 2-bromobenzaldehyde (89). Transformation of the bromide 
functionality into an aldehyde should lead to the monoolefin 85. 
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For the formation of the 2-bromo-phenyl acrylic acid ethyl ester (91) a variant of the HWE-
olefination, by W. R. Roush and S. Masamune71 and M. W. Rathke72, was used. In the classic 
reaction a strong base such as sodium hydride, potassium tert-butylate or n-butyllithium is 
employed. In the modified procedure, the phosphonate carbanion is produced with the help of 
amine bases in addition to lithium or magnesium salts (chloride or bromide). As base, 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), diisopropylethylamine or triethylamine can be used. 
The addition of a chelating Lewis acid induces the formation of a metal enolate and increases 
the C-H acidity of the methylene group of the phosphonate. The chemical yields obtained by 
this mild method are generally high and a very good (E)-selectivity could be reached. In fact 
the desired product 91 was formed in an excellent yield and with an excellent (E)/(Z)-
diastereoselectivity (Scheme 16). 
The transformation of the bromide functionality by lithium/halogen exchange followed by 
attack on N,N-dimethyl-formamide was attempted to obtain the aldehyde 85. However, none 
of the desired product could be isolated (Scheme 16). 
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Scheme 16: Attempts for the synthesis of the monoolefin 85 by formylation 
 
Another way of inserting an aldehyde functionality was described by M. R. Bryce et al. who 
suceeded in the formylation of the activated methyl ester 92 by Friedel-Crafts reaction with 
aluminium chloride and dichloromethyl methyl ether to form 93 in good yield (Scheme 17).73  
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Scheme 17: Introduction of an aldehyde functionality by M. R. Bryce et al.  
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Unfortunately when these reaction conditions were applied on the deactivated ethyl cinnamate 
(94) to form the desired monoolefinated product, no formation of the desired aldehyde 85 was 
detected (Scheme 18). 
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Scheme 18: Attempts for the synthesis of 85 
 
3.1.2.2 SECOND APPROACH: HYDRAZONE FORMATION FIRST 
Our attempts to synthesise the compounds (S)-83 by forming the Michael acceptor first and 
then introducing the SAMP-hydrazone have failed. We thought that the order for the insertion 
of both functionalities could simply be inverted. An advantage of this combination would be 
that a large quantity of the hydrazone could be prepared and then be transformed into the 
different desired alkenes. 
In this second approach, the SAMP-hydrazone (S)-95 was easily prepared using the standard 
conditions developed in our group.74 The condensation of SAMP with o-phthalic 
dicarboxaldehyde (84) in Et2O at 0 °C, using molecular sieves to remove water, furnished 
(S)-95 in good yield. The aldehyde functionality was then elaborated into the different alkenes 
(S)-83a-d by HWE-reaction with the corresponding phosphonates using either the standard 
conditions or the alternative protocol described above (Scheme 19).  
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Scheme 19: Synthesis of the starting material (S)-83a-d for the synthesis of isoindolines 
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The yields were good to excellent and the (E)-selectivity was satisfactory except for the 
acrylonitrile where the system triethylamine/lithium chloride should have probably been used. 
The results are summarised in Table 3. 
 
X Conditions Product Yield (E)/(Z)a
CO2Et 
(EtO)2P(O)CH2CO2Et (1.7 eq), t-BuOK (1.5 eq), 
THF, rt, 14 h (S)-83a quant. 54/1 
CO2t-Bu 
(EtO)2P(O)CH2CO2t-Bu (1.9 eq), Et3N (1.7 eq), 
LiCl (1.7 eq), CH3CN, 0 °C to rt, 16 h 
(S)-83b 81%b 182/1 
CN (EtO)2P(O)CH2CN (1.7 eq), t-BuOK (1.5 eq), THF, rt, 14 h (S)-83c 74% 4.2/1 
SO2Ph 
(EtO)2P(O)CH2SO2Ph (1.7 eq), Et3N (1.5 eq), 
LiCl (1.5 eq), CH3CN, 0 °C to rt, 21 h 
(S)-83d 67% 56/1 
a Determined by 1H-NMR  
b Over 2 steps 
 
Table 3: Synthesis of the starting material (S)-83a-d for the synthesis of isoindolines 
 
For the synthesis of the phenylsulfonyl vinyl derivative (S)-83d, the preparation of the not 
commercially available phenylsulfonylmethyl-phosphonic acid ethyl ester (97) had to be 
performed before. After oxidation of commercial phenylsulfanylmethyl-phosphonic acid 
diethyl ester (96) with H2O2 in AcOH using the protocol described by S. Müller75 the desired 
phosphonate 97 was obtained in good yield after 3 h reflux (Scheme 20). 
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Scheme 20: Preparation of the sulfone phosphonate 97 
 
3.1.3 SYNTHESIS OF 1,2,3-SUBSTITUTED DIHYDRO-1H-ISOINDOLES 
The tandem reaction to synthesise substituted 2,3-dihydro-1H-isoindoles was first attempted 
with the phenylsulfonyl vinyl SAMP-hydrazone (S)-83d. In fact, the risk of a 1,4-addition 
remains the same for the substrates (S)-83d, the acrylic acid ester (S)-83a-b and the 
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acrylonitrile (S)-83c. However, the use of the latter compounds could lead to a 1,2-addition to 
the ester or the nitrile moiety competing with the desired 1,2-addition to the hydrazone.  
It had been shown that SAMP-hydrazones derived from aldehydes react with organolithium 
reagents in a highly stereoselective manner.76 Our first experiment was performed with 
methyllithium, small enough to avoid any hindrance problems. Two equivalents were used as 
usual in literature76 and a low temperature was maintained to ensure the best 
diastereoselectivity possible (Scheme 21). The analysis of the crude mixture (1H-NMR and 
GC) revealed that the reaction led to the formation of only one product. Purification of a small 
portion of the crude mixture, analysis by NMR- and mass-spectroscopy (m/z (%) = 257 
(M●++1, 100), 256 (M●+, 5)) and comparison with the spectroscopic data available in the 
literature77 allowed the identification of the product as 2-benzenesulfonyl-1H-indene (100). In 
1979, J. J. Eisch et al. reported the regioselective generation of α-lithiated phenyl vinylic 
sulfone species with methyllithium and without any competing Michael additions of 
methyllithium occurring.78 The formation of 100 could thus probably be explained by the 
formation of an intermediate (S)-98 after deprotonation in the α-position of the sulfone, 1,2-
addition of this lithiated species to the hydrazone to give the intermediate (S)-99 and cleavage 
of the C─N bond of the hydrazine (Scheme 21). 
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Scheme 21: Suggested mechanism for the formation of 100 
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Classical organolithium reagents were thus too basic and promoted the abstraction of the α-
vinyl proton of the sulfone. T. Imamoto et al. were the first to recognise that organocerium 
reagents show a lower basicity than organolithium and Grignard reagents.79 In addition 
organocerium reagents derived from organolithium or organomagnesium reagents have 
already been used in the past for the highly diastereoselective 1,2-addition to aldehyde 
SAMP- or related hydrazones to form chiral hydrazines in moderate to good yields.80 S. E. 
Denmark et al. studied the effect of reagent stoichiometry on efficiency and selectivity in the 
addition of the methyllithium/cerium chloride system to the chiral hydrocinnamaldehyde 
SAMEMP-hydrazone. They found that the 1/1 reagent showed the highest selectivities and 
yields for all equivalents of available methyl nucleophiles.80f Furthermore, it was postulated 
that one equivalent of the organocerium species chelates with the methoxy group of the 
pyrrolidin ring of the SAMP moiety and the imino nitrogen atom of the hydrazone while 
another equivalent effectively adds to the CN double bond of the hydrazone.81  
According to these results, two equivalents of the methyllithium/cerium chloride system (1/1) 
were added at −100 °C to a solution of the phenylsulfonyl vinyl SAMP-hydrazone (S)-83d. 
We were pleased to see that 9% of the desired N-substituted isoindoline 101a could be 
obtained even if together with 59% of recovered starting material (Scheme 22, Table 4, entry 
1). In the molecule (S)-83d, in addition to the imino nitrogen atom and the methoxy group of 
the SAMP-hydrazone, the oxygen atoms of the sulfone group were two other potential cerium 
coordination sites, due to the high oxophilicity of cerium,79b and this could explain that 
starting material was recovered. The amount of the lanthanide nucleophile was then increased 
to five equivalents which increased the yield to 32% (Entry 2). Although it was impossible to 
determine the diastereoselectivity of these reactions by analysis of the crude mixture it should 
be noted that the presence of a diastereoisomer was detected when 101a was purified by 
column chromatography. Nevertheless, both diastereoisomers were separable and 101a could 
be obtained in high diastereoselectivity.  
Organoytterbium reagents have shown an improvement in the yield and diastereoselectivity 
for certain nucleophile/substrate combinations compared to organolithium or organocerium 
reagents.82 Three equivalents of the methyllithium/ytterbium chloride system (1/1) were 
employed in our reaction system but starting material was entirely recovered suggesting that 
the organoytterbium species was too big and blocked the nucleophilic attack (Entry 3). 
Another possible explanation was that the 'RYbCl2' species did not add to the hydrazone CN 
double bond. In fact, J. Tiebes reported that species of the type 'YbR3' were needed for the 
1,2-addition in his system.82a  
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In 1997, S. Kobayashi reported preferential nucleophilic additions (silyl enol ethers, ketene 
silyl acetals, allyltributylstannane or cyanotrimethylsilane) to aldimines in the presence of 
aldehydes with catalytic amounts of ytterbium triflate by selective formation of an aldimine-
Yb(OTf)3 complex.83 It was also shown that silyl enol ethers or tetraallyltin add to benzoyl 
hydrazones with a catalytic amount of scandium triflate to furnish the corresponding 
hydrazines in moderate to excellent yields.84 Moreover, scandium triflate also catalysed the 
addition of organomagnesium to aldimines85. A catalytic amount of ytterbium triflate could 
selectively complex to the imino nitrogen atom of the hydrazone (S)-83d and promote the 
addition of one equivalent of methyllithium. In our plan, a future experiment was also in 
perspective with the olefin substituted by an ester functionality as in (S)-83a and (S)-83b. 
Since the addition of the nucleophile could occur to several reactive sites in those substrates, 
the presence of Yb(OTf)3 could help to direct the attack to the hydrazones of those substrates. 
The addition of methyllithium in presence of a catalytic amount of ytterbium triflate did not 
lead to any addition after 3 hours at −78 °C in toluene85 and interestingly 100 could not be 
detected (Entry 4).  
The use of an organocerium species derived from ethyl magnesiumbromide was also tested 
but led to a complex mixture of products lacking the desired product (Entry 5). To evaluate 
the range of substituents tolerated by this tandem process two other alkyllithiums in 
conjunction with cerium chloride were tested. With tert-butyllithium the starting material was 
recovered quantitatively suggesting that the organocerium reagent was too bulky to perform a 
1,2-addition (Entry 6). For n-butyllithium 47% of the desired isoindoline 101b was obtained 
in excellent diastereomeric excess (Entry 7). Due to decomposition during the GC analysis 
only a purity of 77% could be found. No other estimation of the purity was undertaken. 
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Scheme 22: Synthesis of N-substituted 1,3-disubstituted 2,3-dihydro-1H-isoindoles 101 
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Entry R Conditions Product Yield  dea  
1 Me MeLi/CeCl3 (2 eq), THF, −100 °C to rt, 22 h (S)-101a
9% 
+ 59% (S)-83d ≥ 96% 
2 Me MeLi/CeCl3 (5 eq), THF, −100 °C to rt, 40 h (S)-101a 32% ≥ 96% 
3 Me MeLi/YbCl3 (3 eq), THF, −100 °C to rt, 22 h - starting material - 
4 Me MeLi (1 eq), Yb(OTf)3 (0.2 eq),toluene, −78 °C, 3 h - starting material - 
5 Et EtMgBr/CeCl3 (3 eq), THF, −100 °C to rt, 18 h - 
complex mixture 
of products - 
6 t-Bu t-BuLi/CeCl3 (3 eq), THF, −100 °C to rt, 41 h - starting material - 
7 n-Bu n-BuLi/CeCl3 (3 eq), THF, −50 °C to rt, 18 h 
(R)-
101bb 47% (min.) ≥ 96% 
a Determined by 1H-NMR after column chromatography  
b With RAMP as auxiliary 
 
Table 4: Tandem 1,2-addition/Michael-addition/ring closure for the formation of 101 
 
To widen the scope of the substituents at the olefin, the combination methyllithium/cerium 
chloride was applied to the acrylic acid tert-butyl ester SAMP-hydrazone (S)-83b, less 
prompted to a 1,2-addition to the ester moiety than the ethyl ester 83a (Scheme 23). After 
reaction with 5 equivalents of this system, the isoindoline 102 was not formed but the product 
(S)-103 was obtained in 63% yield (from GC analysis) (Table 5). This product, identified 
from the NMR-analysis of the crude mixture, resulted from a double addition of 2 methyl 
groups to the ester functionality. In fact, T. Imamoto showed that the strong carbonylophilicity 
of the organocerium reagents results in the exclusive formation of 1,2-addition products with 
α,β-unsaturated carbonyl compounds.79d In addition, an attempt using a catalytic amount of 
ytterbium triflate in combination with methyllithium was performed. A selective 
complexation of the triflate with the hydrazone was expected to promote the 1,2-addition of 
methyllithium to the hydrazone. This experiment mostly left (S)-83b untouched (Table 5). 
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Scheme 23: Attempted formation of the isoindoline 102 
 
Conditions Resultsa
MeLi/CeCl3 (5 eq), THF, −100 °C, 3 h 63% of (S)-103 
MeLi (1 eq), Yb(OTf)3 (0.2 eq), THF,  
−100 °C to −78 °C, 17 h 
81% of (S)-83b 
+ 7% of (S)-103 
a Determined by GC analysis of the crude mixture 
 
Table 5: Conditions of the attempts for the formation of isoindoline 102 
 
3.1.4 TOWARDS THE SYNTHESIS OF 1,3-SUBSTITUTED DIHYDRO-1H-ISOINDOLES 
After the 1,2-addition/ring closure only the cleavage of the chiral auxiliary remained to 
accomplish the synthesis of the desired 1,3-disubstituted 2,3-dihydro-1H-isoindoles 81. It is 
noteworthy that among the large variety of methods offered to cleave the N─N bond, some of 
the procedures are efficient exclusively with an α-carbonyl hydrazine or, if there is no 
carbonyl group, with an hydrazine activated by a carbamate function (cleavage by samarium 
diiodide,86 magnesium monoperoxyphtalate hexahydrate,61,87 lithium in liquid 
ammonia).76a,f,80a-c,g,88  
For our synthesis the methods allowing the cleavage of hydrazines without neighbouring 
carbonyl group should be used (Scheme 24). The cleavage of tetrasubstituted hydrazines 
using an excess of borane-THF complex was published by C. Kibayashi.89 However, in our 
case only starting material was recovered when quenching the reaction with methanol as well 
as with hydrochloric acid (Table 6). Following the procedure described by M. Klatt90 a 
reductive cleavage by means of Raney nickel was also attempted as it was shown to cleave 
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inactivated tri- and tetrasubstituted hydrazines.76d,g,80d,91 Unfortunately, probably due to the 
mild conditions, the starting material stayed untouched (Table 6). 
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Scheme 24: Attempted N─N cleavage of the auxiliary 
 
Conditions Results 
BH3·THF (10 eq), THF, ∆, 4 h 
then MeOH, ∆, 2 h starting material 
BH3·THF (20 eq), THF, ∆, 20 h 
then 1 N HCl, ∆, 1 h starting material 
Ra-Ni, H2, ))), MeOH, rt, 24 h starting material 
 
Table 6: Conditions of the attempts for the N─N cleavage of the auxiliary 
 
For time reasons the attempts for the cleavage of the chiral auxiliary were abandoned. 
However, some possibilities for this step remained, e. g. zinc in acetic acid92 or a preactivation 
of the hydrazines with methoxycarbonyl chloride before using standard conditions such as 
Raney nickel.93
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3.2 TOWARDS THE ASYMMETRIC SYNTHESIS OF TETRAHYDRO-2-
BENZAZEPINES 
 
3.2.1 RETROSYNTHETIC CONCEPT 
The aim of this project was the first diastereo- and enantioselective synthesis of 3,4-
disubstituted 2,3,4,5-tetrahydro-1H-2-benzazepines 82. Our synthetic strategy should allow a 
broad range in the 3- and 4-substitution. The desired tetrahydro-2-benzazepines 82 could 
result from reduction and N─N bond cleavage of the chiral auxiliary of the N-substituted 
tetrahydro-2-benzazepinone 104. The construction of this precursor should rely on a tandem 
1,2-addition/ring closure sequence. Thus, the 1,2-addition of an organometallic reagent to 
SAMP-hydrazone (S)-105, bearing a stereogenic centre in α-position, would introduce the 
second stereogenic centre in the molecule. The anion generated in this process should 
promote a subsequent ring closure with an amide or an ester functionality installed on the 
phenyl ring. The precursor 105 should be formed by α-alkylation of an aliphatic aldehyde 
SAMP-hydrazone (S)-106 with a benzyl halide 107 substituted in ortho-position by an ester 
or an amide (Scheme 25). 
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Scheme 25: Retrosynthetic analysis for disubstituted tetrahydro-2-benzazepines synthesis 
 
38 
RESULTS AND DISCUSSION 
3.2.2 SYNTHESIS OF THE ELECTROPHILES 
For the first step in the synthesis of our first electrophile a protocol developed by 
D. C. H. Bigg et al. for the aluminium chloride mediated aminolysis of lactones was 
repeated.94 The authors reported that for optimal yields at least one equivalent of aluminium 
chloride and two equivalents of the amine have to be employed, consistent with a mechanism 
involving the formation of an amine-aluminium chloride complex which activates the lactone 
towards an attack by the second equivalent of the amine. Phthalide (108) was reacted with an 
excess of aluminium chloride and diethylamine to give the desired 2-hydroxymethyl 
benzamide 109 in a excellent yield of 96% representing an improvement of 15% compared to 
the reported yield (Scheme 26). 
Replacement of the hydroxyl group with a bromine functionality was accomplished using the 
carbon tetrabromide/triphenylphosphine system,95 an extension of the method described by 
R. Appel.96 The 2-hydroxymethyl benzamide 109 was allowed to react with 2.3 equivalents of 
triphenylphosphine and carbon tetrabromide to give the desired 2-bromomethyl benzamide 
107a in 66% yield (Scheme 26). This relatively low yield, compared to the high yields 
generally obtained with the Appel's method, could be explained by the fact that the 
benzylbromide 107a slowly transforms, even at −25 °C, into the corresponding imidate salt. 
However, as the salt is insoluble in THF, 107a can be obtained in pure form. 
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Scheme 26: Synthesis of the bromomethyl benzamide electrophile 107a 
 
The synthesis of the second electrophile also started from the commercially available 
phthalide (108). After transformation into its corresponding sodium 2-hydroxymethyl 
benzoate by reflux with an aqueous solution of NaOH and drying under high vacuum, the salt 
of was converted to an ester using ethyl iodide. Alcohol/bromide exchange was readily 
achieved using the Appel's conditions detailed above. The desired electrophile 107a was 
obtained in good yield (53%) for this three step sequence (Scheme 27). 
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We also tried to reduce the synthesis of this electrophile to only one step by repeating the 
protocol of R. F. Pratt et al. describing the radical bromination of the ethyl o-toluate (110) in 
a Wohl-Ziegler-type reaction.97 Thus, a catalytic amount of dibenzoyl peroxide was used as 
initiator and the benzylic radical derived from 110 reacted with N-bromosuccinimide to give 
the benzylbromide 107b. The flask was irradiated with visible light from a 150 W tungsten 
lamp while the mixture was heated under reflux to prolong the propagation of the reaction. 
However, we were unable to reproduce the literature result and 107b was only obtained in 
37% yield (Scheme 27). 
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Scheme 27: Syntheses of the electrophile 2-bromomethyl benzoic acid ethyl ester (107b) 
 
The synthesis of the third electrophile simply consisted in a bromide/iodine exchange using 
Finkelstein's reaction on the bromide 107b. Thus, the benzylbromide was reacted with an 
excess of NaI in acetone and the benzyliodide 107c was obtained in nearly quantitative yield 
(Scheme 28). 
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Scheme 28: Synthesis of the electrophile 2-iodomethyl benzoic acid ethyl ester (107c) 
 
3.2.3 FORMATION OF THE TANDEM PRECURSOR BY α-ALKYLATION 
To evaluate our synthetic strategy, the propanal SAMP-hydrazone (S)-106a was chosen as 
model nucleophile in the α-alkylation to form the tandem precursor 105. In fact its easy access 
and its good 'behaviour' in standard α-alkylations74 make it the reagent of choice for the 
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optimisation of the reaction. (S)-106a was obtained in excellent yield by condensation of 
propanal and SAMP using the conditions described above (3.1.2.2) (Scheme 29). 
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Scheme 29: Synthesis of the propanal SAMP-hydrazone (S)-106a 
 
3.2.3.1 ATTEMPTS OF AN α-ALKYLATION USING ELECTROPHILE 107a 
The α-alkylation was first attempted with the 2-bromomethyl benzamide 107a. The propanal 
SAMP-hydrazone (S)-106a was deprotonated with LDA at 0 °C within 4 h before two 
equivalents of the electrophile were added at −100 °C. The temperature was allowed to warm 
up to room temperature during the 20 hours of reaction time. A complex mixture of products 
was obtained in which starting materials and traces of the desired product (S,S)-105a could be 
identified (Scheme 30, Table 7).  
In order to increase the yield we thought to let the lithiation of (S)-106a be followed by the 
addition of a supplementary equivalent of n-butyllithium in order to deprotonate the formed 
diisopropylamine. The advantage of this protocol was reported by J. Tiebes who demonstrated 
that the yield of the alkylation of the TBS-protected 5-hydroxy pentanal SAMP-hydrazone 
with methyl iodide could be increased from 58% to 78% when changing from a simple 
lithiation to an additional deprotonation.88b Unfortunately this protocol did not lead to further 
improvements (Table 7). 
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Scheme 30: Attempted formation of (S,S)-105a 
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Conditions Results 
LDA (1.1 eq), 0 °C, 4 h 
then 107a (2.0 eq), −100 °C to rt, 20 h traces of (S,S)-105a 
LDA (1.1 eq), 0 °C, 4 h 
then n-BuLi (1.1 eq), 0 °C, 1 h 
then 107a (2.0 eq), −78 °C, 16 h 
traces of (S,S)-105a 
 
Table 7: Conditions attempted for the synthesis of (S,S)-105a 
 
3.2.3.2 SYNTHESIS OF THE α-ALKYLATED PRODUCT 
It was obvious that the access to the bromide was hindered by the presence of the N,N-diethyl 
amide group and that the two electrophiles 107b and 107c, only substituted by a ethyl ester 
group, had now to be tested then.  
After deprotonation of (S)-106a with LDA at 0 °C, 1.4 equivalents of the benzylbromide 107b 
were added keeping the reaction at −78 °C for 8 hours. Under these conditions 32% yield of 
the desired product (S,S)-105b was obtained with an excellent diastereomeric excess of 96% 
(Scheme 31, Table 8). We then turned to the electrophile 107c to see if the iodide was more 
reactive towards the α-alkylation. By using nearly the same conditions for the α-alkylation as 
for the benzylbromide 107b the yield was very close (30%) showing that in these conditions 
the reactivity of the halide functionality did not play a key role (Table 8). The temperature 
was also a parameter to vary in order to increase the yield of the alkylation. The reaction was 
then performed with the benzyliodide at −100 °C and the temperature was slowly increased 
overnight. An improved yield (59%) was observed with no change concerning the excellent 
diastereoselectivity (Table 8). 
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Scheme 31: Synthesis of the tandem reaction precursor (S,S)-105b 
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Electrophile Conditions Yield dea
107b LDA (1.0 eq), 0 °C, 17 h then 107b (1.4 eq), −78 °C, 8 h 32% ≥ 96% 
107c LDA (1.0 eq), 0 °C, 19 h then 107c (1.1 eq), −78 °C, 21 h 30% n. d. 
107c 
LDA (1.1 eq), 0 °C, 18 h 
then 107c (1.05 eq), −100 °C, 4 h then −100 °C to rt, 18 
h 
59% ≥ 96% 
a Determined by 1H-NMR after column chromatography 
 
Table 8: Conditions for the synthesis of the tandem precursor (S,S)-105b 
 
3.2.4 ATTEMPTS FOR THE TANDEM 1,2-ADDITION/RING CLOSURE SEQUENCE 
A first experiment, using the tandem precursor (S,S)-105b and two equivalents of 
methyllithium at −100 °C and warming up the reaction overnight, did not give any of the 
desired product (R,S,S)-104a (Scheme 32). Instead 41% of ketone (S,S)-112 and 29 % of 
alcohol (S,S)-113 could be isolated showing that the ester functionality on the phenyl ring was 
more reactive than the hydrazone (Figure 17, Table 9). In a second test reaction the use of an 
organocerium reagent was investigated as it could activate the hydrazone compared to the 
ester. Two equivalents of a methyllithium/cerium chloride system were used maintaining the 
temperature at −100 °C over 5 h. Unfortunately, only starting material and alcohol (S,S)-113 
could be isolated showing that the cerium, due to its oxophilicity, preferentially activates the 
ester to allow a double addition of the nucleophile (Figure 17, Table 9). 
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Scheme 32: Attempts for the synthesis of (R,S,S)-104a 
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Figure 17: Products obtained in the 1,2-addition of (S,S)-105b 
 
Conditions Results 
MeLi (2.0 eq), THF, −100 °C, 5 h 
then −100 °C to rt, 16 h 41% of (S,S)-112 + 29% of (S,S)-113 
MeLi/CeCl3 (2.0 eq), THF, −100 °C, 5 h 40% of (S,S)-113 + 20% starting material 
 
Table 9: Conditions of the attempts for the synthesis of (R,S,S)-104a 
 
Taking into account that a tandem 1,2-addition/ring closure sequence could not be perfomed 
on our precursor (S,S)-105b, only a complete change in the synthetic strategy could lead to the 
synthesis of 3,4-disubstituted 2,3,4,5-tetrahydro-1H-2-benzazepines 82. Our project was then 
abandoned. 
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3.3 ASYMMETRIC SYNTHESIS OF TETRAHYDROPALMATINE 
 
In the protoberberine family the substitutions of the A ring are always situated at the same 
positions whereas the substitution pattern of the D ring can slightly vary. In many reported 
formal or total syntheses the ring closure was effected between the isoquinoline core, 
containing the A ring, and the D ring using for example a Pictet-Spengler reaction. Thus, the 
synthesis of the tetrahydropalmatine was rendered difficult, the positions of the methoxy 
substituents favoring another product in this type of ring closure reactions (see 1.3.2).  
Our initial thought was to design the synthetic strategy in a way that the asymmetric total 
synthesis of most of the protoberberines was possible. To achieve this goal, the ring closure 
should be done between the isoquinoline core with the D ring bearing the correct methoxy 
substitution pattern, and the A ring. First the total synthesis of tetrahydropalmatine was 
chosen to show that this molecule was also accessible by our synthesic strategy (Figure 18). 
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Figure 18: (R)-(+)- respectively (S)-(−)-tetrahydropalmatine 
 
3.3.1 RETROSYNTHETIC CONCEPT: REDUCTIVE AMINATION 
The target molecules (R)-(+)- and (S)-(−)-tetrahydropalmatine (59) should be obtained after 
ozonolysis, deprotection and reductive amination of the precursor 114. This protected 
tetrahydroisoquinoline should be substituted in the 3-position by a phenyl bearing an allyl 
chain in ortho-position. The correct methoxy substitution pattern in 59 would be assured by 
this fixed substitution during the ring closure. The construction of 114 could derive from the 
N-substituted 3-phenyl substituted dihydroisoquinolinone 115 after N─N cleavage of the 
chiral auxiliary, reduction of the amide functionality and protection of the resulting free 
amine. However, in order to introduce the allyl chain the protected amine derived from 115, 
substituted by a bromide, would have to be submitted to an additional Stille-coupling with 
allyltributylstannane. As a supplementary option the allyl chain could also be introduced into 
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the protected amine derived from 115 and substituted by a methyl group, which should first 
be transformed into a benzylic bromide by radical bromination in order to be submitted to a 
Stille-coupling with vinyltributylstannane. The generation of the dihydroisoquinolinone 
precursor 115 should be based on the tandem 1,2-addition/ring closure methodology 
developed by V. Braig62 leading to the 2,3-dimethoxy-6-methyl-benzamide 117 and the 3,4-
dimethoxy benzaldehyde SAMP- rsp. RAMP-hydrazone 116 ortho-substituted either by an 
allyl chain, a bromide or a methyl group (Scheme 33). 
 
N
H
OMe
MeO
OMe
OMe
Me
OMe
MeO
O
NEt2
(R)-(+)- rsp. (S)-(−)-59
H
N
OMe
R2N
OMe
X
NPG
OMe
MeO
OMe
OMe
N
OMe
OMe
MeO
O
NR2
X
OMe
*
*
*
*
117
114
*
116
X = allyl, Br, Me 115
X = allyl, Br, Me
 
Scheme 33: Retrosynthetic concept for (R)-(+)- and (S)-(−)-59 by reductive amination 
 
3.3.1.2 MODEL STUDY: SYNTHESIS OF THE STARTING MATERIALS FOR THE TANDEM PROCESS  
 
Our retrosynthetic strategy was based on the tandem 1,2-addition/ring closure process as key 
step. It was then necessary to evaluate in a model study the possibilities in terms of yield and 
diastereoselectivity offered by a reaction between the simple 2-methyl benzamide 75 and the 
2-substituted benzaldehyde SAMP-hydrazone (S)-118a, (S)-118b or (S)-118c (Scheme 34). 
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Scheme 34: Model study for the evaluation of the synthetic strategy  
 
As 2-allyl benzaldehyde is not commercially available it was necessary to synthesise it in the 
shortest possible route to minimize the number of steps of our future total synthesis.  
The ethylene glycol acetal 120 was formed, using the Noyori variant98, by reaction of the 
2-bromo-benzaldehyde (89) with TMS-protected ethylene glycol catalysed by trimethylsilyl 
trifluoromethanesulfonate (TMSOTf). The very good yield of 94% represented a slight 
improvement of the reaction described in the literature with p-toluenesulfonic acid and 
ethylene glycol under azeotropic removal of the water formed during the reaction.99  
We then thought to use palladium catalysis to introduce the allyl chain. The bromide 120 was 
submitted to a Stille-coupling with allyltributylstannane and a catalytic amount of active 
tetrakistriphenylphosphinepalladium(0) in hot toluene. A yield of 68% was obtained for the 
desired compound 121 (Scheme 35). 
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Scheme 35: Synthesis of the allyl-substituted acetal 121 
 
For comparison, the synthesis of the 2-allyl benzaldehyde (122) was achieved repeating a 
protocol that J. A. Kampeier et al. had described.99 After lithium/halogen exchange of the 
bromide 120 with n-butyllithium at −78 °C, a stoichiometric amount of HMPA was added. 
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The lithiated species was then transmetalated at −50 °C with the copper bromide-dimethyl 
sulfide complex. The reductive elimination was performed with allyl bromide at −20 °C. The 
deprotection of the crude allyl compound was realised using a catalytic amount of para-
toluene sulfonic acid in a hot mixture of 1,4-dioxane and water. The pure 2-allylbenzaldehyde 
(122) was obtained in a moderate yield of 51% and despite several attempts we were not 
successful to reproduce the yield of 80% described by the authors (Scheme 36).  
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Scheme 36: Synthesis of 2-allyl benzaldehyde (122) 
 
The synthesis of the SAMP-hydrazones (S)-118a, (S)-118b and (S)-118c were achieved in 
excellent yield by condensation of SAMP with the corresponding benzaldehydes 122, 89 and 
123 in Et2O using molecular sieves to remove the water formed during the reaction 
(Scheme 37). 
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Scheme 37: Synthesis of the 2-substituted benzaldehyde SAMP-hydrazones 
 
The 2-methylbenzamide 75 required for the tandem 1,2-addition/ring closure was synthesised 
using the protocol developed by V. Braig.62 Diethylamine was added to the commercially 
available 2-methyl benzoyl chloride (124) using triethylamine as a proton sponge that formed 
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a salt with the HCl gas formed during the reaction. The reaction occured immediately and 
yielded the desired product in 82% yield (Scheme 38). 
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Scheme 38: Synthesis of the 2-methyl benzamide 75 
 
3.3.1.2 MODEL STUDY: ATTEMPTS FOR THE TANDEM 1,2-ADDITION/RING CLOSURE SEQUENCE 
Having in hand all necessary components, we performed the tandem reaction process. 
7 equivalents of the 2-methyl benzamide 75 were deprotonated using an equimolar amount of 
LDA at −45 °C or −78 °C to minimise the risk of self condensation.55a The lithiated species 
was then reacted with the 2-substituted benzaldehyde SAMP-hydrazones (S)-118a, (S)-118b 
or (S)-118c previously complexed with AlMe3 at −40 °C (Scheme 39, Table 10). 
However, even under optimised conditions,62 we could not detect the dihydroisoquinolinone 
(R,S)-119a. Instead we isolated a complex mixture of products containing some starting 
material together with its isomer the (2E)-2-propenyl benzaldehyde SAMP-hydrazone. For the 
bromide substituted SAMP-hydrazone (S)-118b, only 11% of the dihydroisoquinolone 
(R,S)-119b could be isolated in an excellent diastereoselectivity of 96%. By comparing this 
result with the 65% yield previously obtained62 with the para-bromobenzaldehyde SAMP-
hydrazone (S)-76 (see 1.3.3), we conclude that the bromide was too bulky as ortho-substituent 
and that we should obtain a better result using a smaller substituent. In fact a slight increase in 
the yield of this reaction was observed switching from the bromide to the methyl substituent. 
This time the tandem 1,2-addition/ring closure between 2-methyl benzamide 75 and the 2-
methylbenzaldehyde SAMP-hydrazone (S)-118c gave 27% of the desired 
dihydroisoquinolone (R,S)-119c with a diastereomeric excess beyond 96%. 
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Scheme 39: Synthesis of the N-substituted 3-substituted dihydroisoquinolinone (R,S)-119 
 
X Conditions Product Yield dea
allyl LDA (7.0 eq), THF, −45 °C then (S)-118a, AlMe3 (1.1 eq), THF, −40 °C, 17 h - 
complex 
mixture - 
Br LDA (7.0 eq), THF, −45 °C then (S)-118b, AlMe3 (1.1 eq), THF, −40 °C, 16 h (R,S)-119b 11% ≥ 96% 
Me LDA (7.0 eq), THF, −78 °C then (S)-118c, AlMe3 (1.1 eq), THF, −40 °C, 20 h (R,S)-119c 27% ≥ 96% 
a Determined by 1H-NMR after column chromatography 
 
Table 10: Conditions for the synthesis of the dihydroisoquinolinones (R,S)-119b-c 
 
This series of reactions showed that the system did not tolerate any ortho-substitution on the 
benzaldehyde SAMP-hydrazone. The best yield, obtained for the methyl substituent (27%) in 
our model system, was far too low as second and key step in a total synthesis. Our synthesis 
strategy should be reviewed and include a ring closure of the tetrahydropalmatine core which 
did not require the help of an ortho-substituent on the phenyl ring of our 3-substituted 
dihydroisoquinolone system. 
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3.3.2 RETROSYNTHETIC CONCEPT: NITROGEN FUNCTIONALISATION-RING CLOSURE-
REDUCTION 
In this approach, the target molecules (R)-(+)-59 or (S)-(−)-59 should be obtained from a 
dihydroisoquinolinone precursor 125 bearing on the nitrogen an acetyl group substituted with 
a chloride or a sulfoxide. After a Friedel-Crafts or a Pummerer reaction, securing the correct 
position of the methoxy substitution pattern during the ring closure, the reduction of the two 
carbonyl groups present in the molecule should lead to 59. The introduction of the acetyl 
chain could be done in a nitrogen functionalisation of the dihydroisoquinolinone 126 with the 
corresponding acetyl chloride. The 3-phenyl substituted dihydroisoquinolin-1-one 126 would 
be obtained using the tandem 1,2-addition/ring closure between the 2-methyl benzamide 117 
and the benzaldehyde SAMP- or RAMP-hydrazone 127, lacking ortho-substitution, both 
bearing the correct methoxy substitution patterns. Subsequent removal of the chiral auxiliary 
should lead to 126 (Scheme 40). 
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Scheme 40: Retrosynthetic concept via nitrogen functionalisation-ring closure-reduction 
 
Again the feasibility of our synthetic strategy was first tested by performing all reactions 
without the methoxy substituents on the aromatic rings. 
51 
RESULTS AND DISCUSSION 
3.3.2.1 MODEL STUDY: OPTIMISATION OF THE TANDEM 1,2-ADDITION/RING CLOSURE 
SEQUENCE 
Already having in hands the necessary 2-methyl-benzamide 75 we only needed to synthesise 
the benzaldehyde SAMP- and RAMP-hydrazones, respectively (S)-76a and (R)-76a to 
perform the tandem reaction. This was easily achieved, using the same conditions as 
described above (see 3.1.2.2), by condensation of SAMP respectively RAMP with 
benzaldehyde 128. Both enantiomers were obtained in excellent yields (Scheme 41) 
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Scheme 41: Synthesis of the SAMP- and RAMP-hydrazones (S)-76a and (R)-76a 
 
At this point an optimisation of the tandem process was necessary to ensure the best yield in 
our key step. When performing the reaction several times we noticed that the yield was hardly 
reproducible. Until now only the number of equivalents of 2-methyl benzamide 75 had been 
optimised and some Lewis acids had been tested but a rational variation of some parameters 
such as temperature or solvent had not been realised yet.62  
First the metalation temperature as well as some new additives were evaluated in the tandem 
reaction (Scheme 42, Table 11). A slightly increased yield was observed in the reaction with 
the trimethylaluminium Lewis acid by switching the metalation temperature of the 2-methyl 
benzamide 75 from −45 °C to −78 °C (Entry 1 vs. 2, Table 11). We first thought that the 
differences in the yield were due to an addition of a methyl group of the trimethylaluminium 
to the hydrazone during the complexation period consistent with the gas emission observed 
during the addition of the Lewis acid. Therefore, Al(i-Bu)3, was chosen for its bulkiness in 
order to prevent any addition to the hydrazone during the complexation. This attempt only 
gave rise to 16% of the desired product. In spite of our expectations, a bubbling and an 
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exothermic reaction during its addition showed its even bigger reactivity towards the 
hydrazone (Entry 3). Two other Lewis acids which should not add to the hydrazone were 
tested but trimethylsilyltriflate (TMSOTf) gave only 31% of the product (Entry 4) and 
ytterbium triflate (Yb(OTf)3) led to a yield of 50% (Entry 5). As the yields with trimethyl 
aluminium and ytterbium triflate were similar, both were evaluated in the variation of the next 
parameter. 
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Scheme 42: Variation of the metalation temperature and the additive 
 
Entry Metalation Temp. Additive Yield dea
1 −45 °C AlMe3 30-56% ≥ 96% 
2 −78 °C AlMe3 52-61% ≥ 96% 
3 −45 °C Al(i-Bu)3 16% ≥ 96% 
4 −45 °C TMSOTf 31%b ≥ 96% 
5 −78 °C Yb(OTf)3 50% ≥ 96% 
a Determined by 1H-NMR after column chromatography 
b With RAMP as auxiliary 
 
Table 11: Variation of the additive and the metalation temperature. 
 
The tendancies observed for the addition temperature of the hydrazone were similar for both 
Lewis acids: the yield decreased when we either increased the temperature to −20 °C or 
decreased it to below −60 °C (Scheme 43, Table 12). As no further improvements had been 
established for the ytterbium triflate only the trimethyl aluminium was tested for the solvent 
variation. 
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Scheme 43: Variation of the addition temperature 
 
Additive Addition Temp. Yield dea
AlMe3 −20 °C 45% ≥ 96% 
AlMe3 −40 °C 52-61% ≥ 96% 
AlMe3 −60 to −78 °C 25% ≥ 96% 
Yb(OTf)3 −20 °C 35% ≥ 96% 
Yb(OTf)3 −40 °C 50% ≥ 96% 
Yb(OTf)3 −78 °C 18% ≥ 96% 
a Determined by 1H-NMR 
 
Table 12: Variation of the addition temperature 
 
The solvent was varied and to our surprise the reaction performed in unpolar toluene gave the 
product in a 71% yield with an excellent diastereoselectivity. We then moved to polar diethyl 
ether and the yield climbed to 80%. Two other tests reactions were performed in 
dichloromethane and in 1,2-dimethoxyethane but no further improvements were observed 
(Scheme 44, Table 13). It is noteworthy that the reaction was then performed several times in 
diethyl ether and a yield close to 80% was always obtained proving a well reproducible 
reaction. 
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Scheme 44: Variation of the solvent 
 
Solvent Yield dea
THF 52-61% ≥ 96% 
PhMe 71% ≥ 96% 
Et2O 80% ≥ 96% 
CH2Cl2 0% - 
DME 27% ≥ 96% 
a Determined by 1H-NMR after column chromatography 
 
Table 13: Variation of the solvent 
 
The synthesis of the other enantiomer of the N-substituted 3-substituted 
dihydroisoquinolinone (S,R)-77a was achieved using the optimised conditions and the product 
was obtained in 79% yield and a diastereomeric excess of 96% (Scheme 45). 
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Scheme 45: Synthesis of N-substituted 3-phenyl substituted dihydroisoquinolinone (S,R)-77a 
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3.3.2.2 MODEL STUDY: CLEAVAGE OF THE AUXILIARY 
The synthesis of the 3-phenyl substituted dihydroisoquinolone 79a was first realised using 
magnesium monoperoxyphthalate hexahydrate (MMPP·6H2O) as it was reported to give 71% 
of 79a in excellent enantioselectivity.62 Unfortunately, we could not reproduce the result 
obtained by V. Braig and we then opted for SmI2, efficient for the cleavage of hydrazines 
activated by a benzoyl function.86 Indeed, a carbonyl group was adjacent to the hydrazine. 
The results were highly satisfying as the yield was high, the reaction was reproducible and the 
enantioselectivity obtained was excellent (ee = 98%, determined by chiral stationary phase 
HPLC) (Scheme 46). 
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Scheme 46: N─N cleavage of the chiral auxiliary 
 
Recrystallisation of (R)-79a from diethyl ether provided single crystals to perform an X-ray 
structure analysis (Figure 19). Though, the assignment of the absolute configuration of the 
new stereocentre was not possible: due to a large standard deviation the result of an attempted 
determination using Flack's method100 turned out to be insignificant. However, Davis et al. 
reported the asymmetric synthesis of (S)-79a ([α]D20= −203.4 (c = 1.03, CHCl3)).58b By 
comparison with the optical rotation of (R)-79a ([α]D23 = +195.3 (c = 1.05, CHCl3)) the 
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stereogenic centre could be assigned as (R). This configuration also correlated with the 
relative topicity previously observed in our group in the asymmetric synthesis of 2,3-dihydro-
1H-isoindol-1-ones employing a related methodology.87d Moreover, a crystal structure of the 
N-substituted 3-ferrocenyl substituted dihydroisoquinolinone (R,S)-77 (see 1.3.3) was 
previously obtained by V. Braig. The absolute configuration was determined with certainty, 
but the quality of the crystals did not allow a further refinement of the crystallographic data.62  
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Figure 19: X-ray structure of (R)-79a 
 
The absolute configuration of the centre being assigned, a mechanism can then be proposed to 
explain the diastereoselectivity of the reaction. A complexation would take place between one 
molecule of the lithiated 2-methyl benzamide, the methoxy group and the nitrogen of the 
pyrrolidine ring forcing the pyrrolidin ring to turn by 90°. Another equivalent of lithiated 
2-methyl benzamide would then add to the CN double bond of the hydrazone, activated by 
complexation with one equivalent of trimethyl aluminium, on the less hindered Re face. A 
short-lived intermediate 129 possessing a (R) configuration at the new stereocentre would 
then be obtained before the ring closure (Scheme 47). This proposed mechanism is supported 
by the fact that one untouched equivalent of 2-methyl benzamide 75 can always be isolated 
after the 1,2-addition/ring closure process independent of the time of the reaction and in spite 
of the self-condensation. 
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Scheme 47: Proposed mechanism for the formation of (R,S)-79a 
 
3.3.2.3 MODEL STUDY: ATTEMPTS FOR THE FRIEDEL-CRAFTS REACTION 
The free amide (S)-79a was transformed into the Friedel-Crafts precursor (S)-130 by reaction 
with a slight excess of chloroacetyl chloride in hot acetonitrile (Scheme 48). Unhappily, the 
product was very unstable over silica or aluminium oxide and reverted to the 
dihydroisoquinolinone (S)-79a. By 1H-NMR spectroscopy analysis of the crude mixture no 
more starting material could be detected and a minimal conversion of 96% into the 
chloroacetyl (S)-130 was established. This precursor was then directly subjected to the next 
step. 
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Scheme 48: Synthesis of the Friedel-Crafts precursor (S)-130 
 
The Friedel-Crafts reaction was performed with three equivalents of aluminium chloride in 
nitrobenzene maintaining the temperature at 130 °C for 17 h. The presence of the free amide 
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(S)-79a in the NMR analysis of the crude mixture was mainly detected and after isolation of 
the other products of the reaction, none was found to be the desired product (S)-131 
(Scheme 49). 
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Scheme 49: Attempts for the Friedel-Crafts reaction with the precursor (S)-130 
 
3.3.2.4 MODEL STUDY: ATTEMPTS FOR THE PUMMERER REACTION 
We then turned our attention to the Pummerer reaction. This reaction is the formation of an α-
functionalised sulfide 138 from a sulfoxide 132 bearing at least one α-hydrogen atom 
(Scheme 50).101  
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Scheme 50: Mechanism of the Pummerer reaction 
 
It requires an electrophile (E+) to activate the sulfoxide and a base to abstract the α-hydrogen 
atom and to produce the two mesomeric species 134 and 135. These species will eliminate the 
oxygen atom of the former sulfoxide now bonded to the electrophile (EO−) to give rise to two 
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more stable mesomeric species 136 and 137. A nucleophile (Y−) will then be incorporated 
leading to the final α-functionalised sulfide 138. The advantage of this process is that several 
nucleophiles such as hydroxy, alkoxy, carboxylate, sulfide, amine and alkenyl groups can be 
used or, more interesting in our case, an aromatic nucleus (Scheme 50). 
 
The phenylsulfanyl acetyl substituted compound was prepared analogously to the chloroacetyl 
(S)-130 by reaction of the free amide (R)-79a with 1.05 equivalent of (phenylthio)acetyl 
chloride in hot acetonitrile for 20 h, and it proved to be equally unstable over silica or 
aluminium oxide. A conversion of at least 90% was determined by 1H-NMR analysis of the 
crude mixture (Scheme 51) and the crude sulfide was directly subjected to oxidation with 
meta-chloroperbenzoic acid in a two phase system composed of dichloromethane and a 10% 
aqueous solution of NaHCO3. The sulfoxide (R)-139 was obtained as a mixture of 
diastereoisomers with a conversion of 81% (determined by 13C-NMR analysis), and it was 
directly subjected to the Pummerer reaction without further purification (Scheme 51). 
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Scheme 51: Synthesis of the Pummerer precursor (R)-139 
 
For the next step, two equivalents of trifluoroacetic anhydride were used to form the 
sulfonium ion in toluene for 15 min. TLC plates analysis revealed the complete consumption 
of the starting material. The reaction was then heated to reflux for 2 hours but isolation of the 
different products formed in the reaction did not indicate presence of the desired product 
(R)-140 (Scheme 52). The Pummerer reaction was then attempted with three equivalents of 
trifluoroacetic anhydride and six equivalents of trifluoroacetic acid but here again, in spite of 
the disappearance of the starting material (R)-139, no product could be isolated (Scheme 52). 
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Scheme 52: Attempts for the Pummerer reaction with the precursor (R)-139 
 
At this point it was clear that the precursors that had been prepared for the Friedel-Crafts as 
well as the Pummerer reaction were far too unstable, and it was impossible to determine 
whether the reaction did not take place or whether the precursors decomposed under the 
reaction conditions. The strategy should remain globally the same considering the nitrogen 
functionalisation and the reactions used to perform the ring closure but the nitrogen 
substituent of the precursors should be exchanged. 
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3.3.3 RETROSYNTHETIC CONCEPT: REDUCTION-NITROGEN FUNCTIONALISATION-RING 
CLOSURE 
The target molecule (R)-(+)- and (S)-(−)-tetrahydropalmatine (59) should result from the ring 
closure of a tetrahydroisoquinoline 141 in a Friedel-Crafts, a Pummerer or a Pomeranz-
Fritsch reaction. To achieve this goal 141 should be obtained by functionalising the nitrogen 
position of the tetrahydroisoquinoline 142 with a chain containing respectively a chloride, a 
sulfoxide or a diethyl acetal. This precursor should be the product of the N─N cleavage of the 
chiral auxiliary and reduction of the carbonyl function of the N-substituted 3-phenyl 
substituted dihydroisoquinolinone obtained by the tandem process between 2-methyl 
benzamide 117 and benzaldehyde SAMP- respectively RAMP-hydrazone 127 (Scheme 53). 
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Scheme 53: Retrosynthetic concept via reduction-nitrogen functionalisation-ring closure 
 
3.3.3.1 MODEL STUDY: SYNTHESIS OF THE TETRAHYDROISOQUINOLINE 
The access to the 1,2,3,4-tetrahydroisoquinolines 80a was easily accomplished using the 
protocol developed by V. Braig.62 By using an excess of THF-borane complex on the 
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previously synthesised N-substituted 3-phenyl substituted dihydroisoquinolinones 77a the 
reaction allowed the N─N cleavage of the chiral auxiliary and the reduction of the amide 
moiety in the same step. The yields obtained for the two enantiomers were slightly higher 
than the one previously reported62 and the enantiomeric excess (determined by chiral 
stationary phase HPLC) remained excellent (Scheme 54). 
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Scheme 54: Synthesis of the 1,2,3,4-tetrahydroisoquinolines 80a 
 
3.3.3.2 MODEL STUDY: ATTEMPTS FOR THE FRIEDEL-CRAFTS REACTION 
The synthesis of the precursor (R)-145, for the Friedel-Crafts reaction, was attempted in one 
step starting from our tetrahydroisoquinoline (R)-80a. We thought of the use of 1-chloro-2-
iodo ethane (144) to functionalise the nitrogen. Therefore 1,2-dichloroethane (143) was 
subjected to Finkelstein's conditions to give 144 in 40% yield. Although the yield was 
moderate, it represented an improvement of about 20% compared to the yield described in the 
literature102 (Scheme 55). 
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Scheme 55: Synthesis of 1-chloro-2-iodo ethane (144) 
63 
RESULTS AND DISCUSSION 
Having in hands 1-chloro-2-iodo ethane (144) the reaction was performed by subjecting the 
tetrahydroisoquinoline (R)-80a to sodium hydride in dimethyl formamide. After 1 h at room 
temperature three equivalents of 144 were added to the reaction mixture (Scheme 56). 
Unfortunately, only starting material was recovered from this reaction and 144, as a 
conclusion from other experiments not described in this work, could not be exposed to 
harsher conditions which only promoted its decomposition. 
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Scheme 56: Attempts for the synthesis of the Friedel-Crafts precursor (R)-145 
 
Taking into account this result, the idea came forth that we could use the chloroacetyl-
dihydroisoquinolinone enantiomer (R)-130 of the previously synthesised (S)-130. The crude 
(R)-130 was refluxed for 18 hours with 10 equivalents of lithium aluminium hydride 
(Scheme 57, Table 14). Only an equal amount of the free amine 80a and the N-ethyl 
substituted tetrahydroisoquinoline 147 was detected by NMR analysis of the crude reaction 
mixture. The formation of 147 can be explained by considering the nucleophilic attack of a 
hydride source on the ammonium salt 146 that is formed due to the anchimeric assistance 
inherent to the tetrahydroisoquinoline nitrogen atom of 145, aggravated by the harsh reaction 
conditions employed (Scheme 58). Milder conditions were then applied by exposing (S)-130 
to 6 equivalents of lithium aluminium hydride at room temperature for 2 hours. No more 
formation of the N-ethyl tetrahydroisoquinoline 147 was observed. Instead an equal amount 
of free amine 80a and the desired chloroethyl tetrahydroisoquinoline (S)-145 was detected in 
the NMR of the crude mixture. We were pleased to see that 145 could be isolated however, 
with slight racemisation. The very moderate yield was also due to the unstability of 145 
promoted by the anchimeric effect (Scheme 57, Table 14). We then switched to borane-THF 
complex and only a slight excess was used refluxing the reaction mixture for 2 hours. (R)-145 
was obtained in a 60% yield with an enantiomeric excess of 95%. 
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Scheme 57: Synthesis of the chloroethyl tetrahydroisoquinoline (R)-145 
 
Starting material Conditions Yielda eeb
(R)-79a LiAlH4 (10 eq), THF, ∆, 18 h 80a + 147 - 
(S)-79a LiAlH4 (6 eq), THF, rt, 2 h 31% 93% 
(R)-79a BH3·THF (4.5 eq), THF, ∆, 2 h 60% 95% 
a Over two steps b Determined by chiral stationary phase HPLC 
 
Table 14: Conditions for the synthesis of the chloroethyl tetrahydroisoquinoline (R)-145 
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Scheme 58: Possible mechanism for the formation of the N-ethyl tetrahydroisoquinoline 147 
 
In order to prevent the racemisation we decided to exploit the anchimeric effect exerted by the 
nitrogen atom to optimise the synthesis of 145. (S)-80a was first transformed into the alcohol 
(S)-148 using 1.1 equivalent of both iodoethanol and sodium hydrogenocarbonate in refluxing 
acetonitrile for 24 h (Scheme 59). The alcohol (S)-148 was then deprotonated with 
triethylamine and transformed into the corresponding mesylate by the use of methanesulfonyl 
chloride. The chloride anion produced during the reaction attacked the ammonium salt formed 
by anchimeric assistance of the nitrogen atom. After 5 hours at room temperature 61% of the 
desired product (S)-145 were obtained with an enantiomeric excess of 97% (determined by 
chiral stationary phase HPLC) showing that no racemisation took place here (Scheme 59). It 
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should be noted that in a second attempt four additional equivalents of lithium chloride were 
also added to determine if the yield of the reaction could be further increased. The reaction 
was stirred longer (in total 20 hours), but the yield of 63% showed that the effect of the 
additional lithium chloride was negligeable. 
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Scheme 59: Optimisation of the synthesis of the chloroethyl tetrahydroisoquinoline (R)-145 
 
In 2002, a patent reported the transformation of the N-(2-chloroethyl)-α-methylbenzylamine 
hydrochloride into the (R)-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride 
((R)-150·HCl) using a Friedel-Crafts reaction.103 (R)-149·HCl was added to a suspension of 
1.6 equivalents of aluminium chloride in decaline at 80 °C. After 2 hours at this temperature 
an amine-aluminium chloride layer flowed over the decaline and the reaction mixture was 
heated to 100 °C for 46 hours. After cooling to room temperature, water was added, the 
decaline layer discarded and the aqueous phase basified. After extraction with 
dichloromethane the organic layer was acidified and 69% of the hydrochloride (R)-150·HCl 
was obtained with an enantiomeric excess of 99.6% after recrystallisation (Scheme 60). 
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Scheme 60: Synthesis of the (R)-150·HCl by Friedel-Crafts reaction 
 
Motivated by this example, we applied this conditions on our newly formed chloroethyl 
tetrahydroisoquinoline (S)-145. Unfortunately the starting material remained as a gum on the 
wall of the reaction flask and we only assisted to its decomposition when the reaction mixture 
was heated (Scheme 61). A hydrochloride salt of (S)-145 would probably have been more 
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resistant to the reaction conditions and eventually have led to the product. However, even if 
we could have obtained the tertiary salt of the tetrahydrodibenzoquinolizine system, its 
stability would have made it very difficult to return to the free base (S)-151. 
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Scheme 61: Attempts for the synthesis of (S)-151 by Friedel-Crafts reaction 
 
3.3.3.3 MODEL STUDY: ATTEMPTS FOR THE PUMMERER REACTION 
To synthesise the precursor for the Pummerer reaction a minimal number of steps was 
desirable. An oxidation of a sulfide to a sulfoxide, as previously used (see 3.3.2.4), should be 
avoided. The direct installation was fulfilled by performing a Michael reaction of 1.5 
equivalents of vinyl sulfoxide and the 3-phenyl substituted tetrahydroisoquinoline (R)-80a. 
The N-phenylsulfinylethyl tetrahydroisoquinoline (R)-152 was obtained in an excellent yield 
as a mixture of diastereoisomers (ratio of 57/43 determined by HPLC) after 24 hours reflux in 
methanol without any need of a base to activate the nitrogen atom of the 
tetrahydroisoquinoline moiety (Scheme 62).  
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Scheme 62: Synthesis of the Pummerer precursor (R)-152 
 
The Pummerer reaction was then attempted employing three equivalents of trifluoroacetic 
anhydride and additional six equivalents of trifluoroacetic acid to prevent the formation of a 
vinyl sulfide (Scheme 63).104 After 2 hours reflux in toluene a NMR analysis of the crude 
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mixture showed that all starting material had disappeared. Instead, a complex mixture of 
products was observed in which an aldehyde peak and some vinylic protons could be seen. 
Probably hydrolysis of the sulfonium ion led to the formation of an aldehyde, and the vinylic 
protons can be explained with the formation of a vinyl sulfide derivative. Unable to know if 
the phenylsulfanyl tetrahydrodibenzoquinolizine had been formed, the crude mixture was 
refluxed in ethanol with Raney nickel under hydrogen atmosphere to perform the cleavage of 
the eventual sulfide. Although each product of the reaction was isolated, the presence of the 
tetracyclic ring skeleton of (R)-151 could not be detected (Scheme 63). 
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Scheme 63: Attempts for the Pummerer reaction on (R)-152 
 
The failure of our attempts for the Friedel-Crafts as well as for the Pummerer reaction could 
have been caused by the absence of methoxy substituents on the aromatic ring. Indeed those 
can represent a necessary activation for this kind of ring closure reactions. We decided to 
switch to the corresponding methoxy-substituted starting materials. 
 
3.3.3.4 SYNTHESIS OF THE STARTING MATERIALS FOR THE TOTAL SYNTHESIS OF TETRAHY-
DROPALMATINE 
The 2,3-dimethoxy-6-methyl-benzamide 117 is not commercially available. One possibility 
was to start from the accessible 2,3-dimethoxybenzoic acid (153) and to introduce the amide 
functionality before using its directing effect to install the methyl substituent in ortho-
position. A protocol described by L. Zhuang et al. was followed for the synthesis of the 2,3-
dimethoxy-benzamide 154.105 After transformation of the carboxylic acid group into an acyl 
chloride with oxalyl chloride and a catalytic amount of dimethyl formamide, diethylamine 
was added at low temperature to give after workup the desired product 154 in an excellent 
yield (Scheme 64). 
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Scheme 64: Synthesis of 2,3-dimethoxy-benzamide 154 
 
The initial protocol of L. Zhuang was transformed to perform the synthesis of the 2,3-
dimethoxy-6-methyl-benzamide 117 that is to say that a methyl group was introduced instead 
of an iodide.105 After deprotonation of the benzamide moiety in ortho-position with 1.05 
equivalents of s-butyllithium coordinating to an equimolar amount of 
tetramethylethylenediamine, a stoichiometric amount of methyl iodide was added before 
slowly warming up the reaction mixture to room temperature (Scheme 65). A good yield of 
the desired product 117 could be reached taking into account that this product must be 
absolutely free of any traces of non-methylated and dimethylated benzamide which could 
react in the next step. 
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Scheme 65: Synthesis of the 2,3-dimethoxy-6-methyl-benzamide 117 
 
The next goal was the preparation of 3,4-dimethoxybenzaldehyde SAMP- respectively 
RAMP-hydrazone 127. The hydrazones were easily synthesised, by condensation of the 
commercial 3,4-dimethoxybenzaldehyde and SAMP respectively RAMP. Both SAMP-
hydrazone (S)-127 and RAMP-hydrazone (R)-127 were obtained in virtually quantitative 
yield and the comparison of these results to the precedent yields obtained for the synthesis of 
the benzaldehyde SAMP- and RAMP-hydrazone 76a (93-94%) suggests an activating effect 
of the methoxy substituents on the aromatic ring (Scheme 66). 
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Scheme 66: Synthesis of the 3,4-dimethoxy-benzaldehyde SAMP- and RAMP-hydrazone 127 
 
3.3.3.5 SYNTHESIS OF THE TETRAHYDROISOQUINOLINE VIA 1,2-ADDITION/RING CLOSURE 
PROCESS  
Having now all necessary materials in hands, the tandem process was attempted first with 
LDA in diethyl ether to deprotonate the methyl group of the 2,3-dimethoxy-6-methyl 
benzamide 117. To our surprise the solution did not turn to burgundy red, a typical colour for 
the lithiated species of the 2-methyl benzamide. Literature already has precedence for the 
deprotonation of two equivalents of 2,4-dimethoxy-6-methylbenzamide with three equivalents 
of LDA before the addition to acetylidene-p-toluenesulfinamide.58a Assuming that LDA 
probably formed a chelate with the methoxy groups of the aromatic ring and the amide group, 
we performed another experiment using three equivalents of LDA compared to the 
benzamide. The reaction mixture turned to a bright orange and as the reaction was worked up 
no product could be observed.  
We decided to employ the same system used before for the installation of the methyl 
substituent (see Scheme 65) and we turned ourselves to the use of 7 equivalents of an 
equimolar amount of s-butyllithium and tetramethylethylenediamine. Taking into account that 
the methoxy substituents can play an important role in this reaction the amount of trimethyl 
aluminium was increased to 3.1 equivalents for the complexation with the hydrazone 127. In 
addition to this, a small amount of THF has to be used in order to maintain a good solubility 
of the lithiated species when deprotonating the 2,3-dimethoxy-6-methyl benzamide 117. 
Finally, the cyclised product (R,S)-156 was obtained with excellent diastereoselectivity and 
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reasonable yield taking into account the complex functionalities built up in one step. 
Analogously (S,R)-156 could also be obtained with a similar yield demonstrating the 
reproducibility of the reaction (Scheme 67). 
 
117
Me
OMe
MeO
O
NEt2
N
OMe
MeO
OMe
OMe
O
N
OMeTMEDA (7 eq)/s-BuLi (6.5 eq), 
Et2O/THF (5/1), −78 °C
then (S)-127, AlMe3 (3.1 eq), 
Et2O, −40 °C, 17 h
(7 eq)
(R,S)-156: 55%, de ≥ 96%
(S,R)-156: 54%, de ≥ 96% (with (R)-127) 
 
Scheme 67: Synthesis of the N-substituted 3-phenyl substituted dihydroisoquinolinone 156 
 
Starting from the dihydroisoquinolinone (R,S)-156, 20 equivalents of the borane-THF 
complex were used to cleave the N─N bond of the chiral auxiliary and to reduce the carbonyl 
group of the amide moiety in the same step (Scheme 68). After hydrolysis of the borane using 
a 1 N aqueous solution of hydrochloric acid the tetrahydroisoquinoline (R)-142 was obtained 
in an excellent yield of 82% and an enantiomeric excess of 99% (determined by chiral 
stationary phase HPLC), better than the one previously observed for 80a (97% ee). 
Analogously (S)-156 was obtained in the same enantiomeric purity and a reproducible yield of 
83%. 
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Scheme 68: Synthesis of the 1,2,3,4-tetrahydroisoquinolines 142 
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3.3.3.6 SYNTHESIS OF (S)-(−)-TETRAHYDROPALMATINE VIA PUMMERER REACTION 
The synthesis of the Pummerer precursor was conducted as before in a Michael reaction of 
the vinyl sulfoxide acceptor and the tetrahydroisoquinoline (S)-142 within 22 hours reflux in 
methanol. A diastereoisomeric mixture of (S)-141a (ratio of 64/36 determined by HPLC) was 
obtained in 94% yield.  
The synthesis of the phenylsulfanyl tetrahydrodibenzoquinolizine by Pummerer reaction was 
realised by subjecting (S)-141a to three equivalents of trifluoroacetic anhydride and six 
equivalents of trifluoroacetic acid in refluxing toluene. Although the compound could not be 
detected by NMR analysis, a small amount of the crude mixture was purified using 
preparative thin layer chromatography. A fraction being identified as the desired sulfide (S)-
157, the rest of the crude mixture was roughly purified by column chromatography and then 
directly subjected to the next step (Scheme 69). 
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Scheme 69: Synthesis of (S)-(−)-tetrahydropalmatine (59) by Pummerer reaction 
 
We were pleased to see that, after reductive desulfurisation with Raney nickel, 31% yield of 
the (S)-(−)-tetrahydropalmatine (59) could be obtained after two steps (Scheme 69). However, 
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slight racemisation occurred during this sequence (ee = 90% determined by chiral stationary 
phase HPLC) which can probably be assigned to the strong trifluoroacetic acid necessary for 
this transformation. 
 
3.3.3.7 ATTEMPTS FOR THE SYNTHESIS OF (S)-(−)-TETRAHYDROPALMATINE VIA FRIEDEL-
CRAFTS REACTION 
The tetrahydroisoquinoline (S)-142 was transformed into the chloride (S)-141b using the 
racemisation-free protocol established before (see 3.3.3.2). After reflux with iodoethanol in 
presence of sodium hydrogenocarbonate the alcohol (S)-158 was obtained in 80% yield. The 
exchange of the alcohol functionality to chloride took place after mesylation and nucleophilic 
attack of the intermediate anion in presence of four equivalents of LiCl unlike stated before. A 
yield of 70% of the desired chloroethyl tetrahydroisoquinoline (S)-141b was found 
(Scheme 70). 
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Scheme 70: Synthesis of the Friedel-Crafts precursor (S)-141b 
 
In 1999 T. Hudlicky registered a patent stating the final closure of a morphinane derivative by 
Friedel-Crafts reaction with aluminium chloride in refluxing benzene.106 However, a mixture 
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of the desired product and a free phenol resulting from an aluminium chloride catalysed 
demethylation was obtained.  
Nevertheless, thinking that our system would perhaps act differently, we conducted an 
experiment with only 1.1 equivalent of the aluminium chloride to prevent a possible 
demethylation of our methoxy substituents. After refluxing 28 hours only starting material 
was recovered. Demethylation had obviously not taken place. Assuming that aluminium 
chloride might complex with the methoxy substituents, four more equivalents of aluminium 
chloride were added to our reaction mixture and after 7 hours reflux the workup was 
performed. Unfortunately no tetrahydropalmatine could be observed in the NMR analysis of 
the crude mixture and it seemed that the main products were starting material and a phenol 
derivative (Scheme 71). 
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Scheme 71: Attempts for the Friedel-Crafts reaction with the precursor (S)-141b 
 
3.3.3.8 SYNTHESIS OF (S)-(−)- AND (R)-(+)-TETRAHYDROPALMATINE VIA POMERANZ-FRITSCH 
REACTION 
The original procedure, independently conceived by C. Pomeranz107 and P. Fritsch108, 
involved the formation of isoquinoline (161) in an acid-catalysed cyclisation of the 
benzyliminoacetal 160 prepared from benzaldehyde and aminoacetaldehyde diethyl acetal 
(159) (Scheme 72). 
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Scheme 72: Formation of isoquinoline (161) by C. Pomeranz  and P. Fritsch  
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In later works the procedure was modified and hydrogenation of the benzyliminoacetal prior 
to cyclisation allowed to form saturated tetrahydroisoquinolines in a Pomeranz-Fritsch-type 
reaction.109 In addition, the formation of quinolizin-5-ol was achieved either by formation of 
an aminoacetaldehyde dihydroxy acetal (glycol) oxidised to the aminoaldehyde and then 
submitted to acid-catalysed cyclisation110 or by formation of an aminoacetaldehyde diethyl 
acetal directly cyclised under acidic conditions111. The second method was also applied to the 
synthesis of quinolizin-5-ol as a mixture of diastereoisomers starting from N-alkylated chiral 
tetrahydroisoquinolines.112  
In addition it should be noted that for a mild ring closure without epimerisation, electron-
donating ortho- or para-substituents of the cyclisation site are required.113
First the synthesis of the Pomeranz-Fritsch precursor was attempted on (R)-142 in the 
presence of bromoacetaldehyde diethyl acetal and potassium carbonate in refluxing 
acetonitrile. Only 33% of the desired diethyl acetal (R)-141c could be obtained. In comparison 
with the yield obtained in the reaction with iodoethanol and sodium hydrogenocarbonate 
(80%, see 3.3.3.7) it was clear that the bromide was not reactive enough for the nucleophilic 
substitution. In a second attempt a stoichiometric amount of potassium iodide was employed 
to perform a bromide-iodide exchange in situ before the attack. We were pleased to see that 
75% of the product could be isolated (Scheme 73). The reaction was repeated under the same 
conditions for the other enantiomer, but we obtained only 63% of (S)-141c. For time reasons 
this reaction could not be optimised and the next step was directly tested. The enantiomeric 
excess for both enantiomers of 141c remained excellent (ee = 99% determined by chiral 
stationary phase HPLC). 
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Scheme 73: Synthesis of the diethyl acetal 141c 
 
Slightly modifying a protocol described by D. Badía and E. Domínguez,112a the diethyl acetal 
141c was exposed to concentrated hydrochloric acid in acetone overnight to perform the 
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Pomeranz-Fritsch-type cyclisation. The quinolizin-5-ols 162 were obtained in very good 
yield as a mixture of diastereoisomers (ratio determined by chiral stationary phase HPLC) 
(Scheme 74). 
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Scheme 74: Synthesis of the quinolizin-5-ol 162 
 
The deoxygenation of the alcohols 162 still had to be accomplished to obtain both 
enantiomers of the target molecule tetrahydropalmatine (59). Many examples described the 
formation of quinolizin-5-ol (see above), but to our knowledge no examples other that 
dehydrations are reported in the literature for the removal of the hydroxy group.110a,112b  
First a combination of 2.5 equivalents of trifluoroborane-etherate complex and triethylsilane 
was applied to the diastereoisomeric mixture of the quinolizin-5-ol (R)-162 for 2 hours at 
−78 °C. The choice of these smooth conditions proved to be appropriate as the 
(R)-(+)-tetrahydropalmatine (59) was obtained in excellent enantiomeric purity, yet in a low 
yield (Scheme 75). Possible reasons could be that either the number of equivalents of both 
reagents had to be higher, as often employed in the literature for this combination, or that the 
Lewis acid promoted the demethylation of the methoxy substituents. As no traces of eventual 
phenol could be detected in the NMR spectra of the crude mixture, another attempt was made 
with five equivalents of both reagents slowly warming up to room temperature overnight. The 
isolated yield for the (S)-(−)-tetrahydropalmatine (59) improved to 92%, in excellent 
enantiopurity (determined by chiral stationary phase HPLC) (Scheme 75). 
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Scheme 75: Synthesis of (R)-(+)- and (S)-(−)-tetrahydropalmatine (59) 
 
To summarise, the enantioselective synthesis of both enantiomers of tetrahydropalmatine was 
achieved in seven steps (including the synthesis of the 2,3-dimethoxy-6-methyl benzamide 
117). The overall yield amounted to 9% for the (R)-(+)-tetrahydropalmatine (ee = 98%) 
respectively 17% for the (S)-(−)-tetrahydropalmatine (ee = 98%). For comparison, 
S. G. Pyne et al.49 obtained the (R)-(+)-tetrahydropalmatine with an overall yield of 31% over 
five steps (key step: 84% de, then diastereoisomeric separation) and A. I. Meyers et al.50 
obtained (S)-(−)-tetrahydropalmatine in five steps with an overall yield of 16% (88% ee). 
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4. SUMMARY 
 
4.1 ASYMMETRIC SYNTHESIS OF ISOINDOLINES 
We have demonstrated a straightforward and highly diastereoselective access to 1,2,3-
trisubstituted isoindolines via a tandem 1,2-addition/cyclisation process. 
Attempts to synthesise the tandem precursors (S)-83 by first generating the Michael acceptor 
and then installing the SAMP-hydrazone were not successful. In a second approach, the 
SAMP-hydrazone was easily prepared by condensation of SAMP with the o-phthalic 
dicarboxaldehyde (84) in Et2O at 0 °C in presence of molecular sieves. The aldehyde 
functionality was then transformed into the different alkenes (S)-83a-d by HWE-reaction with 
the corresponding phosphonates. The yields obtained over two steps were moderate to good 
and the (E)-selectivity was excellent except for the acrylonitrile (Scheme 76). 
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Scheme 76: Synthesis of the precursors (S)-83 
 
Our first experiment to perform the tandem reaction used two equivalents of methyllithium 
and only led to the formation of 2-benzenesulfonyl-1H-indene. Among all combinations of 
organometallic/lanthanide reagents tested, the organolithium/cerium chloride (1/1) system 
was found to be the most efficient. When three equivalents of methyllithium/cerium chloride 
were added at −100 °C to a solution of the phenylsulfonyl vinyl SAMP-hydrazone (S)-83d a 
yield of 32% of the methyl substituted isoindoline 101a could be obtained. Five equivalents 
of n-butyllithium/cerium chloride led to the formation of the n-butyl substituted dihydro-1H-
78 
SUMMARY 
isoindole 101b in 47% yield. Both 101a and 101b were obtained in excellent 
diastereoselectivity. However, until now, the cleavage of the auxiliary to synthesise the 1,3-
disubstituted 2,3-dihydro-1H-isoindole 81a could not be achieved in spite of several attempts 
(Scheme 77). 
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Scheme 77: Synthesis of 1,2,3-trisubstituted 2,3-dihydro-1H-isoindoles 101  
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4.2 TOWARDS THE ASYMMETRIC SYNTHESIS OF TETRAHYDRO-2-
BENZAZEPINES 
The first diastereo- and enantioselective synthesis of 3,4-disubstituted 2,3,4,5-tetrahydro-1H-
2-benzazepines in a tandem 1,2-addition/ring closure sequence was attempted. 
The necessary tandem precursor was obtained by α-alkylation of propanal-SAMP hydrazone 
(S)-106a with the electrophile 107c. The synthesis of 107c started with the commercially 
available phthalide 108. After transformation in its corresponding sodium 2-hydroxymethyl 
benzoate with an aqueous solution of NaOH under reflux, the salt was converted into an ester 
by treatment with ethyl iodide. Alcohol/bromide exchange was achieved using carbon 
tetrabromide and triphenylphosphine and the benzylbromide 107b was obtained with an 
overall yield of 53% over three steps. 107b was reacted with an excess of sodium iodide in 
acetone giving rise to the electrophile 107c nearly quantitatively (Scheme 78). 
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Scheme 78: Synthesis of the electrophile 107c 
 
Propanal SAMP-hydrazone (S)-106a, obtained by condensation of propanal and SAMP, was 
chosen as model nucleophile in the α-alkylation to form the tandem precursor (S,S)-105b. 
After deprotonation of (S)-106a with LDA at 0°C, the benzyliodide 107c was added keeping 
the reaction at −100 °C for 4 hours. By slowly increasing the temperature overnight a yield of 
59% and an excellent diastereomeric excess could be obtained for the precursor (S,S)-105b. 
Two attempts for the tandem 1,2-addition/ring closure sequence were made, one with two 
equivalents of methyllithium, the other with two equivalents of the methyllithium/cerium 
chloride system but none of them led to the formation of the desired trisubstituted tetrahydro-
2-benzazepine (R,S,S)-104a (Scheme 79).  
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Scheme 79: Synthesis and attempted cyclisation of the tandem precursor (S,S)-105b 
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4.3 ASYMMETRIC SYNTHESIS OF TETRAHYDROPALMATINE 
Within the context of this work, the asymmetric synthesis of both enantiomers of 
tetrahydropalmatine (S)-(−)- and (R)-(+)-59 using a tandem 1,2-addition/ring closure 
sequence could be achieved. 
The synthesis concept started with the preparation of the SAMP-hydrazone (S)-127 and the 
RAMP-hydrazone (R)-127. The condensation of the commercially available 3,4-dimethoxy-
benzaldehyde with the respective chiral auxiliary led to the formation of the hydrazones in 
virtually quantitative yield (Scheme 80). 
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Scheme 80: Synthesis of the 4,5-dimethoxy-benzaldehyde SAMP/RAMP-hydrazones 127 
 
Transformation of the carboxylic acid group of the commercially available 2,3-
dimethoxybenzoic acid 153 into an acyl chloride was achieved by treatment with oxalyl 
chloride and a catalytic amount of dimethyl formamide. Diethylamine was then added at low 
temperature and gave the desired product 154 in an excellent yield. Deprotonation with s-
butyllithium, coordinated to an equimolar amount of tetramethylethylenediamine, took place 
in ortho-position because of the directing effect of the amide moiety. A stoichiometric amount 
of methyl iodide was then added letting the temperature slowly warm up to room temperature 
and a good yield of 2,3-dimethoxy-6-methyl benzamide 117 could be reached.  
For the tandem reaction, an equimolar amount of s-butyllithium and 
tetramethylethylenediamine had to be employed to deprotonate the methyl group of 117. As 
revealed by optimisation of the reaction conditions, Et2O was found to be the best solvent and 
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a small amount of THF was necessary to ensure for guarantee a good solubility of the lithiated 
species. The hydrazone (S)- or (R)-127, complexed before with trimethyl aluminium, was then 
added at −40 °C. The cyclised product (R,S)-156 was obtained with excellent 
diastereoselectivity and reasonable yield taking into account the various functionalities built 
up in one step. Analogously the dihydroisoquinolone (S,R)-156 could also be obtained with a 
similar yield showing the reproducibility of the reaction.  
An excess of the borane-THF complex was used to cleave the N─N bond of the chiral 
auxiliary and to reduce the carbonyl group of the amide moiety of (R,S)-156 in the same step. 
After hydrolysis of the borane using an aqueous solution of hydrochloric acid, the 
tetrahydroisoquinoline (R)-142 was isolated in an excellent yield of 82% and an enantiomeric 
excess of 99%. Analogously (S)-142 was obtained in the same enantiomeric purity and with a 
reproducible yield of 83%.  
(R)-142 was then heated in presence of bromoacetaldehyde diethyl acetal and potassium 
carbonate. Additional potassium iodide was employed to perform a bromide/iodide exchange 
in situ before the attack on the amine. The Pomeranz-Fritsch precursor (R)-141c could be 
obtained in 75% yield. In the same conditions, only 63% of (S)-141c was obtained. The 
enantiomeric excess obtained for both enantiomers of 141c remained excellent (ee = 99%).  
The diethyl acetals 141c were submitted to concentrated hydrochloric acid in acetone 
overnight to perform the Pomeranz-Fritsch-type cyclisation. Each quinolizin-5-ol 162 was 
obtained in good yield as a mixture of diastereoisomers.  
To our knowledge, the removal of the hydroxy group of a quinolizinol other than by 
dehydration was accomplished for the first time. First a combination of 2.5 equivalents of 
trifluoroborane-etherate complex and triethylsilane were employed together with the 
diastereoisomeric mixture of the quinolizin-5-ol (R)-162 for 2 hours at −78 °C. 
(R)-(+)-tetrahydropalmatine (59) was obtained in excellent enantiomeric purity. Another 
attempt was then made with 5 equivalents of both reagents warming up to room temperature 
overnight. The yield for the (S)-(−)-tetrahydropalmatine (59) increased to 92% together with 
an excellent enantiopurity. The results are summarised in Scheme 81. 
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Scheme 81: Asymmetric synthesis of tetrahydropalmatine via Pomeranz-Fritsch cyclisation 
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Alternatively, the synthesis of tetrahydropalmatine could be achieved via Pummerer reaction. 
The synthesis of the Pummerer precursor was done by Michael reaction between the vinyl 
sulfoxide acceptor and the tetrahydroisoquinoline (S)-142 after 22 hours reflux in methanol. A 
diastereoisomeric mixture of (S)-141a was obtained in 94% yield. The Pummerer reaction 
was performed by treatment of (S)-141a with an excess of trifluoroacetic acid and 
trifluoroacetic anhydride. The roughly purified phenylsulfanyl tetrahydrodibenzoquinolizine 
was directly subjected to the next step. Reductive desulfurisation with Raney nickel gave 31% 
of (S)-(−)-tetrahydropalmatine 59 after two steps. However, during this sequence a slight 
racemisation occurred (ee = 90%) which can probably be attributed to the strong 
trifluoroacetic acid that was necessary for this transformation. 
 
NH
OMe
MeO
OMe
OMe OMe
N
MeO
OMe
OMe
S
Ph
O
dr = 64/36
(S)-142
Ph
O
S
(S)-141a
MeOH, ∆, 22h
94%
ee ≥ 99%
N
MeO
OMe
OMe
OMe
H
1. TFAA (3 eq), TFA (6 eq),
    PhMe, ∆, 15 h
2. Ra-Ni, H2, EtOH, ∆, 22 h
31% 
(over 2 steps)
(S)-(−)-59
ee = 90%
 
Scheme 82: Asymmetric synthesis of (S)-(−)-tetrahydropalmatine (59) via Pummerer reaction 
 
The enantioselective synthesis of both enantiomers of tetrahydropalmatine was achieved in 
seven steps (counting as well the synthesis of the 2,3-dimethoxy-6-methyl benzamide 117). 
The overall yield amounted to 9% for the (R)-(+)-tetrahydropalmatine (ee = 98%) and 17% 
for the (S)-(−)-tetrahydropalmatine (ee = 98%). For comparison, S. G. Pyne et al.49 obtained 
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the (R)-(+)-tetrahydropalmatine with an overall yield of 31% over five steps (key step: 84% 
de, then diastereoisomeric separation) and A. I. Meyers et al.50 synthesised (S)-(−)-
tetrahydropalmatine in five steps with an overall yield of 16% (88% ee). 
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5. OUTLOOK 
 
1. To accomplish the synthesis of the 1,3-disubstituted isoindolines 81, other methods for 
the cleavage of the chiral auxiliary should be investigated. For example, the use of 
zinc in acetic acid92 or a preactivation of the hydrazines with methoxycarbonyl 
chloride before using standard conditions such as Raney nickel93 could be tested on the 
N-substituted isoindolines 101 (Scheme 83). 
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Scheme 83: Final synthetic step for the synthesis of disubstituted isoindolines 81 
 
The absolute configuration of the two stereogenic centres formed in this process still 
have to be determined. 
The tandem reaction should also be performed with the (Z)-isomer of the Michael 
acceptor in order to detect an eventual difference in behaviour and stereoselectivity 
(see 3.1.1). 
 
2. The tandem 1,2-addition/ring closure sequence for the synthesis of 3,4-disubstituted 
tetrahydro-2-benzazepines was unsuccessful. However, a 1,2-addition and a 
cyclisation could be performed in two separated steps to realize the synthesis of the 
desired products. The disubstituted tetrahydro-2-benzazepines 82 should be obtained 
by spontaneous cyclisation after hydrolysis of the oxazoline 163 under acidic 
conditions and deprotection of the resulting amide. The construction of the precursor 
163 should proceed via 1,2-addition of an organometallic reagent to the hydrazone 
functionality of 164, protection of the generated hydrazine and cleavage of the chiral 
auxiliary. The oxazoline moiety should stay intact as similar compounds are reported 
to be inert towards Grignard reagents.114 The compound 164 should be formed by α-
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alkylation of an aliphatic aldehyde SAMP-hydrazone (S)-106 with an ortho-oxazoline-
substituted benzyl halide 165115 (Scheme 84).  
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Scheme 84: Retrosynthetic concept for the synthesis of tetrahydro-2-benzazepines 82 
 
3. As the asymmetric synthesis of (R)-(+)- and (S)-(−)-tetrahydropalmatine was 
accomplished, the established methodology could now be applied to all 
protoberberines lacking substitution at the C-13 position (see Figure 10) as, for 
example, to the naturally occurring alkaloids (S)-(−)-canadine, (S)-(−)-isocorypalmine 
and (S)-(−)-stylopine.34 
Another aspect of the tandem addition process is that one equivalent of a strong base 
(lithium diethyl amide) is formed after the attack of the intermediate nitrogen anion on 
the amide carbonyl group. The generated dialkyl amide deprotonates the 3-substituted 
dihydroisoquinolinone at the benzylic position. Subsequent treatment of the anion of a 
racemic cyclic adduct with various electrophiles was shown to yield exclusively the 
trans-isomers of 3,4-disubstituted dihydroisoquinolinones.54d It would be interesting to 
apply this characteristic reaction to the total synthesis of the naturally occurring 
(R,R)-(+)-thalictrifoline (166), where the hydrogen atoms at C-13 and C-14 are 
trans.116 This 13-methyl-tetrahydroprotoberberine could result from the acetal 167 in a 
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Pomeranz-Fritsch-type cyclisation followed by the removal of the hydroxy group. 
This precursor could be generated from the dihydroisoquinolinone 168 by N─N 
cleavage of the auxiliary, reduction of the carbonyl group and nitrogen 
functionalisation with bromoacetaldehyde diethyl acetal. The tandem 1,2-addition/ring 
closure sequence of lithiated 2-methyl benzamide 169 and SAMP-hydrazone (S)-127 
followed by trapping with methyl iodide between should furnish the N-substituted 
trans-3,4-disubstituted dihydroisoquinolinone 168 in high diastereoselectivity 
(Scheme 85). 
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Scheme 85: Retrosynthetic analysis for the synthesis of (R,R)-(+)-thalictrifoline (166) 
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6.1 PREPARATIVE WORK 
 
6.1.1 WORKING UNDER PROTECTIVE ATMOSPHERE 
All reactions involving air- or moisture-sensitive compounds were carried out in a Schlenk 
flask previously heated in high vacuum, filled with argon and closed by a septum. During the 
course of the reaction a permanent pressure of argon (approximately 0.1 bar) was applied. The 
addition of solvents, liquids or dissolved substances was performed with the help of a syringe 
fitted with a needle through the septum. Solid reagents were added using a flow of argon. 
Column chromatography was performed with a pressure of nitrogen (approximately 0.2 bar). 
 
6.1.2 WORKING AT LOW TEMPERATURE 
In order to perform a reaction at low temperature, the reaction vessel was cooled in a Dewar 
containing the following cooling mixtures: 
• 0 °C:  ice/water 
• −5 °C:  acetone/ice  
• −40 °C:  cooled iso-propanol bath of a cryostat  
• −78 °C:  acetone/dry ice 
• −100 °C:  acetone/liquid nitrogen 
 
6.1.3 SOLVENTS 
Acetone Technical grade 
Acetonitrile Biosolve, anhydrous 
1,2-Dichloroethane Technical grade 
Dichloromethane 2 h reflux over CaH2 and subsequent distillation through a 
column of packings 
1,4-Dioxane Aldrich, pure 
Abs. dichloromethane  Extraction of distilled dichloromethane with conc. HCl until the 
aqueous phase remains clear. Neutralisation, drying over 
MgSO4 and distillation over CaH2 under an argon atmosphere 
Diethylether Distillation over KOH through a column of packings 
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Abs. diethylether Passage through a basic aluminium oxide column and 
distillation over Na-Pb alloy/benzophenone under an argon 
atmosphere 
DMF Acros, anhydrous 
Ethanol Merck, anhydrous 
n-Hexane Distillation over CaH2 
Methanol 2 h reflux over Mg/MgOMe and subsequent distillation 
Abs. methanol 2 h reflux over Mg/MgOMe and subsequent distillation under 
an argon atmosphere 
n-Pentane Distillation over CaH2 through a column of packings 
Petroleum ether Technical grade 
Tetrahydrofurane 2 h reflux over KOH and subsequent distillation through a 
column of packings 
Abs. tetrahydrofurane Passage through a basic aluminium oxide column and 
distillation over Na-Pb alloy/benzophenone under an argon 
atmosphere 
Abs. toluene Distillation over Na-Pb alloy/benzophenone under an argon 
atmosphere 
 
6.1.4 CHEMICALS 
Chemicals were purchased from commercial suppliers (Acros, Aldrich, Fluka, Lancaster and 
Merck) or were available in the group. They were used from freshly opened containers or 
purified according to standard laboratory methods.117
 
Other chemicals were prepared using the following procedures: 
pH 7 buffer 11.64 g NaOH, 68.0 g KH2PO4 and 1000 mL H2O 
Raney-nickel (W2) Raney-nickel was prepared according to the literature118
RAMP RAMP was gently donated by Dr. A. Ridder and Dr. D. 
Steinbusch 
SAMP  SAMP was prepared according to the literature in 6 steps from 
(S)-(−)-proline119
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6.1.5 REACTION CONTROL 
The course of the reactions was monitored by thin layer chromatography using silica gel 60 
with fluorescence indicator F254 coated on glass plates from Merck-Schuchardt. The detection 
of UV-active substances was realised using a UV lamp (λ = 254 nm). UV-inactive substances 
could be detected by dipping the plates in one of the following solutions and subsequent 
heating using a hot air flow: 
• 50 mg of KMnO4 and 100 mL of H2O 
• 5 g of H3[P(Mo3O10)4]·xH2O and 100 mL of EtOH 
• 25 g of (NH4)6Mo7O24·4H2O, 10 g of (NH4)4Ce(SO4)4, 100 mL of H2SO4 and 
900 mL of H2O 
 
6.1.6 PREPARATIVE COLUMN CHROMATOGRAPHY 
For the chromatographic purification of products, glass columns of different widths and 
lengths were used depending on the purification problem. Silica gel 60 (0.040-0.063 nm) 
(Merck) as stationnary phase and acid washed sea sand (Riedel de Haën) were used as filling 
material. The eluent was chosen after preliminary thin layer chromatography experiments. For 
the separation a light pressure (max. 0.2 bar) was applied. After isolation of the fractions, the 
solvents were evaporated under reduced pressure, and the resulting purified product, if not 
volatile, was dried under high vacuum. 
 
6.1.7 PREPARATIVE THIN LAYER CHROMATOGRAPHY 
The crude mixture of reaction products was dissolved in a minimum amount of solvent 
(CH2Cl2 or Et2O) and was carefully placed via a capillary on the concentration zone of a glass 
plate coated with silica gel 60 with fluorescence indicator F254 (Merck). This plate was then 
treated as for normal thin layer chrompatography. By means of a UV lamp the desired product 
was detected and the silica was scratched where the product was present. The silica was then 
poured in a Büchner funnel and the product was extracted several times with CH2Cl2 or Et2O. 
The solvent was then concentrated under reduced pressure. 
6.1.8 STORAGE OF SYNTHESISED SUBSTANCES 
All synthesised solid, liquid and oily substances were kept under argon in the freezer at 
−25 °C and were stable for several months unless otherwise indicated. 
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6.1.9 SPECIAL APPARATUS 
Syringe pump: Bioblock Scientific, Modell A-99 
Lyophilisator: Christ, Alpha 1-2 
Cryostat: Julabo FPW 90 
Ultrasound tank:  Bandelin Sonorex TK 52 
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6.2 CHARACTERISATION OF THE PRODUCTS 
 
6.2.1 APPARATUS AND MEASUREMENT TECHNIQUES 
1H-NMR spectroscopy Varian Inova 400 (400 MHz), Mercury 300 (300 MHz), Gemini 
300 (300 MHz); internal standard: tetramethylsilane 
13C-NMR spectroscopy Varian Inova 400 (100 MHz), Mercury 300 (75 MHz), Gemini 
300 (75 MHz); internal standard: tetramethylsilane; 1H-Broad 
Band Decoupling; J-modulated Spin-Echo-Recording (Waltz-
16-Decoupler Programm) 
31P-NMR spectroscopy Varian Mercury 300 (121.5 MHz); internal standard: 
tetramethylsilane; 1H-Broad Band Decoupling; external 
standard: phosphoric acid (80%) 
Mass spectroscopy GC-MS: Varian 3400 (Sil-8, 25 m × 0.25 mm, ID); MS: 
Finnigan SSQ 7000 (EI 70 eV; CI 100 eV); HR-MS: Finnigan 
MAT 95 
IR spectroscopy Perkin Elmer FT/IR 1760 
Elementary analysis Heraeus CHN-O-Rapid; Elementar Vario EL 
Gas chromatography Varian CP3800; detector: FID; column: Sil-8 (fused silica, 25 m 
× 0.25 mm, ID); gas: nitrogen (p = 1 bar) 
Analytical HPLC Hewlett Packard 1050; columns: Chiralpak AD2 (250 mm × 4.6 
mm, 10 µm), Chiralcel OD (250 mm × 4.6 mm, 10 µm), 
Chiralpak AD (250 mm × 4.6 mm, 10 µm), Chiralcel OJ (250 
mm × 4.6 mm, 10 µm), Lichrosorb Si 60 (250 mm × 4.6 mm, 7 
µm), Spherical silica (150 mm × 3.9 mm, 5 µm); DAD-detector 
Polarimetry Perkin-Elmer Polarimeter P 241; Merck Uvasol chloroform 
Melting point Tottoli melting point apparatus; Büchi 510 
 
6.2.2 REMARKS ON THE ANALYTICAL DATA 
Yield The yield given is referred to the purified substance (≥ 95%) 
and is, if necessary, corrected after GC-analysis. 
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Gas chromatography The retention time (in min) of the product is given followed by 
the used conditions: column, starting temperature-gradient of 
temperature-ending temperature (in °C). 
Boiling point, pressure The boiling temperature (in °C) is measured by means of a 
mercury thermometer in the apparatus and is uncorrected. For 
distillation under vacuum, the reduced pressure is measured by 
a sensor. 
Melting point The melting point is determined in an open capillary using a 
mercury thermometer and is uncorrected. 
Polarimetry The optical rotation is measured at the indicated temperature 
with the sodium-D-line (λ = 589 nm) in a cell of length l = 1 
dm. The concentration is given in g/dl. 
Analytical HPLC The enantiomeric purity is given followed by the column and 
the eluent used for the measurements, the retention time 
(in min) of the differents enantiomers and the wavelenght used 
for their detection. 
1H-NMR spectroscopy The chemical shifts δ are given in ppm relative to the internal 
standard tetramethylsilane (TMS). J is the value of the coupling 
constant in Hz. For the description of the multiplicity of the 
signal the following abbreviations are used: s = singulet, d = 
doublet, t = triplet, q = quadruplet, m = multiplet, br = broad. 
The proton belonging to this signal is marked in italics in the 
added structure section. The measurements are done at room 
temperature. 
13C-NMR spectroscopy The chemical shifts δ are given in ppm relative to the internal 
standard tetramethylsilane (TMS). The signals are assigned to 
the numbered carbon atoms of the structure drawing (arbitrary 
numbering). The measurements are done at room temperature. 
31P-NMR spectroscopy The chemical shifts δ are given in ppm relative to the external 
standard phosphoric acid (80%). 
Mass spectroscopy The mass of the fragments (m/z) is given using a number 
without dimension with the structure element and the peak 
intensity (proportional to the peak basis) added in brackets. 
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Only signals with an intensity ≥ 10% or caracteristic peaks are 
reported. 
IR spectroscopy The measurements are taken as film between 2 plates of KBr 
for liquids, in CHCl3 for oils and using KBr pills for solids. The 
position of the absorption signals are given in cm−1. Only peaks 
with a transmission ≤ 80% are reported. The peak intensity is 
characterised using the following abbreviations: vs = very 
strong (0-20% T), s = strong (21-40% T), m = middle (41-60% 
T), w = weak (61-80% T). 
Elementary analysis A sample is considered as authentic when ∆C,H,N ≤ 0.5% or 
when the HRMS data are accurate within 5 ppm. 
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6.3 GENERAL PROCEDURES 
 
GP-1 SYNTHESIS OF HYDRAZONES 
In a Schlenk flask under argon, SAMP or RAMP (1.0 eq) was added to a suspension of 
crushed molecular sieves (4Å, 0.1 g/mmol hydrazine) and freshly distillated aldehyde (0.8-1.4 
eq) in Et2O (1.35-1.61 mL/mmol hydrazine) at 0 °C. At the end of the addition, the reaction 
mixture was warmed up to room temperature and stirred overnight (12-20 h). After dilution 
with Et2O and filtration over Celite, the solvent was evaporated under reduced pressure. The 
crude hydrazone was then purified by distillation or by column chromatography. 
 
GP-2 SYNTHESIS OF ALKENES WITH t-BuOK  
In a Schlenk flask under argon, phosphonate (1.7 eq) was added to a solution of t-BuOK (1.5 
eq) in THF (2.35 mL/mmol t-BuOK) at 0 °C. The solution was warmed up to room 
temperature and stirred for 3 h. A solution of pure or crude benzaldehyde-SAMP/RAMP-
hydrazone (R)/(S)-95 (1.0 eq) in THF (1.4 mL/mmol hydrazone) was then added dropwise 
over 2-3 h. At the end of the addition the reaction mixture was stirred overnight (13 h). The 
reaction was hydrolysed by H2O (0.018 mL/mmol t-BuOK), diluted with brine (9 mL/mmol 
hydrazone) and extracted 3 times with Et2O. The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude mixture was then 
purified by column chromatography. 
 
GP-3 SYNTHESIS OF ALKENES WITH LiCl/Et3N 
To a suspension of LiCl (1.1-1.5 eq) in anhydrous CH3CN (1 mL/mmol LiCl) in a Schlenk 
flask under an argon atmosphere cooled to 0 °C was added successively phosphonate (1.3-1.7 
eq) and Et3N (1.1-1.5 eq). After stirring 1 h at 0 °C, a solution of the substituted benzaldehyde 
(1.0 eq) in CH3CN (1 mL/mmol aldehyde) was added over 45 min. At the end of the addition, 
the temperature was increased directly to room temperature and the reaction mixture was 
stirred for further 19 h. The reaction was then diluted with H2O (1.35 mL/mmol aldehyde) and 
extracted 3 times with Et2O. The combined organic phases were washed with brine and dried 
over MgSO4. After filtration and concentration under reduced pressure, the crude alkene was 
purified by column chromatography. 
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GP-4 3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONES THROUGH 1,2-ADDITION/RING CLOSURE 
In a 250 mL Schlenk flask under argon, n-BuLi (6.6 mL, 10.50 mmol, 1.59 M in hexane) was 
added to a solution of (i-Pr)2NH (1.5 mL, 10.50 mmol) in abs. THF or Et2O (50 mL) cooled to 
0 °C. The solution was stirred 15 min at 0 °C and cooled to −78 °C before a solution of N,N-
diethyl-2-methyl-benzamide (75) (10.50 mmol) in abs. THF or Et2O (10 mL) was added 
dropwise. The temperature was increased to −40 °C and a solution of the SAMP/RAMP-
hydrazone (1.50 mmol) in abs. THF or Et2O (6 mL), previously complexed with AlMe3 
(0.83 mL, 1.65 mmol, 2 M in heptane) for at least 1 h, was added dropwise over 30 min. The 
reaction mixture was stirred overnight (~ 18 h) at −40 °C. The reaction was quenched with 
10% aqueous potassium and sodium tartrate (5 mL) and sat. aqueous NH4Cl (10 mL). After 
warming up to room temperature and phase separation, the aqueous layer was extracted 3 
times with Et2O (30 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was purified by column 
chromatography. 
 
GP-5 ACETYLATION OF THE 3-PHENYL-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONES 
In a flask under argon, chloroacetyl chloride (1.25 eq) or (phenylthio)acetyl chloride (1.05 eq) 
was added to a solution of 3-phenyl-3,4-dihydro-2H-isoquinolin-1-one ((R)-79a) or ((S)-79a) 
(1.0 eq) in anhydrous CH3CN (2 mL/mmol amide) and the reaction mixture was heated to 
80 °C for 4 or 20 h. The volatiles were then removed under reduced pressure. The residue was 
diluted and extracted with CH2Cl2 (20 mL/mmol amide) and H2O (20 mL/mmol amide) and 
the organic layer was washed with sat. aqueous Na2CO3 (20 mL/mmol amide). After drying 
over MgSO4, filtration and concentration under reduced pressure the resulting crude mixture 
was used directly in the next step. 
 
GP-6 1,2,3,4-TETRAHYDROISOQUINOLINES THROUGH N─N CLEAVAGE WITH BH3·THF 
In a Schlenk flask under argon fitted with a reflux condenser, BH3·THF (20 eq, 1 M in THF) 
was added to a solution of the hydrazine (1.0 eq) in abs. THF (40 mL/mmol hydrazine) and 
the reaction mixture was heated to reflux for 4 h. After cooling the solution to 5 °C, 1 N 
aqueous HCl (7.7 mL/mmol hydrazine) was cautiously added. After 1 min reflux, the solvent 
and most of the water were evaporated under reduced pressure and sat. aqueous NaHCO3 was 
added to the residue until no evolution of gas could be observed any more. The mixture was 
extracted 3 times with Et2O. The combined organic phases were dried over MgSO4, filtered 
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and evaporated under reduced pressure. The resulting crude mixture was purified by column 
chromatography. 
 
GP-7 REACTION OF THE 1,2,3,4-TETRAHYDROISOQUINOLINES WITH IODOETHANOL 
In a flask under argon, a suspension of 1,2,3,4-tetrahydroisoquinoline (1.0 eq), anhydrous 
CH3CN (8.8 mL/mmol amine), 2-iodoethanol (1.1 eq) and NaHCO3 (1.1 eq) was heated to 
reflux overnight (24 h). After being cooled to room temperature, the reaction mixture was 
filtered with CH3CN or CH2Cl2 and the volatiles were evaporated under reduced pressure. 
The resulting crude mixture was purified by column chromatography. 
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6.4 DESCRIPTION OF THE EXPERIMENTS, ANALYTICAL DATA 
 
6.4.1 THE PROJECT ISOINDOLINES 
 
(E)-3-(2-Bromo-phenyl)-acrylic acid ethyl ester [91] 
 
Br
O
O M
1
2
34
56
7
8
9
10
11
e
 
 
According to the general procedure GP-3, LiCl (0.233 g, 5.50 mmol), triethyl 
phosphonoacetate (1.3 mL, 6.50 mmol), Et3N (0.78 mL, 5.50 mmol) and 2-
bromobenzaldehyde (0.58 mL, 5.00 mmol) were reacted overnight. After purification by 
column chromatography (n-pentane/Et2O = 18/1 to 13/1) 91 was obtained as a pale yellow 
liquid. 
 
Yield: m = 1.206 g (4.73 mmol)  95% 
GC:   Rt = 9.46 min    (Sil-8, 100-10-300) 
TLC:   Rf = 0.54    (n-pentane/Et2O = 12/1) 
(E)/(Z) Ratio:  141/1     (1H-NMR) 
 
1H-NMR (300 MHz, CDCl3, major isomer): 
δ = 1.34 (t, J = 7.2 Hz, 3H, CH3), 4.27 (q, J = 7.2 Hz, 2H, CH2), 6.37 (d, J = 16.0 Hz, 1H, 
CHCO), 7.19 (td, J = 1.7 Hz, J = 7.9 Hz, 1H, BrCCHCH or CCHCH) 7.29 (m, 1H, 
BrCCHCH or CCHCH), 7.55-7.60 (m, 2H, BrCCH, CCH), 8.03 (d, J = 16.0 Hz, 1H, 
CH=CHCO) ppm. 
 
13C-NMR (75 MHz, CDCl3, major isomer): 
δ = 14.31 (C-1), 60.69 (C-2), 121.14 (C-4), 125.29 (C-11), 127.69, 127.76 (C-7/C-8/C-9), 
131.14 (C-8/C-9), 133.42 (C-10), 134.55 (C-6), 142.90 (C-5), 166.38 (C-3) ppm. 
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MS (EI):  
m/z (%) = 256 (M●+, 16), 254 (M●+, 16), 211 (18), 209 (18), 175 (M●+−Br, 37), 148 (10), 147 
(M●+−C2H5Br, 100), 103 (14), 102 (32), 101 (12), 75 (10), 51 (11). 
 
IR (capillary): 
ν = 3413 (vs), 3064 (vs), 2981 (m), 2937 (w), 1714 (vs), 1637 (s), 1562 (w), 1467 (s), 1440 
(m), 1367 (m), 1315 (vs), 1284 (s), 1268 (vs), 1245 (m), 1203 (vs), 1180 (vs), 1096 (w), 1028 
(s), 977 (m), 872 (w), 760 (vs), 735 (w), 659 (w), 583 (w). 
 
Elementary analysis: 
Anal. Calcd. for C11H11BrO2: C = 51.79 H = 4.35 
Found:     C = 51.87 H = 4.47 
 
The NMR spectroscopic data are in agreement with those previously reported.120
 
2-{[(1’E)-(2’S)-2’-Methoxymethyl-pyrrolidin-1’-ylimino]-methyl}-benzaldehyde [(S)-95] 
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According to the general procedure GP-1, o-phthalic dicarboxaldehyde (1.000 g, 7.46 mmol) 
and SAMP (0.930 g, 6.21 mmol, 87% purity (GC)) were reacted overnight. The crude mixture 
was purified by column chromatography (n-pentane/Et2O = 6/1 to 2/1 + 3% Et3N) to yield 
(S)-95 as a yellow syrup. Alternatively, it can be used directly for the next step without 
purification. 
 
Yield:   m = 1.137 g (4.62 mmol)  74% 
GC:   Rt = 14.02 min   (Sil-8, 100-10-300) 
TLC:   Rf = 0.52    (n-pentane/Et2O = 2/1 + 3% Et3N) 
Optical rotation: [α]D25 = −169.9   (c = 0.93, CHCl3) 
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ee:   98.5%     (Chiralpak AD2, n-heptane/i-PrOH 
        = 98/2, Rt = 17.73 min, λ = 254 nm) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.85-2.12 (m, 4H, NCH2CH2CH2), 3.12-3.23 (m, 1H, NCH2), 3.39 (s, 3H, OCH3), 3.44-
3.57 (m, 2H, NCH2, OCH2), 3.64 (dd, J = 3.6 Hz, J = 9.3 Hz, 1H, OCH2), 3.71-3.75 (m, 1H, 
NCH), 7.25-7.32 (m, 1H, CHCHCCO), 7.44-7.50 (m, 1H, CHCHCCN), 7.72 (dd, J = 1.6 Hz, 
J = 7.6 Hz, 1H, CHCCO), 7.86 (d, J = 8.1 Hz, 1H, CHCCN), 7.93 (s, 1H, N=CH), 10.25 (s, 
1H, O=CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 22.65 (C-5), 27.28 (C-4), 49.01 (C-6), 59.60 (C-1), 63.29 (C-3), 74.55 (C-2), 126.29, 
126.45 (C-9/C-11), 128.21 (C-7), 132.10 (C-13), 132.47 (C-12), 133.32 (C-10), 139.05 (C-8), 
193.58 (C-14) ppm. 
 
MS (EI):  
m/z (%) = 246 (M●+, 11), 202 (13), 201 (M●+−CH2OCH3, 100), 132 (39), 70 (30). 
 
IR (capillary): 
ν = 2974 (m), 2926 (m), 2877 (s), 2830 (m), 2734 (w), 1687 (vs), 1597 (m), 1568 (m), 1537 
(vs), 1477 (m), 1449 (m), 1374 (s), 1342 (s), 1325 (m), 1308 (m), 1273 (m), 1252 (m), 1186 
(s), 1155 (s), 1122 (s), 973 (w), 897 (w), 853 (w), 823 (w), 760 (s), 660 (w), 529 (w). 
 
Elementary analysis: 
Anal. Calcd. for C14H18N2O2: C = 68.27 H = 7.37 N = 11.37 
Found:     C = 68.16 H = 7.42 N = 11.70 
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2-{[(1’E)-(2’R)-2’-Methoxymethyl-pyrrolidin-1’-ylimino]-methyl}-benzaldehyde [(R)-95] 
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According to the general procedure GP-1, o-phthalic dicarboxaldehyde (2.000 g, 14.91 mmol) 
and RAMP (1.618 g, 10.77 mmol, 87% purity (GC)) were reacted overnight. The crude 
mixture can be purified by column chromatography (n-pentane/Et2O = 6/1 to 1/1 + 3% Et3N) 
to yield (R)-95 as a yellow syrup. Alternatively, it can be used directly for the next step 
without purification. 
 
Yield:   m = 2.385 g (9.68 mmol)           90% 
Optical rotation: [α]D25 = +168.8            (c = 0.81, CHCl3) 
ee:   98.5%              (Chiralpak AD2, n-heptane/i-PrOH  
= 98/2, Rt = 19.47 min, λ = 254 nm) 
 
All other analytical data correspond to those of the enantiomer (S)-95. 
 
(2E)-3-(2-{[(1’E)-(2’S)-2’-Methoxymethyl-pyrrolidin-1’-ylimino]-methyl}-phenyl)-
acrylic acid ethyl ester [(S)-83a] 
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According to the general procedure GP-2, t-BuOK (2.391 g, 21.3 mmol) was reacted with 
diethoxyphosphoryl-acetic acid ethyl ester (4.8 mL, 24.2 mmol) and SAMP-hydrazone (S)-95 
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(3.499 g, 14.2 mmol). After purification by column chromatography (n-pentane/Et2O = 8/1 to 
2/1 + 3% Et3N) (S)-83a was obtained as a yellow oil. 
 
Yield:   m = 4.490 g (14.2 mmol)  quant. 
GC:   Rt = 17.71 min   (Sil-8, 100-10-300) 
TLC:   Rf = 0.31    (n-pentane/Et2O = 5/1 + 3% Et3N) 
Optical rotation: [α]D25.5 = −160.2   (c = 1.17, CHCl3) 
(E)/(Z) Ratio:  54/1     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3, major isomer): 
δ = 1.34 (t, J = 7.1 Hz, 3H, CH2CH3), 1.86-2.11 (m, 4H, NCH2CH2CH2), 3.10-3.17 (m, 1H, 
NCH2), 3.40 (s, 3H, OCH3), 3.46-3.59 (m, 2H, NCH2, OCH2), 3.68 (dd, J = 3.6 Hz, J = 9.3 
Hz, 1H, OCH2), 3.70-3.76 (m, 1H, NCH), 4.26 (q, J = 7.1 Hz, 2H, CH2CH3), 6.32 (d, J = 15.9 
Hz, 1H, CHCO), 7.16 (m, 1H, CHCHCCN), 7.29-7.34 (m, 1H, CHCHCCHCHCO), 7.41 (s, 
1H, N=CH), 7.47 (m, 1H, CHCCN), 7.72 (dd, J = 1.4 Hz, J = 8.0 Hz, 1H, CHCCHCHCO), 
8.25 (d, J = 15.9 Hz, 1H, CH=CHCO) ppm. 
 
13C-NMR (100 MHz, CDCl3, major isomer): 
δ = 11.99 (C-18), 22.62 (C-5), 27.21 (C-4), 49.11 (C-6), 59.57 (C-1), 60.68 (C-17), 63.45 (C-
3), 74.66 (C-2), 119.44 (C-15), 126.65 (C-12), 126.93 (C-10), 127.40 (C-9), 129.11 (C-7), 
129.91 (C-11), 131.71 (C-13), 136.36 (C-8), 143.44 (C-14), 167.26 (C-16) ppm. 
 
MS (EI):  
m/z (%) = 316 (M●+, 10), 272 (18), 271 (M●+−C2H5O, 100), 243 (31), 156 (11), 130 (16), 70 
(34). 
 
IR (capillary): 
ν = 3060 (w), 2977 (s), 2931 (s), 2878 (s), 2828 (s), 1711 (vs), 1629 (vs), 1573 (m), 1545 (s), 
1477 (s), 1459 (s), 1386 (m), 1368 (m), 1342 (w), 1317 (s), 1264 (m), 1174 (vs), 1121 (m), 
1039 (m), 976 (s), 883 (w), 858 (w), 763 (s), 543 (w), 476 (w). 
 
Elementary analysis: 
Anal. Calcd. for C18H24N2O3: C = 68.33 H = 7.65 N = 8.85 
Found:     C = 67.90 H = 7.92 N = 9.24 
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(2E)-3-(2-{[(1’E)-(2’S)-2’-Methoxymethyl-pyrrolidin-1’-ylimino]-methyl}-phenyl)-
acrylic acid tert-butyl ester [(S)-83b] 
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According to the general procedure GP-1, o-phthalic dicarboxaldehyde (1.000 g, 7.46 mmol) 
and SAMP (0.809 g, 5.41 mmol, 87% purity (GC)) were reacted overnight. The crude mixture 
was used directly in the next step without further purification. 
According to the general procedure GP-3 LiCl (0.395 g, 9.32 mmol), diethoxyphosphoryl-
acetic acid tert-butyl ester (2.5 mL, 10.56 mmol), Et3N (1.3 mL, 9.32 mmol) and crude 
SAMP-hydrazone (max. 5.41 mmol) were reacted overnight. After purification by column 
chromatography (n-pentane/Et2O = 10/1 to 4/1 + 3% Et3N) (S)-83b was obtained as a yellow 
syrup. 
 
Yield:   m = 1.501 g (4.36 mmol)  81% (over 2 steps) 
GC:   Rt = 14.07 min   (Sil-8, 140-10-300) 
TLC:   Rf = 0.45    (n-pentane/Et2O = 5/1 + 3% Et3N) 
Optical rotation: [α]D24 = −120.8   (c = 0.71, CHCl3) 
(E)/(Z) Ratio:  182/1     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3, major isomer): 
δ = 1.53 (s, 9H, C(CH3)3), 1.84-2.09 (m, 4H, NCH2CH2CH2), 3.05-3.13 (m, 1H, NCH2), 3.39 
(s, 3H, OCH3), 3.42-3.57 (m, 2H, NCH2, OCH2), 3.64-3.75 (m, 2H, OCH2, NCH), 6.26 (d, J = 
15.9 Hz, 1H, CHCO), 7.16 (t, J = 7.4 Hz, 1H, CHCHCCN), 7.26-7.31 (m, 1H, 
CHCHCCHCHCO), 7.41 (s, 1H, N=CH), 7.47 (d, J = 7.7 Hz, 1H, CHCCN), 7.77 (d, J = 8.0 
Hz, 1H, CHCCHCHCO), 8.16 (d, J = 15.9 Hz, 1H, CH=CHCO) ppm. 
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13C-NMR (100 MHz, CDCl3, major isomer): 
δ = 22.17 (C-5), 26.77 (C-4), 28.15 (C-18), 48.62 (C-6), 59.08 (C-1), 63.00 (C-3), 74.22 (C-
2), 80.05 (C-17), 120.83 (C-15), 126.08 (C-12), 126.47 (C-10), 126.85 (C-9), 128.62 (C-7), 
129.27 (C-11), 131.37 (C-13), 135.81 (C-8), 141.71 (C-14), 166.08 (C-16) ppm. 
 
MS (EI):  
m/z (%) = 344 (M●+, 10), 300 (10), 299 (54), 244 (16), 243 (M●+−CO2(CH3)3, 100), 130 (13), 
70 (26). 
 
IR (in CHCl3): 
ν = 3060 (w), 2976 (s), 2929 (s), 2881 (s), 2829 (m), 1706 (vs), 1629 (s), 1573 (w), 1546 (m), 
1477 (m), 1456 (m), 1389 (m), 1369 (w), 1323 (s), 1286 (w), 1252 (w), 1198 (s), 1152 (vs), 
978 (m), 867 (w), 758 (vs). 
 
Elementary analysis: 
Anal. Calcd. for C20H28N2O3: C = 69.74 H = 8.19 N = 8.13 
Found:     C = 69.65 H = 7.82 N = 8.66 
 
3-(2-{[(1’E)-(2’S)-2’-Methoxymethyl-pyrrolidin-1’-ylimino]-methyl}-phenyl)-
acrylonitrile [(S)-83c] 
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According to the general procedure GP-2, t-BuOK (2.391 g, 21.3 mmol) was reacted with 
cyanomethyl-phosphonic acid ethyl ester (3.9 mL, 24.2 mmol) and SAMP-hydrazone (S)-95 
(3.499 g, 14.2 mmol). After purification by column chromatography (n-pentane/Et2O = 5/1 to 
1/3 + 3% Et3N) and recrystallisation from petroleum ether (S)-83c was obtained as a yellow 
solid. 
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Yield:   m = 2.842 g (10.6 mmol)  74% 
GC:  (E) Rt = 10.44 min   (Sil-8, 160-10-300) 
  (Z) Rt = 10.25 min   (Sil-8, 160-10-300) 
TLC:  (E) Rf = 0.17    (n-pentane/Et2O = 5/1 + 3% Et3N) 
  (Z) Rf = 0.12    (n-pentane/Et2O = 5/1 + 3% Et3N) 
mp:   54 °C 
Optical rotation: [α]D25.5 = −230.7   (c = 0.93, CHCl3) 
(E)/(Z) Ratio:  4.2/1     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3, (E)/(Z) mixture): 
δ = 1.86-2.14 (m, 4H, NCH2CH2CH2), 3.06-3.18 (m, 1H, NCH2), 3.40 (s, 3H, OCH3 (Z)), 
3.43 (s, 3H, OCH3 (E)), 3.44-3.69 (m, 3H, NCH2, OCH2), 3.69-3.77 (m, 1H, NCH), 5.46 (d, J 
= 11.8 Hz, 1H, CHCN (Z)), 5.73 (d, J = 16.5 Hz, 1H, CHCN (E)), 7.15-7.23 (m, 1H, CHarom), 
7.27 (s, 1H, N=CH), 7.33-7.41 (m, 2H, CHarom), 7.55-7.62 (m, 1H, CHarom), 7.73 (d, J = 11.8 
Hz, 1H, CH=CHCN (Z)), 7.79 (d, J = 7.7 Hz, 1H, CHarom (Z)), 8.10 (d, J = 16.5 Hz, 1H, 
CH=CHCN (E)) ppm. 
 
13C-NMR (100 MHz, CDCl3, (E)/(Z) mixture): 
δ = 22.20 (C-5), 26.78 (C-4), 48.47 (C-6), 59.28 (C-1), 63.00 (C-3), 74.06 (C-2 (E)), 74.21 
(C-2 (Z)), 95.65 (C-15 (Z)), 96.14 (C-15 (E)), 118.55 (C-16), 126.46 (CHarom (E)), 126.53 
(CHarom (E)), 126.88 ((CHarom (Z)), 127.30 (CHarom (E)), 128.43 (C-7 (E)), 129.01 (C-7 (Z)), 
129.96 (CHarom (Z)), 130.29 (CHarom (E)), 135.68 (C-8), 149.58 (C-15 (Z)), 150.31 (C-15 (E)) 
ppm. (The missing peaks are covered by other peaks). 
 
MS (EI):  
m/z (%) = 270 (M●++1, 18), 225 (16), 224 (M●+−CH2OCH3, 100), 155 (17), 154 (10), 70 (29). 
 
IR (KBr): 
ν = 3058 (m), 3026 (w), 2974 (vs), 2927 (vs), 2894 (vs), 2816 (vs), 2620 (vs), 2209 (vs), 1963 
(w), 1605 (vs), 1572 (vs), 1544 (vs), 1458 (vs), 1379 (vs), 1341 (vs), 1306 (vs), 1251 (vs), 
1195 (vs), 1108 (vs), 1044 (m), 956 (vs), 902 (s), 881 (vs), 816 (s), 756 (vs), 703 (m), 619 
(w), 551 (s), 516 (s), 500 (m). 
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HRMS: 
m/z Calcd. for C16H19N3O (M●+):  269.1528 
Found:     269.1528 
 
[1-[2’-((1’’E)-2’’-phenylsulfonyl-vinyl)-phenyl]-meth-(1E)-ylidene]-((2’’’S)-2’’’-
methoxymethyl-pyrrolidin-1’’’-yl)-amine [(S)-83d] 
 
H
N
N
OMe
1
2
3
4
5
6
7
8
9
10
11
12
13 14
15
16
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18S
O
O
19  
 
According to the general procedure GP-3 LiCl (0.361 g, 8.51 mmol), phenylsulfonylmethyl-
phosphonic acid diethyl ester (97) (2.820 g, 9.65 mmol), Et3N (1.2 mL, 8.51 mmol) and 
SAMP-hydrazone (S)-95 (1.000 g, 5.68 mmol) were reacted overnight. After column 
chromatography (n-pentane/Et2O = 1/1 to 1/3 + 3% Et3N then Et2O/MeOH = 80/1 to 60/1 + 
3% Et3N) (S)-83d was obtained as a yellow foam. 
 
Yield:   m = 1.456 g (3.79 mmol)  67% 
GC:   decomposition 
HPLC:  Rt = 12.61 min   (Sil-5, n-heptane/ i-PrOH = 99/1, 
λ = 254 nm) 
TLC:   Rf = 0.66    (n-pentane/Et2O = 1/2 + 3% Et3N) 
Optical rotation: [α]D25 = −119.7   (c = 0.76, CHCl3) 
(E)/(Z) Ratio:  56/1     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3, major isomer): 
δ = 1.90-2.14 (m, 4H, NCH2CH2CH2), 3.08-3.17 (m, 1H, NCH2), 3.41 (s, 3H, OCH3), 3.46-
3.53 (m, 1H, NCH2), 3.59 (dd, J = 6.6 Hz, J = 9.3 Hz, 1H, OCH2), 3.75 (dd, J = 3.6 Hz, J = 
9.3 Hz, 1H, OCH2), 3.76-3.83 (m, 1H, NCH), 6.73 (d, J = 15.4 Hz, 1H, CHSO2), 7.12-7.18 
(m, 1H, CHCHCCN), 7.33 (s, 1H, N=CH), 7.31-7.36 (m, 1H, CHCHCCH=CHSO2), 7.38 (d, 
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J = 8.0 Hz, 1H, CHCCN), 7.51-7.63 (m, 4H, CHCCH=CHSO2, SO2CCHCH, 
SO2CCHCHCH), 7.96 (m, 2H, SO2CCH), 8.42 (d, J = 15.4 Hz, 1H, CH=CHSO2) ppm. 
 
13C-NMR (100 MHz, CDCl3, major isomer): 
δ = 22.66 (C-5), 27.18 (C-4), 49.00 (C-6), 59.58 (C-1), 63.52 (C-3), 74.53 (C-2), 126.74 (C-
10), 127.50 (C-15), 127.77, 127.82, 127.092 (C-18/C-17/C-9), 129.04 (C-7), 129.315 (C-13), 
129.46 (C-19), 130.69 (C-11), 133.36 (C-12), 136.86 (C-8), 141.29 (C-16), 142.36 (C-14) 
ppm. 
 
MS (EI): 
m/z (%) = 384 (M●+, 9), 340 (21), 339 (M●+−C2H5O, 100), 243 (15), 197 (16), 70 (11). 
 
IR (in CHCl3): 
ν = 3060 (m), 2974 (s), 2927 (s), 2878 (s), 2829 (m), 1609 (s), 1595 (s), 1572 (s), 1545 (s), 
1479 (s), 1447 (s), 1384 (m), 1341 (s), 1307 (vs), 1252 (m), 1224 (m), 1197 (s), 1146 (vs), 
1122 (s), 1086 (vs), 970 (m), 885 (w), 854 (m), 799 (m), 755 (vs), 735 (s), 717 (m), 689 (s), 
620 (s), 585 (s), 565 (s), 540 (s), 482 (w). 
 
HRMS: 
m/z Calcd. for C19H19N2O2S (M●+−C2H5O):  339.1167 
Found:      339.1168 
 
[1-[2’-((1’’E)-2’’-Phenylsulfonyl-vinyl)-phenyl]-meth-(E)-ylidene]-((2’’’R)-2’’’-
methoxymethyl-pyrrolidin-1’’’-yl)-amine [(R)-83d] 
 
H
N
N
OMe
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O
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According to the general procedure GP-3, LiCl (0.361 g, 8.51 mmol), phenylsulfonylmethyl-
phosphonic acid diethyl ester (97) (2.820 g, 9.65 mmol), Et3N (1.2 mL, 8.51 mmol) and 
RAMP-hydrazone (R)-95 (1.000 g, 5.68 mmol) were reacted overnight. After column 
chromatography (n-pentane/Et2O = 1/1 to 1/3 + 3% Et3N then Et2O/MeOH = 80/1 to 60/1 + 
3% Et3N) (R)-83d was obtained as a yellow foam. 
 
Yield:   m = 1.570 g (4.08 mmol)  72% 
Optical rotation: [α]D25 = +132.1   (c = 1.57, CHCl3) 
 
All other analytical data correspond to those of the enantiomer (S)-83d. 
 
Phenylsulfonylmethyl-phosphonic acid diethyl ester [97] 
 
S P
OO O
O M
O
Me
1
2
3
4
5
6
7
e
 
 
In a 100 mL 3-necked flask fitted with a reflux condenser, an inner thermometer and an 
addition funnel, phenylsulfanylmethyl-phosphonic acid diethyl ester (10.00 g, 38.4 mmol) and 
acetic acid (40 mL) were mixed together. Hydrogen peroxide (12 mL, 30% in H2O) was 
added slowly in order to maintain the inner temperature below 75 °C. The reaction mixture 
was then heated to reflux for 3 h, cooled to room temperature, poured into a large beaker and 
diluted with 200 mL H2O. A conc. aqueous solution of NaOH was slowly added until the pH 
reached 8-9. The reaction mixture was then extracted 5 times with CH2Cl2. The combined 
organic phases were washed with 10% aqueous NaHSO3 (the absence of peroxide was tested 
using KI paper), dried over MgSO4, filtered and concentrated under reduced pressure. After 
purification by column chromatography (Et2O/MeOH = 60/1 to 5/1) 97 was obtained as a 
colorless solid. 
 
Yield:   m = 9.69 g (33.2 mmol)  86% 
GC:   Rt = 13.37 min   (Sil-8, 10 0-10-300) 
TLC:   Rf = 0.34    (Et2O/MeOH = 60/1) 
mp:   47 °C      (Lit.121 59 °C (benzene/n-heptane)) 
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1H-NMR (300 MHz, CDCl3): 
δ = 1.30 (td, J = 0.5 Hz, JH-P = 7.0 Hz, 6H, CH2CH3), 3.77 (d, JH-P = 17 Hz, 2H, CH2S), 4.16 
(m, 4H, CH2CH3), 7.55-7.62 (m, 2H, m-CHarom), 7,65-7,72 (m, 1H, p-CHarom), 7,98-8.03 (m, 
2H, o-CHarom) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 16.23 (d, JC-P = 6.0 Hz, C-1), 53.81 (d, JC-P = 137.7 Hz, C-3), 63.41 (d, JC-P = 6.6 Hz, C-
2), 128.34 (C-5), 129.15, 134.12 (C-6/C-7), 140.02 (C-4) ppm. 
 
31P-NMR (121.5 Hz, CDCl3): 
δ = 11.22 ppm. 
 
All other analytical data correspond to those of the literature.122
 
1-Phenylsulfonylmethyl-2-((2’S)-2’-methoxymethyl-pyrrolidin-1’-yl)-3-methyl-2,3-
dihydro-1H-isoindole [(S)-101a] 
 
N
Me
N
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O
O
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*
 
 
A 250 mL Schlenk flask containing CeCl3·H2O (1.863 g, 5.00 mmol) was heated under high 
vacuum at 140 °C for 2 h. The temperature was then decreased to room temperature and abs. 
THF (50 mL) was added under argon. The suspension was sonicated for 15 h and then cooled 
to −78 °C. MeLi (3.1 mL, 5.00 mmol, 1.59 M in Et2O) was added dropwise and the reaction 
mixture was stirred for 2 h 30. At the end of the addition, the temperature was decreased to 
−100 °C and a solution of SAMP-hydrazone (S)-83d (0.384 g, 1.00 mmol) in abs. THF 
(20 mL) was added dropwise. The reaction was stirred for 4 h before increasing the 
temperature to −78 °C. After 14 h the temperature was allowed to reach room temperature 
slowly for further 22 h. The reaction was hydrolysed with 0.1 mL H2O, diluted with 70 mL 
H2O and extracted 3 times with Et2O. The combined organic phases were washed with brine, 
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dried over MgSO4, filtered and concentrated under reduced pressure. The crude mixture was 
purified by column chromatography (n-pentane/Et2O = 5/1 to 1/2 + 3% Et3N) to give (S)-101a 
as a pale pink oil. 
 
Yield:   m = 0.135 g (0.32 mmol)  32% 
GC:   decomposition 
 
HPLC:  Rt = 5.14 min    (Spherical silica, n-heptane/i-PrOH  
= 95/5, λ = 230 nm) 
TLC:   Rf = 0.35    (n-pentane/Et2O = 2/1) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.36 (d, J = 6.3 Hz, 3H, CHCH3), 1.43-1.69 (m, 3H, NCH2CH2CH2), 1.75-1.87 (m, 1H, 
NCH2CH2CH2), 2.72-2.80 (m, 1H, NCH2), 2.87-2.93 (m, 1H, NCH2), 2.97-3.03 (m, 1H, 
OCH2), 3.13-3.22 (m, 1H, NCH), 3.24 (s, 3H, OCH3), 3.27-3.33 (m, 1H, OCH2), 3.51 (dd, J = 
8.0 Hz, J = 14.8 Hz, 1H, CH2SO2), 3.89 (dd, J = 1.4 Hz, J = 14.8 Hz, 1H, CH2SO2), 4.29 (q, J 
= 6.3 Hz, 1H, CHCH3), 4.78 (d, J = 8.0 Hz, 1H, CHCH2SO2), 7.05-7.09 (m, 1H, CHarom), 
7.23-7.28 (m, 2H, CHarom), 7.58-7.63 (m, 3H, CHarom), 7.66-7.71 (m, 1H, CHarom), 7.99-8.03 
(m, 2H, SO2CCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 21.07 (C-8), 21.11 (C-5), 27.84 (C-4), 48.39 (C-6), 58.29 (C-3), 58.58 (C-15), 59.28 (C-
1), 60.09 (C-7), 63.22 (C-16), 75.95 (C-2), 121.66, 123.39, 127.69, 127.82 (Carom), 128.53 (C-
18), 129.57 (C-19), 133.91 (Carom), 139.91, 140.12 (C-14/C-17), 142.82 (C-9) ppm. 
 
MS (CI):  
m/z (%) = 402 (26), 401 (M●++1, 100), 400 (M●+, 11). 
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1-Phenylsulfonyl-3-butyl-2-((2’R)-2’-methoxymethyl-pyrrolidin-1’-yl)-2,3-dihydro-1H-
isoindole [(R)-101b] 
 
N N
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A Schlenk flask containing CeCl3·H2O (1.863 g, 5.00 mmol) was heated under high vacuum 
at 140 °C for 2 h. The temperature was then decreased to room temperature and abs. THF 
(50 mL) was added under argon. The suspension was sonicated for 16 h and cooled to −78 °C. 
n-BuLi (3.1 mL, 5.00 mmol, 1.59 M in hexanes) was then added dropwise. At the end of the 
addition the reaction was stirred for 3 h before increasing the temperature to −50 °C. A 
solution of RAMP-hydrazone (R)-83d (0.344 g, 0.89 mmol) in abs. THF (20 mL) was added 
dropwise. The reaction was stirred for 16 h while warming up slowly to room temperature. 
The reaction was hydrolysed with 0.1 mL H2O, diluted with 50 mL H2O and extracted 3 times 
with Et2O. The combined organic phases were washed with brine, dried over MgSO4, filtered 
and concentrated under reduced pressure. The crude mixture was purified by column 
chromatography (n-pentane/Et2O = 8/1 to 2/1 + 3% Et3N) to yield impure (R)-101b (77% 
purity min. after GC-analysis). 
 
Yield:   m = 0.184 g (0.42 mmol)  47% (min. after GC-analysis) 
GC:   Rt = 17.11 min (decomposition) (Sil-8, 160-10-300)  
TLC:   Rf = 0.42    (n-pentane/Et2O = 2/1 + 3% Et3N) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.82-0.90 (t, J = 7.2 Hz, 3H, CH2CH3), 1.00-1.80 (m, 10H, NCH2CH2CH2, 
CH2CH2CH2CH3), 2.52-2.64 (m, 1H, NCH2), 2.72-2.80 (m, 1H, NCH2), 2.98-3.08 (m, 1H, 
NCH), 3.12-3.21 (m, 1H, OCH2), 3.26 (s, 3H, OCH3), 3.32-3.41 (m, 1H, OCH2), 3.43 (dd, J = 
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7.7 Hz, J = 14.6 Hz, 1H, CH2SO2), 3.84 (dd, J = 1.7 Hz, J = 14.6 Hz, 1H, CH2SO2), 4.31 (t, J 
= 4.5 Hz, 1H, CHCH2CH2), 4.91 (d, J = 7.7 Hz, 1H, CHCH2SO2), 7.04-7.11 (m, 1H, CHarom), 
7.19-7.27 (m, 2H, CHarom), 7.55-7.70 (m, 4H, CHarom), 7.98-8.30 (m, 2H, SO2CCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 14.09 (C-11), 20.54 (C-5), 22.92 (C-10), 26.33, 26.85 (C-4/C-9), 34.19 (C-8), 46.01 (C-
6), 56.99 (C-18), 58.46 (C-3), 58.82 (C-1), 64.31 (C-19), 66.32 (C-7), 75.04 (C-2), 121.69, 
123.02 (C-14/C-15), 127.15, 127.35 (C-13/C-16), 127.99 (C-21), 129.12 (C-22), 133.45 (C-
23), 139.74, 140.24, 141.63 (C-12/C-17/C-20) ppm. 
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6.4.2 THE PROJECT TETRAHYDRO-2-BENZAZEPINES 
 
N,N-Diethyl-2-hydroxymethyl-benzamide [109] 
 
N
O
Me
Me
OH
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In a 50 mL Schlenk flask under argon, a suspension of AlCl3 (4.330 g, 32.5 mmol) in 1,2-
dichloroethane (22.5 mL) was cooled to 0 °C. A solution of Et2NH (6.5 mL,  62.5 mmol) in 
1,2-dichloroethane (7.5 mL) was added over 20 min (the evolving HCl gas was removed by 
means of a needle through the septum). At the end of the addition the temperature was 
increased directly to room temperature and the reaction mixture was stirred for 15 min. 
Phthalide (3.353 g, 25.0 mmol) was then added in one portion and the reaction was stirred 
overnight (16 h). The flask was cooled to 0 °C and 10 mL of H2O were slowly added. After 
warming up to room temperature the reaction mixture was filtered over a pad of celite. The 
filter cake was washed successively with H2O (20 mL) and 1,2-dichloroethane (50 mL) and 
discarded. The organic phase was washed with H2O (100 mL) and brine (100 mL). After 
drying over MgSO4, filtration and concentration under reduced pressure, the resulting red-
brown oil was purified by column chromatography (n-pentane/Et2O = 1/5 then pure Et2O then 
Et2O/MeOH = 60/1) to yield 109 as a colourless oil. 
 
Yield:   m = 4.949 g (23.9 mmol)  96% 
GC:   Rt = 13.55 min   (Sil-8, 60-10-300) 
TLC:   Rf = 0.09    (n-pentane/Et2O = 1/4) 
 
1H-NMR (400 MHz, CDCl3, mixture of rotamers): 
δ = 1.05 (t, J = 7.1 Hz, 3H, CH2CH3), 1.25 (t, J = 7.1 Hz, 3H, CH2CH3), 3.18 (q, J = 7.1 Hz, 
2H, CH2CH3), 3.55 (q, J = 7.1 Hz, 2H, CH2CH3), 4.16 (br s, 1H, OH), 4.49 (s, 2H, CH2OH), 
7.19 (dd, J = 1.1 Hz, J = 7.4 Hz, 1H, CHCCO), 7.28 (dt, J = 1.4 Hz, J = 7.4 Hz, 1H, 
CHCHCCO), 7.35 (dt, J = 1.4 Hz, J = 7.7 Hz, 1H, CHCHCCH2), 7.43 (d, J = 7.7 Hz, 1H, 
CHCCH2) ppm. 
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13C-NMR (100 MHz, CDCl3, mixture of rotamers): 
δ = 12.86 (C-1), 14.10 (C-1'), 39.32 (C-2), 43.41 (C-2'), 63.12 (C-10), 125.55 (C-5), 127.25 
(C-6), 129.18, 129.30 (C-7/C-8), 135.71 (C-9), 138.36 (C-4), 171.10 (C-3) ppm. 
 
MS (EI):  
m/z (%) = 207 (M●+, 48), 206 (15), 178 (10), 135 (M●+−NEt2, 92), 134 (83), 133 (37), 118 
(19), 106 (13), 105 (50), 90 (14), 79 (24), 77 (57), 74 (100), 58 (95), 51 (16). 
 
The other analytical data are in agreement with those previously reported.123
 
2-Bromomethyl-N,N-diethyl-benzamide [107a] 
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In a 250 mL Schlenk flask under argon, a solution of alcohol 109 (2.073 g, 10.00 mmol) in 
anhydrous CH3CN (80 mL) was cooled to 0 °C. PPh3 (6.033 g, 23.00 mmol) was added in one 
portion and the mixture was stirred for 15 min. CBr4 (7.628 g, 23.00 mmol) was added in one 
portion and the mixture was stirred for 45 min before sat. aqueous CuSO4 was added (50 mL). 
The reaction was then diluted successively with Et2O (60 mL) and H2O (60 mL) and the 
organic phase was kept. The aqueous phase was extracted 2 times with Et2O (60 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
pressure. The resulting crude red oil was purified by column chromatography (n-pentane/Et2O 
= 2/1 to 1/4) to yield 107a as a yellow liquid. 
 
Remark: upon standing, even at −25°C, 107a slowly transforms into the corresponding 
imidate salt. However, in THF, 107a is soluble whereas the salt remains insoluble, a 
separation is then possible. 
 
Yield:   m = 1.786 g (6.61 mmol)  66% 
GC:   Rt = 12.45 min   (Sil-8, 80-10-300) 
TLC:   Rf = 0.25    (n-pentane/Et2O = 2/1) 
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1H-NMR (400 MHz, CDCl3, mixture of rotamers): 
δ = 1.44 (t, J = 7.1 Hz, 3H, CH2CH3), 1.56 (t, J = 7.1 Hz, 3H, CH2CH3), 3.16 (q, J = 7.1 Hz, 
2H, CH2CH3), 3.20-4.00 (br, 2H, CH2CH3), 4.20-4.90 (br, 2H, CH2Br), 7.21 (m, 1H, 
CH=CCO), 7.27-7.35 (m, 2H, CHCH=CCO, CHCH=CCH2), 7.42 (d, J = 7.1 Hz, 1H, 
CH=CCH2) ppm. 
 
13C-NMR (100 MHz, CDCl3, mixture of rotamers): 
δ = 12.58 (C-1), 13.97 (C-1'), 30.52 (C-10), 38.82 (C-2), 43.38 (C-2'), 125.74 (C-5), 128.31, 
129.17 (C-6/C-7), 130.79 (C-8), 134.41 (C-4), 137.38 (C-9), 169.36 (C-3) ppm. 
 
MS (EI):  
m/z (%) = 271 (M●+, 37), 270 (76), 269 (M●+, 17), 268 (48), 199 (M●+−NEt2, 73), 198 (46), 
197 (M●+−NEt2, 86), 196 (47), 190 (50), 188 (18), 176 (46), 174 (30), 162 (17), 160 (16), 146 
(16), 134 (12), 125 (12), 119 (49), 118 (M●+−BrNEt2, 100), 116 (11), 91 (25), 90 (74), 89 
(54), 63 (18), 51 (10). 
 
IR (in CHCl3): 
ν = 3456 (m), 3409 (m), 3060 (w), 2973 (m), 2935 (m), 1766 (w), 1671 (s), 1628 (vs), 1494 
(w), 1436 (vs), 1382 (m), 1362 (w), 1287 (s), 1223 (m), 1185 (w), 1101 (m), 1076 (m), 980 
(w), 948 (w), 866 (w), 818 (w), 785 (m), 762 (m), 741 (s), 631 (w), 609 (m). 
 
Elementary analysis: 
Anal. Calcd. for C12H16BrNO: C = 53.35 H = 5.97 N = 5.18 
Found:     C = 53.02 H = 5.69 N = 5.41 
 
The 1H-NMR spectrum is in agreement with the one previously reported.124
 
2-Bromomethyl-benzoic acid ethyl ester [107b] 
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In a 100 mL flask phthalide (5.365 g, 40.0 mmol) was suspended in 1 N aqueous NaOH 
(40 mL) and heated to reflux for 2 h. After cooling, most of the water was evaporated under 
reduced pressure and the remaining syrup was coevaporated 2 times with toluene. The white 
crystalline powder was dried in a lyophilisator overnight. The sodium salt was dissolved in 
abs. DMF (50 mL) under argon and cooled to 0 °C. Ethyl iodide (4.8 mL,  60.0 mmol) was 
added dropwise and the temperature was slowly increased to room temperature. The reaction 
mixture was stirred for 24 h and then hydrolysed with pH 7 phosphate buffer (50 mL). The 
aqueous phase was extracted 2 times with Et2O (100 mL) and the combined organic phases 
were washed with a sat aqueous solution of NaCl (50 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting 2-hydroxymethyl-benzoic acid ester, 
obtained as a colourless liquid, was used directly in the next step without further purification. 
 
TLC:   Rf = 0.20    (n-pentane/Et2O = 2/1) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.40 (t, J = 7.2 Hz, 3H, CH2CH3), 4.11 (br s, 1H, OH), 4.38 (q, J = 7.2 Hz, 2H, CH2CH3), 
4.80 (s, 2H, CH2OH), 7.32-7.37 (m, 1H, CHarom), 7.46-7.55 (m, 2H, CHarom), 7.96-8.02 (m, 
1H, CHarom) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 14.23, 61.39, 64.43, 127.60, 128.99, 129.81, 130.98, 132.84, 143. 16, 167.95 ppm. 
 
In a 500 mL Schlenk flask a solution of crude alcohol (max. 40.0 mmol) in anhydrous CH3CN 
(200 mL) was cooled to 0 °C. PPh3 (24.131 g, 92.0 mmol) was added in one portion and the 
reaction mixture was stirred for 15 min. CBr4 was added in one portion (30.512 g, 
92.0 mmol), and after 1 h, sat. aqueous CuSO4 (200 mL) was added. Upon dilution with Et2O 
(280 mL) and H2O (280 mL), the organic phase was kept. The aqueous phase was extracted 2 
times with Et2O (200 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude product was absorbed in silica and purified 
by column chromatography (pure n-pentane then n-pentane/Et2O = 9/1 to 6/1) providing 107b 
as a pale yellow oil. 
 
Yield:   m = 5.145 g (21.2 mmol)  53% (over 3 steps) 
GC:   Rt = 9.66 min    (Sil-8, 80-10-300) 
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TLC:   Rf = 0.53    (n-pentane/Et2O = 9/1) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.42 (t, J = 7.2 Hz, 3H, CH2CH3), 4.41 (q, J = 1.2 Hz, 2H, CH2CH3), 4.95 (s, 2H, CH2Br), 
7.31-4.39 (m, 1H, CHarom), 7.41-7.51 (m, 2H, CHarom), 7.94-7.98 (m, 1H, CHCCO) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 14.23 (C-1), 31.57 (C-10), 61.30 (C-2), 128.49 (Carom), 129.52 (C-4), 131.22, 131.61 (C-
5/Carom), 132.36 (Carom), 139.05 (C-9), 166.61 (C-3) ppm. 
 
Elementary analysis:  
Anal. Calcd. for C10H11BrO2: C = 49.41 H = 4.56  
Found:     C = 49.42 H = 4.61  
 
All other analytical data correspond to those described in the literature.125
 
2-Iodomethyl-benzoic acid ethyl ester [107c] 
 
O
O
Me
I
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In a 250 mL Schlenk flask under argon, a solution of NaI (2.698 g, 18.00 mmol) in dry 
acetone (70 mL) was cooled to 0 °C. A solution of bromide 107b (1.459 g, 6.00 mmol) in dry 
acetone (14 mL) was added dropwise over 1 h. At the end of the addition the temperature was 
increased to room temperature and the reaction was stirred for 26 h. The reaction mixture was 
then diluted with H2O (140 mL) and extracted 4 times with Et2O (40 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
product 107c obtained as a brownish liquid was used without further purification (97% purity 
by GC). 
 
Yield:   m = 1.691 g (5.83 mmol)  97% 
GC:   Rt = 10.75 min   (Sil-8, 80-10-300) 
TLC:   Rf = 0.32    (n-pentane/Et2O = 30/1) 
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1H-NMR (400 MHz, CDCl3): 
δ = 1.43 (t, J = 7.1 Hz, 3H, CH2CH3), 4.42 (q, J = 7.1 Hz, 2H, CH2CH3), 4.93 (s, 2H, CH2I), 
7.29-7.34 (m, 1H, CHarom), 7.39-7.46 (m, 2H, CHarom), 7.92-7.96 (m, 1H, CHCCO) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 4.02 (C-10), 14.30 (C-1), 61.18 (C-2), 127.76 (Carom), 128.55 (C-4), 131.04, 131.25 (C-
5/Carom), 132.25 (Carom), 140.83 (C-9), 166.42 (C-3) ppm. 
 
MS (EI):  
m/z (%) = 290 (M●+, 3), 245 (10), 163 (78), 135 (M●+−C2H5I, 100), 118 (18), 90 (14), 89 (12). 
 
IR (in CHCl3): 
ν = 3064 (w), 2980 (m), 2935 (w), 2903 (w), 1765 (w), 1715 (vs), 1598 (w), 1575 (w), 1487 
(w), 1447 (m), 1366 (m), 1296 (s), 1264 (vs), 1166 (s), 1103 (vs), 1070 (m), 1016 (w), 758 
(s), 707 (m), 572 (m). 
 
Elementary analysis: 
Anal. Calcd. for C10H11IO2:  C = 41.40 H = 3.82  
Found:     C = 41.43 H = 3.91  
 
((2’S)-2’-Methoxymethyl-pyrrolidin-1’-yl)-prop-(1E)-ylidene-amine [(S)-106a] 
 
Me
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N
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According to the general procedure GP-1, propanal (2.788 g, 48.0 mmol) and SAMP (5.528 g, 
40.0 mmol, 94% purity (GC)) were reacted overnight. After distillation under reduced 
pressure (S)-106a was obtained as a colourless oil. 
 
Yield:   m = 6.241 g (36.7 mmol)  92% 
GC:   Rt = 7.38 min    (Sil-8, 60-10-300) 
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bp:   68-72 °C/3 mbar   (Lit.126 73-74 °C/1 Torr) 
Optical rotation: [α]D24 = −126.9   (c = 1.42, CHCl3) (Lit.119 [α]D22 =  
−150.2 (neat)) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.06 (t, J = 7.4 Hz, 3H, CH2CH3), 1.74-1.99 (m, 4H, NCH2CH2CH2), 2.23 (dq, J = 5.5 Hz, 
J = 7.4 Hz, 2H, CH2CH3), 2.67-2.75 (m, 1H, NCH2), 3.38 (s, 3H, OCH3), 3.33-3.45 (m, 3H, 
NCH2, NCH, OCH2), 3.57 (dd, J = 3.6 Hz, J = 8.8 Hz, 1H, OCH2), 6.66 (t, J = 5.5 Hz, 1H, 
N=CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 12.12 (C-9), 22.14 (C-5), 26.38 (C-8), 26.58 (C-4), 50.41 (C-6), 59.11 (C-1), 63.42 (C-3), 
74.79 (C-2), 140.34 (C-7) ppm. 
 
All other analytical data correspond to those reported in the literature.119 
 
2-{(2’S)-3’-[(1’’E)-(2’’S)-2’’-Methoxymethyl-pyrrolidin-1’’-ylimino]-2’-methyl-propyl}-
benzoic acid ethyl ester [(2’S,2’’S)-105b] 
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In a 25 mL Schlenk flask under argon, a solution of (i-Pr)2NH (0.23 mL, 1.65 mmol) in abs. 
THF (8 mL) was cooled to 0 °C. n-BuLi (1.2 mL, 1.65 mmol, 1.39 M in hexanes) was added 
dropwise and the reaction mixture was stirred for 15 min. Propanal SAMP-hydrazone 
(S)-106a (0.255 g, 1.50 mmol) was added dropwise and the reaction was stirred for 21 h at 
0 °C. The temperature was decreased to −100 °C and 2-iodomethyl-benzoic acid ethyl ester 
(107c) (0.457 g, 1.58 mmol) was added dropwise over 15 min. The solution was stirred for 4 
h and the temperature was slowly increased to room temperature overnight (18 h). The 
reaction was quenched with 10 mL of H2O and extracted 4 times with Et2O (20 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
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pressure. The resulting crude yellow-brown oil was purified by column chromatography (n-
pentane/Et2O = 4/1 to 3/1) to give (2’S,2’’S)-105b as a yellow liquid. 
 
Yield:   m = 0.292 g (0.88 mmol)  59% 
GC:   Rt = 19.85 min   (Sil-8, 60-10-300) 
TLC:   Rf = 0.19    (n-pentane/Et2O = 4/1) 
Optical rotation: [α]D24 = −15.3    (c = 2.47, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.05 (d, J = 6.9 Hz, 3H, CHCH3), 1.39 (t, J = 7.1 Hz, 3H, CH2CH3), 1.69-1.96 (m, 4H, 
NCH2CH2CH2), 2.56-2.73 (m, 2H, CHCH3, NCH2), 3.02 (dd, J = 7.4 Hz, J = 13.2 Hz, 1H, 
CH2CHCH3), 3.17 (dd, J = 7.4 Hz, J = 13.2 Hz, 1H, CH2CHCH3), 3.21-3.34 (m, 2H, NCH, 
NCH2), 3.36 (s, 3H, OCH3), 3.37-3.41 (m, 1H, OCH2), 3.53 (dd, J = 3.9 Hz, J = 9.1 Hz, 1H, 
OCH2), 4.35 (qd, J = 0.5 Hz, J = 7.1 Hz, 2H, CH2CH3), 6.58 (d, J = 6.1 Hz, 1H, N=CH), 7.21-
7.26 (m, 2H, CHarom), 7.36-7.41 (m, 1H, CHarom), 7.85-7.89 (m, 1H, CHCCO) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 14.30 (C-19), 18.58 (C-9), 22.05 (C-5), 26.48 (C-4), 38.77 (C-8), 39.50 (C-10), 50.14 (C-
6), 59.08 (C-1), 60.74 (C-18), 63.38 (C-3), 74.64 (C-2), 125.71 (C-14), 130.17 (C-16), 
130.41, 131.15, 131.78 (C-12/C-13/C-15), 141.89 (C-11), 142.61 (C-7), 167.67 (C-17) ppm. 
 
MS (EI):  
m/z (%) =332 (M●+, 13), 288 (19), 287 (20), 287 (81), 173 (11), 172 (100), 169 (30), 145 (14), 
131 (10), 117 (13), 71 (14), 70 (45), 69 (16), 57 (11), 55 (10), 51 (14), 45 (19). 
 
IR (capillary): 
ν = 3064 (w), 2970 (vs), 1718 (vs), 1602 (m), 1577 (w), 1454 (s), 1369 (w), 1258 (vs), 1198 
(m), 1092 (vs), 874 (w), 750 (s), 716 (m), 536 (w). 
 
Elementary analysis: 
Anal. Calcd. for C19H28N2O3: C = 68.65 H = 8.49 N = 8.43 
Found:     C = 68.85 H = 8.95 N = 8.00 
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6.4.3 THE PROJECT TETRAHYDROPALMATINE 
 
2-(2’-Bromo-phenyl)-1,3-dioxolane [120] 
 
Br
H
OO
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In a 25 mL Schlenk flask under argon, a solution of 1,2-bis-(trimethylsilyloxy)-ethane 
(3.0 mL, 12.00 mmol) and trimethylsilyl trifluoromethanesulfonate (0.19 mL, 1.00 mmol) in 
abs. CH2Cl2 (5 mL) was cooled to −78 °C. 2-Bromobenzaldehyde (1.2 mL, 10.00 mmol) was 
added rapidly and the reaction mixture was stirred overnight (16 h) at −78 °C. The reaction 
was hydrolysed with 3.5 mL of pH 7 puffer and extracted 3 times with Et2O. The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced pressure. The 
resulting crude product was distilled in high vacuum to yield 120 as a colourless liquid 
 
Yield:   m = 2.154 g (9.41 mmol)  94% 
GC:   Rt = 9.00 min    (Sil-8, 80-10-300) 
bp:   57-65 °C/0.1-0.01 mbar  (Lit.127 78-80 °C/0.15 Torr) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 4.01-4.20 (m, 4H, CH2CH2), 6.10 (s, 1H, CH), 7.22 (td, J = 1.6 Hz, J = 7.7 Hz, 1H, 
CHCHCBr), 7.34 (t, J = 7.7 Hz, 1H, CHCHCCH), 7.56 (d, J = 8.0 Hz, 1H, CHCBr), 7.61 (dd, 
J = 1.4 Hz, J = 7.7 Hz, 1H, CHCCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 65.39 (C-2), 102.48 (C-1), 122.77 (C-8), 127.24 (C-5), 127.63 (C-4), 130.42 (C-6), 132.78 
(C-7), 136.42 (C-3) ppm. 
 
All other analytical data correspond to those of the literature.127,128
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2-(2’-Allyl-phenyl)-1,3-dioxolane [121] 
 
H
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1
2
3
4
5
6
7
8 CH29
10
11  
 
Method A: 
In a 250 mL Schlenk flask under argon, s-BuLi (8.5 mL, 11.00 mmol, 1.3 M in hexane) was 
added dropwise to a solution of bromoacetal 120 (2.291 g, 10.00 mmol) in abs. THF 
(100 mL) cooled to −78 °C. After 2 h 30 min at −78 °C, hexamethylphosphoramide (1.7 mL, 
10.00 mmol) was added and the solution was transferred via a double ended needle into a 
solution of CuBr·SMe2 (2.056 g, 10.00 mmol) in abs. THF (50 mL) at −50 °C. After 30 min at 
−50 °C, the solution was warmed up to −20 °C and allyl bromide (5.6 mL, 65.00 mmol) was 
added rapidly. The temperature was slowly increased to room temperature (13 h). The 
reaction mixture was then hydrolysed with sat. aqueous NH4Cl (150 mL) and extracted 4 
times with Et2O. The combined organic phases were washed 2 times with conc. aqueous 
NH4OH (250 mL) and once with H2O. After drying over MgSO4, filtration and concentration 
under reduced pressure, the crude product was used directly in the next step. 
 
Method B: 
In a 25 mL Schlenk flask under argon, bromoacetal 120 (0.687 g, 3.00 mmol) and 
allyltributylstannane (1.02 mL, 3.30 mmol) were successively added to a suspension of 
Pd(PPh3)4 (0.347 g, 0.30 mmol) in abs. toluene (6 mL). The reaction mixture was then heated 
to reflux for 16 h and the reaction was filtered through a pad of celite using Et2O (360 mL). 
The combined organic phases were succesively washed with sat. aqueous Na2S2O3 (240 mL), 
with H2O (120 mL) and brine. After drying over MgSO4, filtration and concentration under 
reduced pressure, the crude mixture was purified by column chromatography (n-pentane/Et2O 
= 25/1 to 6/1) providing 121 as a colourless liquid. 
 
Yield:   m = 0.387 g (2.03 mmol)  68% 
GC:   Rt = 6.76 min    (Sil-8, 100-10-300) 
TLC:   Rf = 0.47    (n-pentane/Et2O = 40/1) 
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1H-NMR (300 MHz, CDCl3): 
δ = 3.55 (d, J = 6.2 Hz, 2H, CCH2CH=CH2), 3.98-4.19 (m, 4H, CH2CH2), 4.97-5.10 (m, 2H, 
CCH2CH=CH2), 5.99 (s, 1H, CH(OCH2)2), 5.94-6.08 (m, 1H, CCH2CH=CH2), 7.17-7.34 (m, 
3H, CHarom), 7.57 (dd, J = 1.5 Hz, J = 7.4 Hz, 1H, CHCCH(OCH2)2) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 36.48 (C-9), 65.24 (C-2), 101.63 (C-1), 115.85 (C-11), 126.12 (C-4), 126.34, 129.19, 
129.90 (C-5/C-6/C-7), 135.27 (C-3), 137.19 (C-10), 138.42 (C-8) ppm. 
 
MS (EI):  
m/z (%) = 190 (M●+, 18), 189 (18), 175 (13), 163 (11), 162 (M●+−C2H4, 97), 147 (14), 146 
(11), 145 (28), 133 (12), 131 (19), 130 (27), 129 (100), 128 (90), 127 (12), 118 (14), 117 (37), 
116 (12), 115 (37), 105 (44), 91 (21), 73 (31), 45 (13). 
 
IR (capillary): 
ν = 3073 (m), 2976 (s), 2886 (vs), 1638 (m), 1606 (w), 1486 (m), 1452 (m), 1395 (s), 1287 
(w), 1223 (s), 1183 (w), 1073 (vs), 970 (vs), 946 (vs), 917 (vs), 760 (vs), 632 (w). 
 
HRMS: 
m/z Calcd. for C12H14O2 (M+):  190.0994 
Found:     190.0994 
 
The 1H-NMR spectrum is in accordance with the one reported in the literature.99 
 
2-Allyl-benzaldehyde [122] 
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In a 100 mL Schlenk flask, the crude acetal 121 (max. 10.00 mmol) was dissolved in a 
mixture of dioxane (30 mL) and H2O (15 mL). p-TsOH (0.190 g, 1.00 mmol) was added and 
the reaction mixture was heated to 90 °C for 15 h. Brine (150 mL) was added and the solution 
126 
EXPERIMENTAL PART 
was extracted 4 times with Et2O. The combined organic phases were washed 2 times with 
H2O, dried over MgSO4, filtered and concentrated under reduced pressure. The residue was 
distilled in high vacuum using a microdistillation apparatus to give 122 as a colourless liquid. 
 
Yield:   m = 0.743 g (5.08 mmol)  51% (over 2 steps) 
GC:   Rt = 5.32 min    (Sil-8, 80-10-300) 
bp:   75-78 °C/2 Torr   (Lit.99 51-52 °C/0.35 Torr) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 3.82 (d, J = 6.0 Hz, 2H, CH2CH=CH2), 4.98 (dq, J = 1.7 Hz, J = 17.0 Hz, 1H, 
CH2CH=CH2), 5.09 (dq, J = 1.7 Hz, J = 10.2 Hz, 1H, CH2CH=CH2), 6.04 (tdd, J = 6.0 Hz, J 
= 10.2 Hz, J = 17.0 Hz, 1H, CH2CH=CH2), 7.29 (d, J = 7.7 Hz, 1H, CHCCH2), 7.39 (td, J = 
1.1 Hz, J = 7.4 Hz, 1H, CHCHCCO), 7.53 (td, J = 1.4 Hz, J = 7.7 Hz, 1H, CHCHCCH2), 7.84 
(dd, J = 1.4 Hz, J = 7.7 Hz, 1H, CHCCO), 10.25 (s, 1H, CHO) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 36.47 (C-8), 116.22 (C-10), 126.72 (C-4), 130.87 (C-6), 131.39 (C-3), 133.66 (C-2), 
133.76 (C-5), 136.73 (C-9), 142.03 (C-7), 192.02 (C-1) ppm. 
 
All other analytical data correspond to those reported in the literature.99,129
 
[1-(2’-Allyl-phenyl)-meth-(1E)-ylidene]-((2’’S)-2’’-methoxymethyl-pyrrolidin-1’’-yl)-
amine [(S)-118a] 
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According to the general procedure GP-1, 2-allyl-benzaldehyde (122) (1.038 g, 7.10 mmol) 
and SAMP (1.079 g, 7.81 mmol, 94% purity (GC)) were reacted overnight. After purification 
by column chromatography (n-pentane/Et2O = 20/1 to 3/1 + 2% Et3N) (S)-118a was obtained 
as a pale yellow liquid. 
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Yield:   m = 1.747 g (6.76 mmol)  95% 
GC:   Rt = 10.98 min   (Sil-8, 120-10-300) 
TLC:   Rf = 0.60    (n-pentane/Et2O = 15/1 + 2% Et3N) 
Optical rotation: [α]D24.5 = −156.2   (c = 1.84, CHCl3) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.84-2.09 (m, 4H, NCH2CH2CH2), 2.98-3.06 (m, 1H, NCH2), 3.40 (s, 3H, OCH3), 3.41-
3.56 (m, 4H, NCH2, CH2CH=CH2, OCH2), 3.64-3.70 (m, 2H, NCH, OCH2), 4.99 (dq, J = 1.7 
Hz, J = 17.0 Hz, 1H, CH2CH=CH2), 5.05 (dq, J = 1.7 Hz, J = 10.1 Hz, 1H, CH2CH=CH2), 
5.92 (tdd, J = 6.0 Hz, J = 10.1 Hz, J = 17.0 Hz, J = 17.0 Hz, 1H, CCH2CH=CH2), 7.10-7.22 
(m, 3H, CHarom), 7.39 (s, 1H, N=CH), 7.81 (dd, J = 1.4 Hz, J = 7.7 Hz, 1H, CHCCH=N) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 22.20 (C-5), 26.79 (C-4), 37.50 (C-14), 49.04 (C-6), 59.20 (C-1), 63.08 (C-3), 74.50 (C-
2), 115.43 (C-16), 124.86 (C-9), 126.33, 126.84, 129.77 (C-10/C-11/C-12), 130.73 (C-7), 
134.81 (C-8), 135.88 (C-13), 136.98 (C-15) ppm. 
 
MS (EI):  
m/z (%) = 258 (M●+, 17), 214 (17), 213 (M●+−CH2OCH3, 100), 144 (16), 130 (13), 129 (33), 
116 (12), 115 (17), 114 (10), 85 (22), 70 (44). 
 
IR (in CHCl3): 
ν = 3062 (m), 2974 (vs), 2880 (vs), 2827 (vs), 1636 (m), 1580 (vs), 1552 (vs), 1477 (s), 1450 
(vs), 1382 (s), 1342 (s), 1305 (m), 1285 (m), 1248 (m), 1197 (vs), 1119 (vs), 995 (m), 975 
(m), 911 (vs), 756 (vs), 645 (w), 560 (w), 480 (w). 
 
Elementary analysis: 
Anal. Calcd. for C16H22N2O:  C = 74.38 H = 8.58 N = 10.84 
Found:     C = 74.14 H = 8.09 N = 11.18 
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[1-(2’-Bromo-phenyl)-meth-(1E)-ylidene]-((2’’S)-2’’-methoxymethyl-pyrrolidin-1’’-yl)-
amine [(S)-118b] 
 
Br
H
N
N
OMe
1
2
3
4
5
6
7
8
9
10
11
12
13
 
 
According to the general procedure GP-1, 2-bromo-benzaldehyde (1.17 mL, 10.00 mmol) and 
SAMP (1.658 g, 12.00 mmol, 94% purity (GC)) were reacted overnight. After distillation 
under high vacuum (S)-118b was obtained as a yellow liquid. 
 
Yield:   m = 2.743 g (9.23 mmol)  92% 
GC:   Rt = 15.89 min   (Sil-8, 80-10-300) 
bp:   115-122 °C/0.1-0.01 mbar 
Optical rotation: [α]D25 = −132.6   (c = 2.47, CHCl3) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.85-2.11 (ca, 4H, NCH2CH2CH2), 3.11-3.17 (m, 1H, NCH2), 3.40 (s, 3H, OCH3), 3.45-
3.52 (m, 1H, NCH2), 3.53 (dd, J = 6.6 Hz, J = 9.3 Hz, 1H, OCH2), 3.67 (dd, J = 3.9 Hz, J = 
9.3 Hz, 1H, OCH2), 3.70-3.77 (m, 1H, NCH), 6.99-7.05 (m, 1H, CHarom), 7.21-7.26 (m, 1H, 
CHarom), 7.42 (s, 1H, N=CH), 7.48 (dd, J = 1.1 Hz, J = 8.0 Hz, 1H, CHarom), 7.89 (dd, J = 1.7 
Hz, J = 8.0 Hz, 1H, CHCCH=N) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 22.24 (C-5), 26.88 (C-4), 48.81 (C-6), 59.23 (C-1), 62.93 (C-3), 74.39 (C-2), 121.95 (C-
13), 125.67 (C-9), 127.05, 127.64 (C-10/C-11), 130.16 (C-7), 132.54 (C-12), 135.73 (C-8) 
ppm. 
 
MS (EI):  
m/z (%) =298 (M●+, 10), 296 (M●+, 13), 254 (12), 253 (M●+−CH2OCH3, 100), 251 
(M●+−CH2OCH3, 98), 70 (37). 
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IR (capillary): 
ν = 3060 (w), 2972 (vs), 2924 (vs), 2878 (vs), 2826 (vs), 2736 (w), 1568 (vs), 1544 (vs), 1463 
(vs), 1436 (s), 1375 (vs), 1342 (vs), 1308 (s), 1284 (m), 1248 (s), 1197 (vs), 1156 (s), 1114 
(vs), 1042 (w), 1019 (vs), 974 (m), 900 (w), 870 (m), 851 (m), 753 (vs), 651 (w), 545 (m), 
530 (m). 
 
Elementary analysis: 
Anal. Calcd. for C13H17BrN2O: C = 52.54 H = 5.77 N = 9.43 
Found:     C = 52.10 H = 6.16 N = 9.92 
 
((2’S)-2’-Methoxymethyl-pyrrolidin-1’-yl)-[1-o-tolyl-meth-(1E)-ylidene]-amine 
[(S)-118c] 
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According to the general procedure GP-1, 2-methyl-benzaldehyde (1.39 mL, 12.00 mmol) and 
SAMP (1.382 g, 10.00 mmol, 94% purity (GC)) were reacted overnight. After distillation 
under high vacuum with the help of a microdistillation apparatus (S)-118c was obtained as a 
yellow liquid. 
 
Yield:   m = 2.088 g (8.99 mmol)  90% 
GC:   Rt = 12.23 min   (Sil-8, 100-10-300) 
bp:   84 °C/0.1-0.01 mbar 
Optical rotation: [α]D25 = −158.9   (c = 1.23, CHCl3) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.84-2.09 (m, 4H, NCH2CH2CH2), 2.39 (s, 3H, CCH3), 2.99-3.07 (m, 1H, NCH2), 3.40 (s, 
3H, OCH3), 3.45-3.58 (m, 2H, NCH2, OCH2), 3.64-3.71 (m, 2H, OCH2, NCH), 7.09-7.18 (m, 
3H, CHarom), 7.38 (s, 1H, N=CH), 7.75 (d, J = 7.4 Hz, 1H, CHCCH=N) ppm. 
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13C-NMR (100 MHz, CDCl3): 
δ = 19.69 (C-14), 22.20 (C-5), 26.76 (C-4), 49.00 (C-6), 59.19 (C-1), 63.15 (C-3), 74.50 (C-
2), 124.62 (C-9), 125.78, 126.59, 130.26 (C-10/C-11/C-12), 130.92 (C-7), 134.20, 134.89 (C-
8/C-13) ppm. 
 
MS (EI):  
m/z (%) = 232 (M●+, 13), 188 (12), 187 (M●+−CH2OCH3, 100), 70 (34). 
 
IR (capillary): 
ν = 3057 (m), 2879 (vs), 1697 (m), 1670 (w), 1579 (vs), 1553 (vs), 1458 (vs), 1379 (s), 1342 
(s), 1305 (w), 1284 (w), 1248 (m), 1198 (vs), 1154 (s), 1120 (vs), 973 (m), 879 (m), 755 (vs), 
719 (m), 560 (w), 539 (w), 499 (m). 
 
Elementary analysis: 
Anal. Calcd. for C14H20N2O:  C = 72.38 H = 8.68 N = 12.06 
Found:     C = 71.96 H = 8.21 N = 12.07 
 
N,N-Diethyl-2-methyl-benzamide [75] 
 
Me
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To a solution of Et2NH (10.3 mL, 100.0 mmol) and Et3N (13.9 mL, 100.0 mmol) in Et2O 
(350 mL) at 0 °C, 2-methylbenzoyl chloride (13.0 mL, 100.0 mmol) was slowly added. Upon 
completion of the addition the precipitate was filtered off, washed with Et2O (75 mL) and 
discarded. The combined organic layers were concentrated under vacuum and the crude 
product was recrystallized from petroleum ether to yield 75 as a colourless crystalline solid. 
 
Yield:   m = 15.715 g (82.2 mmol)  82% 
GC:   Rt = 11.14 min   (Sil-8, 60-10-300) 
mp:   48 °C     (Lit.130 49-50 °C) 
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1H-NMR (300 MHz, CDCl3, mixture of rotamers): 
δ = 1.03 (t, J = 7.2 Hz, 3H, CH2CH3), 1.26 (t, J = 7.2 Hz, 3H, CH2CH3), 2.29 (s, 3H, CCH3), 
3.12 (q, J = 7.2 Hz, 2H, CH2CH3), 3.20-3.85 (br, 2H, CH2CH3), 7.13-7.29 (m, 4H, CHarom) 
ppm. 
 
13C-NMR (75 MHz, CDCl3, mixture of rotamers): 
δ = 12.88 (C-1), 13.99 (C-1'), 18.79 (C-10), 38.66 (C-2), 42.59 (C-2'), 125.44, 125.77, 128.51, 
130.29 (Carom), 133.84 (C-4), 137.17 (C-9), 170.87 (C-3) ppm. 
 
MS (EI):  
m/z (%) =191 (M●+, 20), 190 (26), 176 (29), 119 (M●+−NEt2, 100), 118 (15), 91 (43), 65 (15). 
 
All other analytical data correspond to those reported in the literature.130,131  
 
(3R)-3-(2’-Bromo-phenyl)-2-((2’’S)-2’’-methoxymethyl-pyrrolidin-1’’-yl)-3,4-dihydro-
2H-isoquinolin-1-one [(3R,2’’S)-119b] 
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According to the general procedure GP-4, 2-methyl benzamide 75 and SAMP-hydrazone 
(S)-118b were reacted overnight in abs. THF. After purification by column chromatography 
(n-pentane/Et2O = 8/1 to 1/3) (3R,2’’S)-119b was obtained as a yellow syrup. 
 
Yield:   m = 0.066 g (0.16 mmol)  11% 
GC:   Rt = 13.65 min   (Sil-8, 160-10-300) 
TLC:   Rf = 0.45    (petroleum ether/Et2O = 2/3) 
Optical rotation: [α]D27 = +62.3    (c = 0.83, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
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1H-NMR (400 MHz, CDCl3): 
δ = 1.37-1.47 (m, 1H, NCH2CH2CH2), 1.57-1.68 (m, 1H, NCH2CH2CH2), 1.92-2.02 (m, 1H, 
NCH2CH2CH2), 2.05-2.14 (m, 1H, NCH2CH2CH2), 2.78-2.85 (dt, J = 4.4 Hz, J = 7.7 Hz, 1H, 
NCH2), 3.05 (dd, J = 1.7 Hz, J = 15.9 Hz, 1H, O=CNCHCH2), 3.40-3.47 (m, 2H, OCH2), 3.42 
(s, 3H, OCH3), 3.69-3.78 (m, 2H, O=CNCHCH2, NCH2), 4.00-4.10 (m, 1H, NCH), 5.53 (dd, 
J = 1.7 Hz, J = 7.4 Hz, 1H, O=CNCHCH2), 6.93-6.98 (m, 2H, CHarom), 7.01-7.06 (m, 2H, 
CHarom), 7.29-7.34 (m, 2H, CHarom), 7.51-7.56 (m, 1H, CHarom), 8.05-8.11 (m, 1H, O=CCCH) 
ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 23.20 (C-5), 26.95 (C-4), 34.15 (C-14), 51.56 (C-6), 58.89 (C-1), 60.66 (C-3), 64.98 (C-
15), 77.30 (C-2), 122.54 (C-21), 126.82, 126.85, 127.13, 127.48, 127.67, 128.55 (Carom), 
130.08 (C-8), 131.77, 132.98 (Carom), 134.56 (C-13), 139.49 (C-16), 163.46 (C-7) ppm. 
 
MS (EI):  
m/z (%) =417 (M●++1, 5), 415 (M●++1, 6), 372 (20), 371 (M●+−CH2OCH3, 100), 370 (24), 
369 (M●+−CH2OCH3, 99), 304 (14), 303 (16), 302 (16), 206 (25), 178 (13), 114 (72), 113 
(18), 68 (10). 
 
IR (in CHCl3): 
ν = 3065 (w), 2925 (s), 2875 (s), 1653 (vs), 1604 (m), 1462 (s), 1406 (vs), 1329 (s), 1249 (s), 
1102 (s), 1025 (s), 964 (w), 754 (vs), 694 (w), 665 (w), 587 (w), 488 (w). 
 
Elementary analysis: 
Anal. Calcd. for C21H23BrN2O2: C = 60.73 H = 5.58 N = 6.74 
Found:     C = 60.27 H = 5.42 N = 7.06 
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(3R)-2-((2’S)-2’-Methoxymethyl-pyrrolidin-1’-yl)-3-o-tolyl-3,4-dihydro-2H-isoquinolin-
1-one [(3R,2’S)-119c] 
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According to the general procedure GP-4, 2-methyl benzamide 75 and SAMP-hydrazone 
(S)-118c were reacted overnight in abs. THF. After purification by column chromatography 
(n-pentane/Et2O = 4/1) (3R,2’S)-119c was obtained as a pale pink crystalline solid. 
 
Yield:   m = 0.142 g (0.41 mmol)  27% 
GC:   Rt = 16.88 min   (Sil-8, 120-10-300) 
TLC:   Rf = 0.40    (petroleum ether/Et2O = 2/3) 
mp:   88 °C 
Optical rotation: [α]D21 = +7.7    (c = 0.65, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.36-1.48 (m, 1H, NCH2CH2CH2), 1.54-1.64 (m, 1H, NCH2CH2CH2), 1.87-2.01 (m, 1H, 
NCH2CH2CH2), 2.04-2.16 (m, 1H, NCH2CH2CH2), 2.44 (s, 3H, CCH3), 2.73 (dt, J = 4.2 Hz, J 
= 7.9 Hz, 1H, NCH2), 2.86 (dd, J = 1.7 Hz, J = 15.6 Hz, 1H, O=CNCHCH2), 3.39-3.43 (m, 
2H, OCH2), 3.40 (s, 3H, OCH3), 3.66 (dt, J = 7.9 Hz, J = 7.9 Hz, 1H, NCH2), 3.77 (ddd, J = 
0.7 Hz, J = 7.7 Hz, J = 15.6 Hz, 1H, O=CNCHCH2), 4.01-4.12 (m, 1H, NCH), 5.38 (dd, J = 
1.7 Hz, J = 7.7 Hz, 1H, O=CNCHCH2), 6.85-6.98 (m, 3H, CHarom), 7.07 (td, J = 1.7 Hz, J = 
7.0 Hz, 1H, CHarom), 7.11-7.16 (m, 1H, CHarom), 7.29-7.36 (m, 2H, CHarom), 8.06-8.13 (m, 1H, 
O=CCCH) ppm. 
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13C-NMR (100 MHz, CDCl3): 
δ = 19.28 (C-22), 23.25 (C-5), 27.01 (C-4), 34.59 (C-14), 51.62 (C-6), 58.88 (C-1), 60.43 (C-
3), 62.01 (C-15), 77.46 (C-2), 125.69, 126.04, 126.99, 127.06, 127.33, 127.63 (Carom), 130.45 
(C-8), 130.66, 131.86 (Carom), 134.57, 135.05 (C-13/C-21), 139.18 (C-16), 163.59 (C-7) ppm. 
 
MS (EI):  
m/z (%) =351 (M●++1, 0.4), 306 (24), 305 (M●+−CH2OCH3, 100), 221 (16), 178 (13), 158 
(10), 114 (83), 91 (10), 84 (11). 
 
IR (KBr): 
ν = 3449 (m), 3066 (w), 3027 (w), 2923 (s), 2875 (s), 2838 (s), 2749 (w), 1648 (vs), 1602 (s), 
1488 (m), 1458 (s), 1410 (s), 1385 (s), 1331 (s), 1255 (s), 1201 (w), 1128 (m), 1105 (vs), 
1041 (m), 982 (w), 963 (w), 753 (s), 731 (s), 692 (m), 641 (w). 
 
Elementary analysis: 
Anal. Calcd. for C22H26N2O2: C = 75.40 H = 7.48 N = 7.99 
Found:     C = 75.00 H = 7.14 N = 7.78 
 
((2’S)-2’-Methoxymethyl-pyrrolidin-1’-yl)-[1-phenyl-meth-(1E)-ylidene]-amine [(S)-76a] 
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According to the general procedure GP-1, freshly distilled benzaldehyde (2.4 mL, 24.0 mmol) 
and SAMP (2.704 g, 20.0 mmol, 96% purity (GC)) were reacted overnight. After distillation 
under high vacuum with the help of a microdistillation apparatus (S)-76a was obtained as a 
yellow liquid. 
 
Yield:   m = 4.125 g (18.9 mmol)  94% 
GC:   Rt = 11.20 min   (Sil-8, 100-10-300) 
bp:   104 °C/0.1-0.01 mbar   (Lit.132 123 °C/0.05 Torr) 
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Optical rotation: [α]D26 = −171.7   (c = 1.96, CHCl3) (Lit.132 [α]D22 =  
−130.8 (neat)) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.82-2.08 (m, 4H, NCH2CH2CH2), 3.00-3.08 (m, 1H, NCH2), 3.40 (s, 3H, OCH3), 3.43-
3.55 (m, 2H, NCH2, OCH2), 3.64-3.70 (m, 2H, OCH2, NCH), 7.16-7.21 (m, 1H, p-CHarom), 
7.21 (s, 1H, N=CH), 7.27-7.32 (m, 2H, m-CHarom), 7.52-7.56 (m, 2H, o-CHarom) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 22.20 (C-5), 26.79 (C-4), 48.87 (C-6), 59.19 (C-1), 62.97 (C-3), 74.50 (C-2), 125.12 (C-
9), 126.73 (C-11), 128.20 (C-10), 132.22 (C-7), 137.08 (C-8) ppm. 
 
All other analytical data correspond to those reported in the literature.132 
 
((2’R)-2’-Methoxymethyl-pyrrolidin-1’-yl)-[1-phenyl-meth-(1E)-ylidene]-amine 
[(R)-76a] 
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According to the general procedure GP-1, freshly distilled benzaldehyde (2.4 mL, 24.0 mmol) 
and RAMP (3.038 g, 20.0 mmol, 86% purity (GC)) were reacted overnight. After distillation 
under high vacuum with the help of a microdistillation apparatus (R)-76a was obtained as a 
yellow liquid. 
 
Yield:   m = 4.042 g (18.5 mmol)  93% 
Optical rotation: [α]D26 = +169.9   (c = 2.07, CHCl3) (Lit.132 [α]D20 =  
+133.6 (neat)) 
 
All other analytical data correspond to those of the other enantiomer (S)-76a. 
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(3R)-2-((2’S)-2’-Methoxymethyl-pyrrolidin-1’-yl)-3-phenyl-3,4-dihydro-2H-isoquinolin-
1-one [(3R,2’S)-77a] 
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According to the general procedure GP-4, 2-methyl benzamide 75 and SAMP-hydrazone 
(S)-76a were reacted overnight in abs. Et2O. After purification by column chromatography 
(n-pentane/Et2O = 3/2) (3R,2’S)-77a was obtained as a pale yellow oil which crystallised on 
standing. 
 
Yield:   m = 0.404 g (1.20 mmol)  80% 
GC:   Rt = 16.23 min   (Sil-8, 120-10-300) 
TLC:   Rf = 0.16    (n-pentane/Et2O = 3/2) 
mp:   81 °C 
Optical rotation: [α]D24 = −29.7    (c = 1.02, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.39-1.48 (m, 1H, NCH2CH2CH2), 1.54-1.66 (m, 1H, NCH2CH2CH2), 1.89-2.00 (m, 1H, 
NCH2CH2CH2), 2.04-2.14 (m, 1H, NCH2CH2CH2), 2.76 (dt, J = 4.4 Hz, J = 8.0 Hz, 1H, 
NCH2), 2.95 (dd, J = 2.5 Hz, J = 15.8 Hz, 1H, O=CNCHCH2), 3.38 (s, 3H, OCH3), 3.38-3.46 
(m, 2H, OCH2), 3.66 (dt, J = 8.0 Hz, J = 8.0 Hz, 1H, NCH2), 3.77 (dd, J = 7.2 Hz, J = 15.8 
Hz, 1H, O=CNCHCH2), 4.04-4.13 (m, 1H, NCH), 5.07 (dd, J = 2.5 Hz, J = 7.2 Hz, 1H, 
O=CNCHCH2), 6.63-7.02 (m, 1H, CHarom), 7.10-7.22 (m, 5H, CHarom), 7.29-7.33 (m, 2H, 
CHarom), 8.06-8.12 (m, 1H, O=CCCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 23.06 (C-5), 26.98 (C-4), 36.51(C-14), 51.68 (C-6), 58.76 (C-1), 60.10 (C-3), 65.93 (C-
15), 77.04 (C-2), 126.44 (C-18), 126.75, 127.05, 127.15, 127.24 (C-9/C-10/C-11/C-12/C-19), 
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128.01 (C-17), 130.19 (C-8), 131.67 (C-9/C-10/C-11/C-12/C-19), 135.02 (C-13), 141.20 (C-
16), 163.07 (C-7) ppm. 
 
MS (EI):  
m/z (%) = 336 (M●+, 1), 292 (21), 291(M●+− CH2OCH3, 100), 207 (23), 178 (12), 114 (55), 
113 (10). 
 
IR (capillary): 
ν = 3062 (w), 3029 (w), 2971 (s), 2934 (s), 2873 (s), 2829 (w), 1652 (vs), 1634 (vs), 1603 (s), 
1584 (w), 1494 (m), 1458 (vs), 1427 (vs), 1406 (s), 1382 (m), 1364 (m), 1338 (m), 1293 (s), 
1280 (m), 1247 (m), 1222 (w), 1189 (w), 1157 (w), 1125 (m), 1099 (s), 1045 (w), 1033 (w), 
983 (w), 966 (w), 769 (m), 735 (s), 701 (m), 632 (w). 
 
Elementary analysis: 
Anal. Calcd. for C21H24N2O2: C = 74.97 H = 7.19 N = 8.33  
Found:     C = 74.91 H = 7.33 N = 8.31 
 
(3S)-2-((2’R)-2’-Methoxymethyl-pyrrolidin-1’-yl)-3-phenyl-3,4-dihydro-2H-isoquinolin-
1-one [(3S,2’R)-77a] 
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According to the general procedure GP-4, 2-methyl benzamide 75 and RAMP-hydrazone 
(R)-76a were reacted overnight in abs. Et2O. After purification by column chromatography 
(n-pentane/Et2O = 3/2) (3S,2’R)-77a was obtained as a pale yellow oil. 
 
Yield:   m = 0.397 g (1.18 mmol)  79% 
Optical rotation: [α]D24 = +26.2    (c = 0.39, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
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All other analytical data correspond to those of the other enantiomer (3R,2’S)-77a. 
 
(3R)-3-Phenyl-3,4-dihydro-2H-isoquinolin-1-one [(R)-79a] 
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In a 50 mL Schlenk flask under argon, a THF solution of SmI2 (14.5 mL, 1.45 mmol, 0.1 M in 
THF) was added dropwise at room temperature to a solution of dihydroisoquinolinone 
(3R,2’S)-77a (0.162 g, 0.48 mmol) and DMPU (0.85 mL) in abs. THF (3.5 mL). After 30 min 
(the solution should remain deep blue otherwise more SmI2 is needed) the reaction mixture 
was quenched with 10% aqueous NaHCO3 (80 mL) and diluted with CH2Cl2 (33 mL). After 
phase separation the aqueous phase was extracted 2 times with CH2Cl2 (50 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography (n-pentane/Et2O = 1/3) to yield 
(R)-79a as a colourless solid. 
 
Yield:   m = 0.100 g (0.45 mmol)  94% 
GC:   Rt = 13.64 min   (Sil-8, 120-10-300) 
TLC:   Rf = 0.26    (n-pentane/Et2O = 1/2) 
mp:   105 °C     (Lit.54b 130-131 °C (hexane)) 
Optical rotation: [α]D23 = +195.3   (c = 1.05, CHCl3) 
ee:   = 98%     (Chiralcel OD, n-heptane/i-PrOH 
= 9/1, Rt = 13.06 min, λ = 254 nm) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.12 (dd, J = 5.2 Hz, J = 15.8 Hz, 1H, NCHCH2), 3.21 (dd, J = 10.6 Hz, J = 15.8 Hz, 1H, 
NCHCH2), 4.86 (ddd, J = 1.0 Hz, J = 5.2 Hz, J = 10.6 Hz, 1H, NCHCH2), 6.03 (br, 1H, NH), 
7.18 (d, J = 7.4 Hz, 1H, NCHCH2C=CH), 7.31-7.50 (m, 7H, CHarom), 8.12 (dd, J = 1.5 Hz, J = 
7.7 Hz, 1H, O=CCCH) ppm. 
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13C-NMR (75 MHz, CDCl3): 
δ = 37.50 (C-8), 56.21 (C-9), 126.43 (Carom), 127.32 (C-6), 128.08 (Carom), 128.42 (C-2), 
128.43, 129.03, 132.52 (Carom), 137.57 (C-7), 140.95 (C-10), 166.29 (C-1) ppm. (the missing 
peaks were covered by other peaks) 
 
MS (EI):  
m/z (%) = 224 (13), 223 (M●+, 75), 119 (12), 118 (M●+−NH2Bn, 100), 90 (26), 89 (10). 
 
All other analytical data correspond with those reported in the literature.54d,58b
 
(3S)-3-Phenyl-3,4-dihydro-2H-isoquinolin-1-one [(S)-79a] 
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In a 100 mL Schlenk flask under argon, a THF solution of SmI2 (49 mL, 4.85 mmol, 0.1 M in 
THF) was added dropwise at room temperature to a solution of dihydroisoquinolinone 
(3S,2’R)-77a (0.544 g, 1.62 mmol) and DMPU (2.8 mL) in abs. THF (11 mL). After 30 min 
30 mL of the THF solution of SmI2 were added in order to keep the solution deep blue. The 
reaction mixture was then quenched with 10% aqueous NaHCO3 (280 mL) and diluted with 
CH2Cl2 (110 mL). After phase separation the aqueous phase was extracted 2 times with 
CH2Cl2 (170 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The 
residue was purified by column chromatography (n-pentane/Et2O = 1/3) providing (S)-79a as 
a colourless solid. 
 
Yield:   m = 0.335 g (1.50 mmol)  93% 
Optical rotation: [α]D26 = −191.9   (c = 1.04, CHCl3) (Lit.58b [α]D20 =  
−203.4 (c = 1.03, CHCl3)) 
ee:   = 98%     (Chiralcel OD, n-heptane/i-PrOH  
= 9/1, Rt = 16.81 min, λ = 254 nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-79a. 
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(3R)-2-(2’-Chloro-acetyl)-3-phenyl-3,4-dihydro-2H-isoquinolin-1-one [(R)-130] 
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According to the general procedure GP-5, chloroacetyl chloride (20 µL, 0.25 mmol) and 
dihydroisoquinolinone (R)-79a (0.044 g, 0.20 mmol) were heated to 80 °C for 4 h. The 
resulting crude product was used directly in the next step. 
 
Conversion:  ≥ 96%     (1H-NMR) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.28 (dd, J = 2.0 Hz, J = 16.6 Hz, 1H, NCHCH2), 3.66 (dd, J = 6.2 Hz, J = 16.6 Hz, 1H, 
NCHCH2), 4.93 (d, J = 16.3 Hz, 1H, CH2Cl), 5.03 (d, J = 16.3 Hz, 1H, CH2Cl), 6.16 (dd, J = 
2.0 Hz, J = 6.2 Hz, 1H, NCHCH2), 7.03-7.22 (m, 6H, CHarom), 7.32-7.39 (m, 1H, CHarom), 
7.48 (td, J = 1.5 Hz, J = 7.4 Hz, 1H, CHarom), 8.13 (m, 1H, CHarom) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 34.19 (C-10), 47.73 (C-1), 55.35 (C-11), 126.02 (C-13), 127.58, 127.65, 128.17 (Carom), 
128.59 (C-14), 129.24 (Carom), 134.38 (C-7), 137.31 (C-9), 139.15 (C-12), 165.78, 169.88 (C-
2/C-3) ppm. (the missing peak was hidden by other peaks). 
 
(3S)-2-(2’-Chloro-acetyl)-3-phenyl-3,4-dihydro-2H-isoquinolin-1-one [(S)-130] 
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141 
EXPERIMENTAL PART 
According to the general procedure GP-5, chloroacetyl chloride (47 µL, 0.60 mmol) and 
dihydroisoquinolinone (S)-79a (0.107 g, 0.48 mmol) were heated to 80 °C for 4 h. The 
resulting crude product was used directly in the next step. 
 
Conversion:  ≥ 96%     (1H-NMR) 
 
The spectroscopic data correspond to those of the other enantiomer (R)-130. 
 
(3R)-2-(2’-Phenylsulfinyl-acetyl)-3-phenyl-3,4-dihydro-2H-isoquinolin-1-one [(R)-139] 
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According to the general procedure GP-5, (phenylthio)acetyl chloride (70 µL, 0.47 mmol) and 
dihydroisoquinolinone (R)-79a (0.099 g, 0.44 mmol) were heated to 80 °C for 20 h. The 
resulting crude (3R)-3-phenyl-2-(2’-phenylsulfanyl-acetyl)-3,4-dihydro-2H-isoquinolin-1-one 
was used directly in the next step. 
 
Conversion:  ≥ 90%     (1H-NMR) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.24 (dd, J = 1.7 Hz, J = 16.3 Hz, 1H, NCHCH2), 3.58 (dd, J = 5.8 Hz, J = 16.3 Hz, 1H, 
NCHCH2), 4.52 (dd, J = 1.5 Hz, 2H, CH2S), 6.10 (d, J = 5.8 Hz, 1H, NCHCH2), 7.06-7.47 
(m, 13H, CHarom), 8.14 (d, J = 7.7 Hz, 1H, CHCCO) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 34.12, 42.38, 54.72, 126.01, 126.75, 126.92, 127.34, 127.50, 128.04, 128.48, 128.72, 
128.93, 129.29, 130.26, 134.18, 137.29, 139.41, 165.78, 172.18 ppm. 
 
In a 100 mL flask a solution of (3R)-3-phenyl-2-(2’-phenylsulfanyl-acetyl)-3,4-dihydro-2H-
isoquinolin-1-one (max. 0.44 mmol) in CH2Cl2 (10 mL) and 10% aqueous Na2CO3 (5 mL) 
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were vigourously stirred at 0 °C. A solution of m-CPBA (0.109 g, 0.44 mmol, 70-75% in 
H2O) in CH2Cl2 (5 mL) was added dropwise over 45 min. After another 10 min at 0 °C, the 
organic layer was separated and the aqueous phase was extracted once with CH2Cl2 (10 mL). 
The combined organic layers were washed with brine (10 mL), dried over MgSO4, filtered 
and concentrated under reduced pressure. The residue was used in the next step without 
further purification. 
 
Conversion:  ~ 81%     (13C-NMR) 
 
1H-NMR (300 MHz, CDCl3, mixture of diastereomers): 
δ = 3.22 (dd, J = 1.6 Hz, J = 18.7 Hz, 1H, NCHCH2 (min.)), 3.25 (dd, J = 1.6 Hz, J = 16.8 Hz, 
1H, NCHCH2 (maj.)), 3.55 (dd, J = 5.8 Hz, J = 18.7 Hz, 1H, NCHCH2 (min.)), 3.60-3.69 (m, 
1H, NCHCH2 (maj.)), 4.52-4.65 (m, 3H, CH2SO), 4.82 (d, J = 14.3 Hz, 1H, CH2SO), 6.06 (d, 
J = 5.8 Hz, 1H, NCH (min.)), 6.15 (d, J = 6.1 Hz, 1H, NCH (maj.)), 7.02-7.52 (m, 23H, 
CHarom), 7.71-7.78 (m, 3H, CHarom), 8.02-8.08 (m, 1H, CHarom), 8.08-8.14 (m, 1H, CHarom) 
ppm. 
 
13C-NMR (75 MHz, CDCl3, mixture of diastereomers): 
δ = 33.91 (C-14 (min.)), 34.01 (C-14 (maj.)), 54.96 (C-15), 67.64 (C-5), 124.26 (Carom (maj.)), 
124.44 (Carom (min.)), 125.94 (Carom), 127.47 (Carom (maj.)), 127.50 (Carom (min.)), 127.54, 
128.53 (Carom), 129.23 (Carom (maj.)), 129.29 (Carom (min.)), 131.28 (Carom (maj.)), 131.38 
(Carom min.)), 137.38 (Carom (min.)), 134.44 (Carom (maj.)), 137.39, 137.53 (C-8/C-13), 138.98 
(C-16 (min.)), 139.05 (C-16 (maj.)), 143.38 (C-4 (maj.)), 143.69 (C-4 (min.)), 165.86 (C-7), 
167.70 (C-6 (min.)), 168.06 (C-6 (maj.)) ppm. (the missing peaks were covered by the other 
peaks). 
 
(R)-3-Phenyl-1,2,3,4-tetrahydroisoquinoline [(R)-80a] 
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According to the general procedure GP-6, dihydroisoquinolinone (3R,2’S)-77a (0.381 g, 
1.13 mmol) was reacted with BH3·THF (23 mL, 22.65 mmol, 1 M in THF). After purification 
by column chromatography (n-pentane/Et2O = 7/3) (R)-80a was obtained as a pale yellow oil. 
 
Yield:   m = 0.197 g (0.94 mmol)  83% 
GC:   Rt = 8.13 min    (Sil-8, 140-10-300) 
TLC:   Rf = 0.10    (n-pentane/Et2O = 1/1) 
Optical rotation: [α]D23.5 = +112.9   (c = 1.39, CHCl3) 
ee:   = 97%     (Chiralcel OJ, n-heptane/i-PrOH =  
98/2, Rt = 38.45 min, λ = 214 nm) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 2.15 (br, 1H, NH), 2.94 (d, J = 7.1 Hz, 2H, NCHCH2), 3.98 (t, J = 7.1 Hz, 1H, NCHCH2), 
4.14 (d, J = 15.7 Hz, 1H, NCH2CCH), 4.24 (d, J = 15.7 Hz, 1H, NCH2CCH), 7.03-7.18 (m, 
4H, CHarom), 7.23-7.45 (m, 5H, CHarom) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 37.65 (C-8), 49.17 (C-1), 58.53 (C-9), 125.84, 126.12, 126.20, 126.49, 127.34 (Carom), 
128.57 (C-12), 129.04 (Carom), 134.82, 134.91 (C-2/C-7), 144.22 (C-10) ppm. 
 
All other analytical data correspond to those reported in the literature.133
 
(3S)-3-Phenyl-1,2,3,4-tetrahydroisoquinoline [(S)-80a] 
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According to the general procedure GP-6, dihydroisoquinolinone (3S,2’R)-77a (0.809 g, 
2.41 mmol) was reacted with BH3·THF (48 mL, 48.09 mmol, 1 M in THF). After purification 
by column chromatography (n-pentane/Et2O = 7/3) (S)-80a was obtained as a pale yellow oil. 
 
Yield:   m = 0.428 g (2.04 mmol)  84% 
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Optical rotation: [α]D25 = −137.5   (c = 1.03, CHCl3) 
ee:   = 97%     (Chiralcel OJ, n-heptane/i-PrOH = 
98/2, Rt = 43.44 min, λ = 214 nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-80a. 
 
1-Chloro-2-iodo-ethane [144] 
 
I
Cl
1
2
 
 
Sodium iodide (30.0 g, 200.0 mmol) was placed in a Soxhlet socket and extracted with the 
condensate from the vapours of a boiling mixture of 1,2-dichloroethane (500 mL) and acetone 
(200 mL) during 21 h. The acetone was distilled from the reaction mixture which was then 
washed 2 times with sat. aqueous Na2S2O5 (500 mL), dried over MgSO4 and filtered. The 
solution was fractionally distilled to yield 144 as a brown liquid. 
 
Yield:   m = 15.387 g (80.8 mmol)  40% 
GC:   Rt = 3.08 min    (Sil-8, 40-10-300) 
bp:   133 °C     (Lit.134 137-139 °C) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.38-3.45 (m, 2H, CH2I), 3.78-3.86 (m, 2H, CH2Cl) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 2.35 (C-2), 43.73 (C-1) ppm. 
 
MS (EI):  
m/z (%) = 192 (M●+, 10), 190 (M●+, 34), 65 (28), 63 (100). 
 
IR (capillary): 
ν = 2970 (w), 1434 (s), 1276 (m), 1234 (s), 1163 (vs), 1047 (m), 906 (w), 822 (s), 708 (vs), 
659 (m), 576 (vs). 
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Elementary analysis: 
Anal. Calcd. for C2H4ClI:  C = 12.62 H = 2.12 
Found:     C = 12.65 H = 2.51 
 
(3R)-2-(2’-Chloro-ethyl)-3-phenyl-1,2,3,4-tetrahydroisoquinoline [(R)-145] 
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In a 5 mL flask under argon, BH3·THF (0.89 mL, 0.89 mmol, 1 M in THF) was added to a 
solution of crude chloroacetyl (R)-130 (max. 0.20 mmol) in abs. THF (2 mL). The reaction 
mixture was heated to reflux for 2 h and then cooled to 0 °C. MeOH (1.5 mL)  was carefully 
added and the mixture was diluted with CH2Cl2 (10 mL)  and H2O (10 mL). The organic 
phase was kept and the remaining aqueous phase was extracted 2 times with CH2Cl2 (10 mL). 
The combined organic phases were dried over MgSO4, filtered and concentrated under 
reduced pressure. The residue was absorbed over silica and purified by column 
chromatography (n-pentane/Et2O = 15/1) to give (S)-145 as a colourless syrup. 
 
Yield:   m = 0.032 g (0.12 mmol)  60% 
GC:   Rt = 12.76 min   (Sil-8, 120-10-300) 
TLC:   Rf = 0.46    (n-pentane/Et2O = 15/1) 
Optical rotation: [α]D20 = +69.1    (c = 0.49, CHCl3) 
ee:   = 95%     (Chiralpak AD, n-heptane/i-PrOH  
= 98/2, Rt = 9.75 min, λ = 214 nm) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.58 (dt, J = 6.6 Hz, J = 13.5 Hz, 1H, NCH2CH2Cl), 2.92 (dt, J = 7.4 Hz, J = 13.5 Hz, 1H, 
NCH2CH2Cl), 3.03 (dd, J = 4.7 Hz, J = 16.5 Hz, 1H, NCHCH2), 3.13 (dd, J = 9.1 Hz, J = 16.5 
Hz, 1H, NCHCH2), 3.54 (t, J = 7.4 Hz, 2H, NCH2CH2Cl), 3.75-3.82 (m, 2H, NCHCH2, 
NCH2CCH), 4.11 (d, J = 15.4 Hz, 1H, NCH2CCH), 7.06-7.11 (m, 2H, CHarom), 7.14-7.18 (m, 
2H, CHarom), 7.26-7.38 (m, 5H, CHarom) ppm. 
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13C-NMR (100 MHz, CDCl3): 
δ = 36.82 (C-10), 41.51 (C-1), 54.70 (C-3), 55.51 (C-2), 63.95 (C-11), 125.77, 126.05, 
126.27, 127.42 (Carom), 127.70 (C-13), 128.01, 128.26 (Carom), 128.46 (C-14), 133.67, 133.90 
(C-4/C-9), 141.85 (C-12) ppm. 
 
MS (EI):  
m/z (%) = 271 (M●+, 8), 223 (16), 222 (M●+−COCH2Cl, 100), 194 (17), 193 (42), 115 (13), 
104 (33). 
 
IR (in CHCl3): 
ν = 3062 (w), 3027 (m), 2925 (m), 2836 (w), 2794 (w), 1715 (w), 1659 (m), 1604 (w), 1495 
(m), 1452 (s), 1379 (w), 1316 (w), 1257 (w), 1219 (w), 1134 (w), 1105 (w), 754 (vs), 702 (s), 
666 (w). 
 
A correct elementary analysis could not be obtained due to the insufficient stability of the 
product. 
 
(3S)-2-(2’-Chloro-ethyl)-3-phenyl-1,2,3,4-tetrahydroisoquinoline [(S)-145] 
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Method A: 
In a 10 mL Schlenk flask under argon, a solution of crude chloroacetyl (S)-130 (max. 
0.48 mmol) in abs. THF (2 mL) was added dropwise to a suspension of LiAlH4 (0.109 g, 
2.87 mmol) in abs. THF (4 mL). After 2 h at room temperature, the reaction was carefully 
quenched with H2O (1.5 mL). The organic phase was washed successively with 10% aqueous 
NaOH (2.5 mL) and H2O (2.5 mL). The combined aqueous phases were then extracted with 
CHCl3 (10 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude mixture was absorbed in silica and purified 
by column chromatography (n-pentane/Et2O = 15/1) to yield (S)-145 as a colourless syrup. 
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Yield:   m = 0.040 g (0.15 mmol)  31% 
ee:   = 93%     (Chiralpak AD, n-heptane/i-PrOH  
        = 98/2, Rt = 12.04 min, λ = 214 nm) 
 
Method B: 
In a 25 mL Schlenk flask under argon, a solution of alcohol (S)-148 (0.101 g, 0.40 mmol) in 
abs. CH2Cl2 (13 mL) was cooled to 0 °C. Et3N (61 µL, 0.44 mmol) and methanesulfonyl 
chloride (34 µL, 0.44 mmol) were successively added. After 5 min at 0 °C the temperature 
was increased to room temperature and the reaction mixture was stirred for 5 h. The reaction 
was then diluted with CH2Cl2 and the organic phase was washed 2 times with sat. aqueous 
NaHCO3 and 2 times with H2O. After drying over MgSO4, filtration and concentration under 
reduced pressure, the residue was absorbed in silica and purified by column chromatography 
(n-pentane/Et2O = 20/1) to yield (S)-145 as a colourless syrup. 
 
Yield:   m = 0.066 g (0.24 mmol)  60% 
Optical rotation: [α]D24 = −61.6    (c = 0.88, CHCl3) (ee = 97%) 
ee:   = 97%     (Chiralpak AD, n-heptane/i-PrOH  
        = 98/2, Rt = 12.21 min, λ = 254 nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-145. 
 
2-((3’S)-3’-Phenyl-3’,4’-dihydro-1H-isoquinolin-2’-yl)-ethanol [(S)-148] 
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According to the general procedure GP-7, tetrahydroisoquinoline (S)-80a (0.238 g, 
1.14 mmol), 2-iodoethanol (0.10 mL, 1.25 mmol) and NaHCO3 (0.105 g, 1.25 mmol) were 
heated to reflux for 24 h. The resulting crude mixture was purified by column 
chromatography (n-pentane/Et2O = 1/2) to yield (S)-148 as a colourless syrup. 
 
Yield:   m = 0.239 g (0.94 mmol)  82% 
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GC:   Rt = 10.64 min   (Sil-8, 140-10-300) 
TLC:   Rf = 0.18    (n-pentane/Et2O = 1/2) 
Optical rotation: [α]D26 = −42.6    (c = 0.35, CHCl3) 
ee:   ≥ 97%     (deduced from the ee obtained for 
the corresponding chloride (S)-145) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.32 (dt, J = 4.7 Hz, J = 12.6 Hz, 1H, NCH2CH2OH), 2.61 (br, 1H, OH), 2.71-2.79 (m, 
1H, NCH2CH2OH), 3.06-3.19 (m, 2H, NCHCH2), 3.50 (dt, J = 4.7 Hz, J = 11.0 Hz, 1H, 
NCH2CH2OH), 3.63 (d, J = 15.4 Hz, 1H, NCH2CCH), 3.63-3.73 (m, 1H, NCH2CH2OH), 3.82 
(dd, J = 5.5 Hz, J = 8.0 Hz, 1H, NCHCH2), 4.2 (d, J = 15.4 Hz, 1H, NCH2CCH), 7.05-7.13 
(m, 2H, CHarom), 7.15-7.20 (m, 2H, CHarom), 7.24-7.36 (m, 5H, CHarom) ppm 
 
13C-NMR (100 MHz, CDCl3): 
δ = 36.09 (C-10), 53.24 (C-3), 54.76 (C-2), 58.19 (C-1), 63.75 (C-11), 125.74, 126.13, 
126.28, 127.34 (Carom), 127.82 (C-13), 128.04 (Carom), 128.42 (C-14), 133.79, 133.98 (C-4/C-
9), 141.50 (C-12) ppm. 
 
MS (EI):  
m/z (%) = 253 (M●+, 4), 223 (18), 222 (M●+−CH2CH2OH, 100), 193 (49), 178 (10), 115 (19). 
 
IR (in CHCl3): 
ν = 3400 (w), 3063 (w), 3011 (w), 2926 (m), 2829 (w), 1495 (w), 1452 (m), 1376 (w), 1217 
(w), 1132 (w), 1102 (w), 1060 (m), 1034 (m), 973 (w), 754 (vs), 703 (m), 667 (w). 
 
HRMS: 
m/z Calcd. for C17H19NO (M●+):  253.1466 
Found:     253.1466 
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(3R)-2-(2’-Phenylsulfinyl-ethyl)-3-phenyl-1,2,3,4-tetrahydroisoquinoline [(R)-152] 
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In a 10 mL flask under argon, a solution of tetrahydroisoquinoline (R)-80a (0.161 g, 
0.77 mmol) and phenyl vinyl sulfoxide (0.15 mL, 1.15 mmol) in abs. MeOH (2.7 mL) was 
heated to reflux for 24 h. The solvent was evaporated under reduced pressure and the residue 
was purified by column chromatography (n-pentane/Et2O = 1/3 then pure Et2O) to yield 
(R)-152 as a pale yellow oil. 
 
Yield:   m = 0.248 g (0.69 mmol)  90% 
HPLC:  (maj.) Rt = 13.12 min   (LiChrosorb Si 60 7µ; pure Et2O; 
λ = 254 nm) 
   (min.) Rt = 15.03 min   (LiChrosorb Si 60 7µ; pure Et2O; 
λ = 254 nm) 
TLC:   Rf = 0.15    (n-pentane/Et2O = 1/3) 
dr:   = 57/43    (LiChrosorb Si 60 7µ; pure Et2O; 
λ = 254 nm) 
 
1H-NMR (400 MHz, CDCl3, mixture of diastereomers): 
δ = 2.46-2.53 (m, 1H, CH2SO), 2.70-3.15 (m, 11H, CH2CH2SO, CH2SO, NCHCH2), 3.67 (d, 
J = 15.2 Hz, 1H, NCH2C), 3.69-3.78 (m, 3H, NCH2C, NCH), 3.97 (d, J = 15.2 Hz, 1H, 
NCH2C), 3.98 (d, J = 15.2 Hz, 1H, NCH2C), 7.01-7.09 (m, 4H, CHarom), 7.12-7.16 (m, 4H, 
CHarom), 7.23-7.32 (m, 10H, CHarom), 7.39-7.48 (m, 8H, CHarom), 7.50-7.54 (m, 2H, CHarom) 
ppm. 
 
13C-NMR (100 MHz, CDCl3, mixture of diastereomers): 
δ = 36.51 (C-14 (min.)), 36.69 (C-14 (maj.)), 47.06 (C-5 (maj.)), 47.41 (C-5 (min.)), 53.90 
(C-7 (maj.)), 53.99 (C-7 (min.)), 55.28 (C-6 (maj.)), 55.33 (C-6 (min.)), 63.60 (C-15 (min.)), 
63.75 (C-15 (maj.)), 123.68 (C-3 (maj.)), 123.72 (C-3 (min.)), 125.67, 126.00 (Carom), 126.20 
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(Carom (maj.)), 126.23, 127.33 (Carom (min.)), 127.41 (Carom (maj.)), 127.73 (Carom), 127.88 
(Carom (min.)), 127.94 (Carom (maj.)), 128.31 (Carom (min.)), 128.39 (Carom (maj.)), 128.90 (C-
2), 130.57 (C-1), 133.56, 133.86 (C-8/C-13), 141.30 (C-4 (maj.)), 141.35 (C-4 (min.)), 143.60 
(C-16 (min.)), 143.88 (C-16 (maj.)) ppm. 
 
MS (EI):  
m/z (%) = 345 (23), 344 (M●+−OH, 100), 235 (12), 234 (16), 193 (14), 137 (35), 115 (14), 104 
(19). 
 
IR (capillary): 
ν = 3058 (s), 3028 (m), 2921 (s), 2793 (m), 2723 (w), 1588 (w), 1494 (s), 1448 (s), 1377 (w), 
1134 (w), 1097 (s), 1043 (vs), 966 (w), 746 (vs), 700 (vs), 556 (w). 
 
HRMS: 
m/z Calcd. for C23H22NS (M●+−OH):  344.1473 
Found:      344.1472 
 
N,N-Diethyl-2,3-dimethoxy-benzamide [154] 
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In a 500 mL flask oxalyl chloride (13 mL, 150.0 mmol) was added dropwise to a solution of 
2,3-dimethoxybenzoic acid (18.218 g, 100.0 mmol) and anhydrous DMF (0.77 mL, 
10.0 mmol) in CH2Cl2 (200 mL). The reaction mixture was stirred 1 h at room temperature 
and the solvent was evaporated under reduced pressure. The residue was coevaporated 2 times 
with benzene. The crude acyl chloride was dissolved in CH2Cl2 (200 mL) and the temperature 
was decreased to −45 °C. Et2NH (41 mL, 400.0 mmol) was added dropwise and the 
temperature was allowed to increase slowly to room temperature overnight. The reaction 
mixture was diluted with CH2Cl2 and the organic phase was washed successively with H2O, 1 
N aqueous HCl and brine. The organic layer was dried over MgSO4, filtered and concentrated 
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under reduced pressure. The resulting crude mixture was purified by column chromatography 
(n-pentane/Et2O = 1/2) to give 154 as a pale yellow liquid. 
 
Yield:   m = 21.818 g (91.9 mmol)  92% 
GC:   Rt = 9.98 min    (Sil-8, 100-10-300) 
TLC:   Rf = 0.22    (n-pentane/Et2O = 1/2) 
 
1H-NMR (300 MHz, CDCl3, mixture of rotamers): 
δ = 1.04 (t, J = 7.2 Hz, 3H, CH2CH3), 1.25 (t, J = 7.2 Hz, 3H, CH2CH3), 3.16 (qd, J = 2.5 Hz, 
J = 7.2 Hz, 2H, CH2CH3), 3.35-3.57 (br, 1H, CH2CH3), 3.64-3.78 (br, 1H, CH2CH3), 3.85 (s, 
3H, OCH3), 3.88 (s, 3H, OCH3), 6.78-6.83 (m, 1H, CH3OCCH), 6.92 (dd, J = 1.5 Hz, J = 8.2 
Hz, 1H, O=CCCH), 7.07 (dd, J = 8.2 Hz, 1H, CH3OCCHCH) ppm. 
 
13C-NMR (75 MHz, CDCl3, mixture of rotamers): 
δ = 12.81 (C-1'), 13.99 (C-1), 38.91 (C-2'), 43.01 (C-2), 55.82 (C-8), 61.53 (C-6), 112.59 (C-
11), 118.85 (C-9), 124.62 (C-10), 132.48 (C-4), 144.79 (C-5), 152.70 (C-7), 168.39 (C-3) 
ppm. 
 
All other analytical data correspond to those reported in the literature.135
 
N,N-Diethyl-2,3-dimethoxy-6-methyl-benzamide [117] 
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In a 500 mL Schlenk flask under argon, a solution of TMEDA (7.9 mL, 52.5 mmol) in abs. 
THF (200 mL) was cooled to −78 °C. s-BuLi (40.4 mL, 52.50 mmol, 1.3 M in hexane) was 
rapidly added and the reaction mixture was stirred at −78 °C for 15 min. A solution of 2,3-
dimethoxy benzamide 154 (11.865 g, 50.0 mmol) in abs. THF (50 mL) was added and the 
reaction was stirred for 1 h 30 min. Methyl iodide (15.6 mL, 250.0 mmol) was rapidly added 
and the reaction was warmed up slowly overnight. The reaction was quenched with H2O and 
the organic layer was kept. The aqueous phase was extracted 2 times with Et2O and the 
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combined organic layers were washed with H2O and brine. After drying over MgSO4, 
filtration and concentration under reduced pressure, the resulting crude mixture was purified 
by column chromatography (n-hexane/acetone = 4/1) providing 117 as a pale yellow oil. 
 
Remark: in order to obtain a good yield in the next step (formation of the 
dihydroisoquinolinone 156), 117 should be absolutely free of the non-substituted and the 
dimethyl-substituted benzamide. An appropriate 60 cm column filled with silica should be 
used for the purification. 
 
Yield:   m = 10.926 g (43.5 mmol)  87% 
GC:   Rt = 11.95 min   (Sil-8, 100-10-300) 
TLC:   Rf = 0.20    (n-pentane/Et2O = 1/1) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.04 (t, J = 7.2 Hz, 3H, CH2CH3), 1.26 (t, J = 7.2 Hz, 3H, CH2CH3), 2.19 (s, 3H, CCH3), 
3.03-3.23 (m, 2H, CH2CH3), 3.47-3.72 (m, 2H, CH2CH3), 3.84 (s, 3H, OCH3), 3.86 (s, 3H, 
OCH3), 6.80 (d, J = 8.4 Hz, 1H, CH3OCCH), 6.89 (d, J = 8.4 Hz, 1H, CH3CCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 12.71 (C-1), 13.81 (C-1'), 17.97 (C-12), 38.54 (C-2), 42.61 (C-2'), 55.72 (C-8), 61.39 (C-
6), 111.99 (C-9), 125.49 (C-10), 126.42 (C-4), 132.11 (C-11), 144.37 (C-5), 150.34 (C-7), 
167.63 (C-3) ppm. 
 
Elementary analysis: 
Anal. Calcd. for C14H21NO3:  C = 66.91 H = 8.42 N = 5.57 
Found:     C = 66.72 H = 8.80 N = 5.87 
 
All other analytical data correspond to those of the literature.135a
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[1-(3’,4’-Dimethoxy-phenyl)-meth-(1E)-ylidene]-((2’’S)-2’’-methoxymethyl-pyrrolidin-
1’’-yl)-amine [(S)-127] 
 
MeO
H
N
N
OMeMeO
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According to the general procedure GP-1, 3,4-dimethoxybenzaldehyde (3.988 g, 24.0 mmol) 
and SAMP (2.791 g, 20.0 mmol, 93% purity (GC)) were reacted overnight. After distillation 
under high vacuum using a microdistillation apparatus (S)-127 was obtained as an orange 
syrup. 
 
Yield:   m = 5.466 g (19.6 mmol)  98% 
GC:   Rt = 15.67 min   (Sil-8, 100-10-300) 
bp:   136 °C/0.1-0.01 mbar 
Optical rotation: [α]D25 = −114.7   (c = 0.89, CHCl3) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.78-2.08 (m, 4H, NCH2CH2CH2), 2.94-3.05 (m, 1H, NCH2), 3.40 (s, 3H, CH2OCH3), 
3.42-3.53 (m, 2H, NCH2, OCH2), 3.59-3.72 (m, 2H, OCH2, NCH), 3.86 (s, 3H, COCH3), 3.92 
(s, 3H, COCH3), 6.80 (d, J = 8.2 Hz, 1H, CH3OCCHCH), 6.96 (dd, J = 1.8 Hz, J = 8.2 Hz, 
1H, N=CHCCHCH), 7.20 (s, 1H, N=CH), 7.25 (d, J = 1.8 Hz, 1H, N=CHCCHCO) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 22.23 (C-5), 26.83 (C-4), 49.37 (C-6), 55.78, 55.89 (C-11/C-13), 59.26 (C-1), 63.18 (C-
3), 74.77 (C-2), 107.17 (C-9), 110.04 (C-14), 119.04 (C-15), 130.59 (C-8), 133.05 (C-7), 
148.59, 149.19 (C-10/C-12) ppm. 
 
MS (EI):  
m/z (%) = 278 (M●+, 32), 234 (16), 233 (M●+−CH2OCH3, 100), 70 (18). 
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IR (capillary): 
ν = 3075 (w), 2933 (vs), 2833 (vs), 1597 (vs), 1563 (s), 1513 (vs), 1461 (s), 1416 (s), 1379 
(m), 1342 (m), 1268 (s), 1229 (w), 1166 (w), 1118 (s), 1028 (vs), 973 (m), 885 (s), 807 (s), 
758 (vs), 668 (w), 626 (m), 607 (m), 565 (w), 528 (w), 480 (w). 
 
Elementary analysis: 
Anal. Calcd. for C15H22N2O3: C = 64.73 H = 7.97 N = 10.06 
Found:     C = 64.91 H = 7.52 N = 10.26 
 
[1-(3’,4’-Dimethoxy-phenyl)-meth-(1E)-ylidene]-((2’’R)-2’’-methoxymethyl-pyrrolidin-
1’’-yl)-amine [(R)-127] 
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According to the general procedure GP-1, 3,4-dimethoxybenzaldehyde (3.988 g, 24.0 mmol) 
and RAMP (3.493 g, 20.0 mmol, 75% purity (GC)) were reacted overnight. After distillation 
under high vacuum using a microdistillation apparatus (R)-127 was collected as a pale yellow 
syrup. 
 
Yield:   m = 5.539 g (19.9 mmol)  quant. 
Optical rotation: [α]D28 = +114.1   (c = 1.27, CHCl3) 
 
All other analytical data correspond to those of the other enantiomer (S)-127. 
155 
EXPERIMENTAL PART 
(3R)-3-(3’,4’-Dimethoxy-phenyl)-7,8-dimethoxy-2-((2’’S)-2’’-methoxymethyl-pyrrolidin-
1’’-yl)-3,4-dihydro-2H-isoquinolin-1-one [(3R,2’’S)-156] 
 
N
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OMe
1
2 3 4
5
67
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
 
 
In a 250 mL Schlenk flask under argon, s-BuLi (7.5 mL, 9.75 mmol, 1.3 M in hexane) was 
added to a solution of TMEDA (1.59 mL, 10.50 mmol) in abs. THF (10 mL) and abs. Et2O 
(50 mL) at −78 °C. After 15 min a solution of 2,3-dimethoxy-6-methyl benzamide 117 
(2.639 g, 10.50 mmol) in abs. Et2O (10 mL) was added dropwise. The temperature was 
increased to −40 °C and a solution of SAMP-hydrazone (S)-127 (0.418g, 1.50 mmol) in abs. 
Et2O (6 mL), previously complexed with AlMe3 (2.3 mL, 4.65 mmol, 2 M in heptane) for at 
least 1 h, was added dropwise over 45 min. The reaction mixture was stirred overnight (17 h) 
at −40 °C. The reaction was quenched with 10% aqueous potassium and sodium tartrate 
(10 mL) and sat. aqueous NH4Cl (10 mL). After phase separation, the aqueous layer was 
extracted 4 times with Et2O (30 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated under reduced pressure. The crude mixture was purified by column 
chromatography (n-pentane/AcOEt = 1/2) to yield (3R,2’’S)-156 as a pale yellow syrup. 
 
Yield:   m = 0.375 g (0.82 mmol)  55% 
GC:   Rt = 15.64 min   (Sil-8, 180-10-300) 
TLC:   Rf = 0.24    (pure Et2O) 
Optical rotation: [α]D24 = +21.18   (c = 1.67, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.40-1.53 (m, 1H, NCH2CH2CH2), 1.56-1.72 (m, 1H, NCH2CH2CH2), 1.88-2.02 (m, 1H, 
NCH2CH2CH2), 2.06-2.20 (m, 1H, NCH2CH2CH2), 2.83 (dd, J = 2.2 Hz, J = 15.3 Hz, 1H, 
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O=CNCHCH2), 2.95 (dt, J = 3.7 Hz, J = 7.7 Hz, 1H, NCH2), 3.40 (s, 3H, CH2OCH3), 3.38-
3.50 (m, 2H, OCH2), 3.65-3.91 (m, 2H, NCH2, O=CNCHCH2), 3.73 (s, 3H, COCH3), 3.78 (s, 
3H, COCH3), 3.81 (s, 3H, COCH3), 3.98 (s, 3H, COCH3), 4.10-4.22 (br, 1H, NCH), 4.98 (dd, 
J = 2.2 Hz, J = 6.2 Hz, 1H, O=CNCHCH2), 6.62-6.69 (m, 4H, CHarom), 6.84 (d, J = 8.4 Hz, 
1H, CHarom) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 22.89 (C-5), 26.83 (C-4), 36.99 (C-16), 51.70 (C-6), 55.67, 55.75, 56.12 (C-10/C-12/C-
21/C-23), 58.90 (C-1), 59.85 (C-3), 61.61 (C-10/C-12/C-21/C-23), 65.82 (C-17), 77.17 (C-2), 
109.83, 110.77, 115.30, 118.73, 122.84 (Carom), 124.56 (C-8), 128.93 (C-15), 133.38 (C-18), 
147.56, 148.52, 149.81, 152.70 (C-9/C-11/C-20/C-22), 161.81 (C-7) ppm. 
 
MS (EI):  
m/z (%) =456 (M●+, 1), 412 (24), 411 (M●+−CH2OCH3, 87), 344 (24), 343 (M●+−SMP+1, 
100), 342 (14), 327 (15), 325 (18), 324 (12), 312 (17), 205 (15), 192 (10), 178 (11), 166 (11), 
151 (46). 
 
IR (in CHCl3): 
ν = 3001 (s), 2937 (vs), 2876 (s), 2836 (s), 1653 (vs), 1581 (m), 1516 (vs), 1484 (vs), 1455 
(vs), 1419 (vs), 1389 (m), 1351 (w), 1302 (s), 1265 (vs), 1140 (s), 1102 (m), 1064 (m), 1033 
(vs), 1002 (m), 956 (w), 906 (w), 855 (w), 810 (w), 792 (m), 755 (vs), 666 (w). 
 
A correct elementary analysis could not be obtained. 
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(3S)-3-(3’,4’-Dimethoxy-phenyl)-7,8-dimethoxy-2-((2’’R)-2’’-methoxymethyl-pyrrolidin-
1’’-yl)-3,4-dihydro-2H-isoquinolin-1-one [(3S,2’’R)-156] 
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According to the procedure described for (3R,2’’S)-156, s-BuLi (7.5 mL, 9.75 mmol, 1.3 M in 
hexane), TMEDA (1.59 mL, 10.50 mmol), 2,3-dimethoxy-6-methyl benzamide 117 (2.639 g, 
10.50 mmol), RAMP-hydrazone (R)-127 (0.418 g, 1.50 mmol) and trimethylaluminium 
(2.3 mL, 4.65 mmol, 2 M in heptane) were reacted overnight (17 h). The crude mixture was 
purified 2 times by column chromatography (pure Et2O) to yield (3S,2’’R)-156 as a pale 
yellow syrup. 
 
Yield:   m = 0.371 g (0.81 mmol)  54% 
Optical rotation: [α]D30 = −20.76   (c = 0.79, CHCl3) 
de:   ≥ 96%     (1H-NMR) 
 
All other analytical data correspond to those of the other enantiomer (3R,2’’S)-156. 
 
(3R)-3-(3’,4’-Dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline [(R)-142] 
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According to the general procedure GP-6, dihydroisoquinolinone (3R,2’’S)-156 (0.126 g, 
0.28 mmol) was reacted with BH3·THF (5.5 mL, 5.52 mmol, 1 M in THF). After purification 
by column chromatography (n-hexane/acetone = 1/1) (R)-142 was obtained as a champagne-
beige solid. 
 
Yield:   m = 0.075 g (0.23 mmol)  82% 
GC:   Rt = 13.63 min   (Sil-8, 160-10-300) 
TLC:   Rf = 0.09    (Et2O/MeOH = 20/1) 
mp:   103-104 °C 
Optical rotation: [α]D30 = +81.6    (c = 0.70, CHCl3) 
ee:   = 99%     (Chiralpak AD; n-heptane/i-PrOH  
= 65/35; Rt = 14.96 min; λ = 214  
nm) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.99 (br, 1H, NH), 2.86-2.96 (m, 2H, NCHCH2), 3.83-3.91 (m, 1H, NCHCH2), 3.84 (s, 
3H, OCH3), 3.85 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 4.10 (d, J = 16.4 
Hz, 1H, NCH2), 4.36 (d, J = 16.4 Hz, 1H, NCH2), 6.78 (d, J = 8.5 Hz, 1H, CHarom), 6.82 (d, J 
= 8.5 Hz, 1H, CHarom), 6.85 (d, J = 8.2 Hz, 1H, NCHCCHCH), 6.95 (dd, J = 1.9 Hz, J = 8.2 
Hz, 1H, NCHCCHCH), 7.02 (d, J = 1.9 Hz, 1H, NCHCCHCOCH3) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 37.26 (C-10), 44.75 (C-1), 55.83, 55.86 (C-4/C-6/C-15/C-17), 58.15 (C-11), 60.02 (C-
4/C-6/C-15/C-17), 109.44 (C-13), 110.70, 110.91 (C-7/C-8/C-18), 118.50 (C-19), 123.92 (C-
7/C-8), 127.99, 128.73 (C-2/C-9), 136.86 (C-12), 145.14, 148.03, 148.91, 150.09 (C-3/C-5/C-
14/C-16) ppm. (the missing peak was covered by the other signals). 
 
MS (EI):  
m/z (%) = 330 (M●++1, 10), 329 (M●+, 49), 328 (11), 165 (14), 164 ((CH3O)2C6H3(C2H2)+, 
100), 149 (40). 
 
 
 
IR (KBr): 
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ν = 3976 (m), 3948 (w), 3905 (w), 3855 (w), 3459 (vs), 3330 (s), 3236 (s), 2990 (s), 2936 
(vs), 2831 (s), 1596 (s), 1515 (vs), 1492 (vs), 1461 (vs), 1421 (vs), 1360 (w), 1323 (m), 1272 
(vs), 1228 (vs), 1157 (vs), 1080 (m), 1030 (vs), 869 (s), 800 (vs), 758 (s), 654 (w). 
 
Elementary analysis: 
Anal. Calcd. for C19H23NO4:  C = 69.28 H = 7.04 N = 4.25 
Found:     C = 69.48 H = 7.36 N = 4.38 
 
(3S)-3-(3’,4’-Dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline [(S)-142] 
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According to the general procedure GP-6, dihydroisoquinolinone (3S,2’’R)-156 (0.300 g, 
0.66 mmol) was reacted with BH3·THF (13.1 mL, 13.14 mmol, 1 M in THF). After 
purification by column chromatography (Et2O/MeOH = 20/1) (S)-142 was obtained as a 
champagne-beige solid. 
 
Yield:   m = 0.182 g (0.55 mmol)  83% 
Optical rotation: [α]D27 = −94.0    (c = 0.70, CHCl3) 
ee:   = 99%     (Chiralpak AD; n-heptane/i-PrOH  
= 65/35; Rt = 11.47 min; λ = 214  
nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-142. 
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(3S)-2-(2’-Phenylsulfinyl-ethyl)-3-(3’’,4’’-dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline [(S)-141a] 
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In a 10 mL flask under argon, a solution of tetrahydroisoquinoline (S)-142 (0.109 g, 
0.33 mmol) and phenyl vinyl sulfoxide (66 µL, 0.50 mmol) in abs. MeOH (2 mL) was heated 
to reflux for 22 h. The solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography (pure Et2O then Et2O/MeOH = 20/1) to give (S)-141a as 
a yellow syrup. 
 
Yield:   m = 0.150 g (0.31 mmol)  94% 
HPLC:  (maj.) Rt = 21.82 min   (Spherical silica; n-heptane/i-PrOH 
= 9/1; λ = 254 nm) 
   (min.) Rt = 27.90 min   (Spherical silica; n-heptane/i-PrOH  
= 9/1; λ = 254 nm) 
TLC:  (1st diast.) Rf = 0.56    (Et2O/MeOH = 20/1) 
(2nd diast.) Rf = 0.62    (Et2O/MeOH = 20/1) 
dr:   = 64/36    (Spherical silica; n-heptane/i-PrOH  
= 9/1; λ = 254 nm) 
 
1H-NMR (400 MHz, CDCl3, mixture of diastereomers): 
δ = 2.46-2.54 (m, 1H, CH2SO), 2.73-3.18 (m, 11H, NCHCH2, CH2CH2SO, CH2SO), 3.55 (d, 
J = 16.1 Hz, 1H, NCH2C (maj.)), 3.58-3.75 (m, 3H, NCH2C (min.), NCH), 3.78 (s, 3H, 
OCH3), 3.83 (s, 6H, OCH3), 3.85 (s, 9H, OCH3), 3.88 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 
4.06 (d, J = 16.2 Hz, 1H, NCH2C (min.)), 4.18 (d, J = 16.1 Hz, 1H, NCH2C (maj.)), 6.75-6.84 
(m, 9H, CHarom), 6.91 (s, 1H, CHarom), 7.43-7.49 (m, 8H, CHarom), 7.51-7.55 (m, 2H, CHarom) 
ppm. 
 
161 
EXPERIMENTAL PART 
13C-NMR (100 MHz, CDCl3, mixture of diastereomers): 
δ = 36.12 (C-16 (min.)), 36.69 (C-16 (maj.)), 47.14 (C-5), 49.36 (C-7 (min.)), 49.54 (C-7 
(maj.)), 54.84 (C-6 (min.)), 55.28 (C-6 (maj.)), 55.69, 55.78, 55.83 (C-12/C-22/C-24), 60.11 
(C-10 (maj.)), 60.16 (C-10 (min.)), 63.02 (C-17 (min.)), 63.57 (C-17 (maj.)), 110.36, 110.48, 
110.62, 110.95 (C-13/C-20/C-25), 119.93 (C-14/C-19 (maj.)), 120.00 (C-14/C-19 (min.)), 
123.14 (C-14/C-19), 123.74 (C-3), 127.18 (C-8/C-15 (min.)), 127.29, 127.69 (C-8/C-15 
(maj.)), 127.91 (C-8/C-15 (min.)), 128.89 (C-2 (min.)), 128.94 (C-2 (maj.)), 130.64 (C-1), 
133.79 (C-18 (min.)), 134.08 (C-18 (maj.)), 143.50 (C-4/C-11/C-21/C-23 (min.)), 143.97 (C-
4/C-11/C-21/C-23 (maj.)), 144.97 (C-4/C-11/C-21/C-23), 148.13 (C-4/C-11/C-21/C-23 
(min.)), 148.24 (C-4/C-11/C-21/C-23 (maj.)), 148.81 (C-4/C-11/C-21/C-23 (min.)), 149.06 
(C-4/C-11/C-21/C-23 (maj.)), 150.07 (C-9) ppm. 
 
MS (EI):  
m/z (%) = 466 (10), 465 (31), 464 (M●+−OH, 100), 355 (10), 354 (12), 313 (17), 164 (27), 149 
(11), 137 (25). 
 
IR (in CHCl3): 
ν = 3013 (m), 2962 (m), 2935 (m), 2836 (w), 1595 (w), 1513 (s), 1497 (s), 1461 (m), 1423 
(w), 1263 (s), 1219 (s), 1143 (m), 1083 (m), 1032 (s), 758 (vs), 693 (w), 667 (m).  
 
HRMS: 
m/z Calcd. for C27H30NO4S (M●+−OH): 464.1896 
Found:          464.1896 
 
(13aS)-2,3,9,10-Tetramethoxy-5-phenylsulfanyl-5,8,13,13a-tetrahydro-6H-
dibenzo[a,g]quinolizine [(S)-157] 
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In a 25 mL flask under argon, a solution of sulfoxide (S)-141a (0.124 g, 0.26 mmol), TFAA 
(0.11 mL, 0.77 mmol) and TFA (0.12 mL, 1.55 mmol) in abs. toluene (12 mL) was heated to 
reflux for 15 h. The volatiles were removed under reduced pressure and a part of the resulting 
crude mixture was purified by preparative TLC (Et2O/MeOH = 20/1) for analysis whereas the 
rest was purified by column chromatography (Et2O/MeOH = 20/1). The combined impure 
products were then used in this state of purity for the next step. 
 
TLC:   Rf = 0.78    (Et2O/MeOH = 20/1) 
 
1H-NMR (400 MHz, CDCl3, mixture of diastereomers): 
δ = 2.71-3.00 (m, 4H, NCHCH2, NCH2CHS), 3.18-3.40 (m, 4H, NCHCH2, NCH2CHS), 3.42-
3.71 (m, 4H, NCH, NCH2C), 3.78 (s, 3H, OCH3 (min.)), 3.82 (s, 3H, OCH3 (maj.)), 3.85 (s, 
3H, OCH3 (maj.)), 3.86 (s, 3H, OCH3 (min.)), 3.86 (s, 3H, OCH3 (min.)), 3.89 (s, 3H, OCH3 
(maj.)), 3.90 (s, 3H, OCH3 (min.)), 3.92 (s, 3H, OCH3 (maj.)), 4.15 (d, J = 15.9 Hz, 1H, 
NCH2C (maj.)), 4.21 (d, J = 15.9 Hz, 1H, NCH2C (min.)), 4.36 (s, 1H, CHS (min.)), 4.72 (dd, 
J = 5.2 Hz, J = 9.9 Hz, 1H, CHS (maj.)), 6.64 (s, 1H, CHarom (min.)), 6.73 (s, 1H, CHarom 
(maj.)), 6.75-6.90 (m, 4H, CHarom), 7.24-7.35 (m, 8H, CHarom), 7.42-7.52 (m, 4H, CHarom) 
ppm. 
 
13C-NMR (100 MHz, CDCl3, mixture of diastereomers): 
δ = 35.75 (C-16 (maj.)), 36.12 (C-16 (min.)), 45.94 (C-5 (maj.)), 47.68 (C-5 (min.)), 53.06 
(C-7 (maj.)), 53.28 (C-7 (min.)), 55.78, 55.83, 55.95 (C-12/C-21/C-23), 57.72 (C-6), 58.93 
(C-17 (min.)), 59.09 (C-17 (maj.)), 60.84 (C-10), 107.98 (C-13/C-19/C-24 (min.)), 108.20, 
110.68 (C-13/C-19/C-24 (maj.)), 110.77 (C-13/C-19/C-24 (min.)), 110.85 (C-13/C-19/C-24 
(maj.)), 111.66 (C-13/C-19/C-24 (min.)), 123.63 (C-14), 126.22 (C-8/C-15/C-18/C-25), 
126.98 (C-1), 127.98 (C-8/C-15/C-18/C-25), 128.73 (C-2 (min.)), 128.88 (C-2 (maj.)), 130.81 
(C-8/C-15/C-18/C-25), 131.56 (C-3), 132.31 (C-8/C-15/C-18/C-25), 134.51 (C-4), 144.87 (C-
11), 147.36, 147.99 (C-20/C-22), 150.10 (C-9) ppm. 
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2-[(3’S)-3’-(3’’,4’’-Dimethoxy-phenyl)-7’,8’-dimethoxy-3’,4’-dihydro-1H-isoquinolin-2’-
yl]-ethanol [(S)-158] 
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According to the general procedure GP-7, tetrahydroisoquinoline (S)-142 (0.097 g, 
0.30 mmol), 2-iodoethanol (25 µL, 0.32 mmol) and NaHCO3 (0.027 g, 0.32 mmol) were 
heated to reflux for 24 h. The resulting crude mixture was purified by column 
chromatography (Et2O/MeOH = 80/1 to 20/1) providing (S)-158 as a pale yellow foam. 
 
Yield:   m = 0.089 g (0.24 mmol)  80% 
GC:   Rt = 16.93 min   (Sil-8, 140-10-300) 
TLC:   Rf = 0.45    (n-pentane/Et2O = 20/1) 
Optical rotation: [α]D25 = −36.9    (c = 0.45, CHCl3) 
ee:   n. d.      
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.38 (dt, J = 4.7 Hz, J = 12.9 Hz, 1H, NCH2CH2), 2.59 (br, 1H, OH), 2.80 (ddd, J = 4.7 
Hz, J = 12.9 Hz, 1H, NCH2CH2), 2.99-3.12 (m, 2H, NCHCH2), 3.55 (dt, J = 4.7 Hz, J = 11.0 
Hz, 1H, NCH2CH2), 3.61 (d, J = 16.5 Hz, 1H, NCH2C), 3.71-3.78 (m, 2H, NCHCH2, 
NCH2CH2), 3.83 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 
4.17 (d, J = 16.5 Hz, 1H, NCH2C), 6.79-6.88 (m, 5H, CHarom) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 35.62 (C-12), 48.75 (C-3), 54.68 (C-2), 55.73, 55.77, 55.83 (C-8/C-17/C-19), 58.29 (C-1), 
60.12 (C-6), 63.09 (C-13), 110.93, 110.76, 110.93, 120.01, 123.19 (Carom), 127.28, 127.92 (C-
4/C-11), 134.14 (C-14), 145.06, 148.09, 148.86, 150.11 (C-5/C-7/C-16/C-18) ppm. 
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MS (EI):  
m/z (%) = 373 (M●+, 10), 343 (23), 342 (M●+−OCH3, 100), 314 (11), 313 (49), 282 (13), 175 
(12), 164 (16), 151 (12), 149 (16). 
 
IR (in CHCl3): 
ν = 3971 (w), 3920 (w), 3764 (w), 3698 (w), 3674 (w), 3563 (m), 3536 (m), 3379 (m), 3314 
(m), 3234 (w), 3012 (vs), 2936 (vs), 2836 (vs), 1596 (s), 1497 (vs), 1461 (vs), 1423 (s), 1373 
(m), 1339 (w), 1263 (vs), 1233 (vs), 1145 (vs), 1087 (vs), 1030 (vs), 986 (s), 915 (w), 877 
(m), 756 (vs), 667 (vs), 625 (w), 522 (w), 497 (w). 
 
HRMS: 
m/z Calcd. for C21H27NO5 (M●+):  373.1889 
Found:     373.1890 
 
(3S)-2-(2’-Chloro-ethyl)-3-(3’’,4’’-dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline [(S)-141b] 
 
N
OMe
MeO
OMe
OMe
Cl1
23
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
16
 
 
In a 25 mL Schlenk flask under argon, a solution of alcohol (S)-158 (0.135 g, 0.36 mmol) in 
abs. CH2Cl2 (12 mL) was cooled to 0 °C. Et3N (55 µL, 0.40 mmol), methanesulfonyl chloride 
(31 µL, 0.40 mmol) and LiCl (0.061 g, 1.45 mmol) were successively added and the 
temperature was increased to room temperature. After 5 h the reaction was diluted with 
CH2Cl2 and the organic phase was washed 2 times with sat. aqueous NaHCO3 and 2 times 
with H2O. After drying over MgSO4, filtration and concentration under reduced pressure, the 
residue was purified by column chromatography (n-pentane/Et2O = 1/1) to yield (S)-141b as a 
white solid. 
 
Yield:   m = 0.097 g (0.25 mmol)  70% 
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GC:   Rt = 14.79 min   (Sil-8, 160-10-300) 
TLC:   Rf = 0.40    (n-pentane/Et2O = 1/1) 
mp:   113-115 °C 
Optical rotation: n. d. 
ee:   n. d. 
 
1H-NMR (300 MHz, CDCl3): 
δ = 2.51-2.62 (m, 1H, NCH2CH2), 2.88-3.11 (m, 3H, NCH2CH2, NCHCH2), 3.53-3.68 (m, 
4H, NCH2CH2, NCHCH2, NCH2CCOCH3), 3.85 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.86 (s, 
3H, OCH3), 3.88 (s, 3H, OCH3), 4.26 (d, J = 16.1 Hz, 1H, NCH2CCOCH3), 6.85-6.88 (m, 4H, 
CHarom) 6.97 (d, J = 1.2 Hz, 1H, NCHCCHCOCH3) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 36.64 (C-12), 41.76 (C-1), 50.24 (C-3), 55.52 (C-2), 55.86, 55.91 (C-8/C-17/C-19), 60.19 
(C-6), 63.47 (C-13), 110.54, 110.84, 111.11, 120.06, 123.32 (Carom), 127.46, 128.01 (C-4/C-
11), 134.86 (C-14), 145.22, 148.37, 149.23, 150.32 (C-5/C-7/C-16/C-18) ppm. (the missing 
peak was covered by other signals). 
 
MS (EI):  
m/z (%) =393 (M●+, 22), 392 (18), 391 (M●+, 61), 390 (11), 343 (13), 342 (68), 328 (19), 313 
(46), 312 (24), 165 (13), 164 ((CH3O)2C6H3(C2H2)+, 100), 149 (36). 
 
IR (KBr): 
ν = 2999 (m), 2931 (s), 2831 (s), 2362 (m), 2338 (w), 1596 (m), 1512 (vs), 1458 (vs), 1373 
(s), 1340 (w), 1325 (m), 1263 (vs), 1234 (vs), 1153 (vs), 1081 (vs), 1030 (vs), 980 (s), 878 (s), 
807 (vs), 761 (s), 741 (s), 660 (w). 
 
A correct elementary analysis could not be obtained. 
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(3R)-2-(2’,2’-Diethoxy-ethyl)-3-(3’’,4’’-dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline [(R)-141c] 
 
N
OMe
MeO
OMe
OMe
O O
Me
Me
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
16
22
23
 
 
In a 10 mL flask bromoacetaldehyde diethyl acetal (72 µL, 0.48 mmol) was added to a 
suspension of tetrahydroisoquinoline (R)-142 (0.132 g, 0.40 mmol), K2CO3 (0.061 g, 
0.44 mmol) and KI (0.080 g, 0.48 mmol) in anhydrous DMF (5 mL). The reaction mixture 
was heated to 110 °C for 24 h and diluted with H2O. The organic phase was kept and the 
aqueous phase was extracted 4 times with Et2O. The combined organic phases were dried 
over MgSO4, filtered and concentrated under reduced pressure. The resulting crude mixture 
was purified by column chromatography (n-pentane/Et2O = 1/3) to yield (R)-141c as a yellow 
syrup. 
 
Yield:   m = 0.135 g (0.30 mmol)  75% 
GC:   Rt = 15.19 min   (Sil-8, 160-10-300) 
TLC:   Rf = 0.51    (n-pentane/Et2O = 1/3) 
Optical rotation: [α]D24 = +46.8    (c = 1.10, CHCl3) 
ee:   = 99%     (Chiralpak AD; n-heptane/i-PrOH  
= 9/1; Rt = 15.54 min; λ = 230 nm) 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.15 (t, J = 7.2 Hz, 3H, OCH2CH3), 1.19 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.39 (dd, J = 5.2 
Hz, J = 13.4 Hz, 1H, CH2CH(OCH2CH3)2), 2.76 (dd, J = 5.2 Hz, J = 13.4 Hz, 1H, 
CH2CH(OCH2CH3)2), 2.95 (dd, J = 4.7 Hz, J = 16.3 Hz, 1H, NCHCH2), 3.05 (dd, J = 9.2 Hz, 
J = 16.3 Hz, 1H, NCHCH2), 3.38-3.72 (m, 6H, NCHCH2CCH, OCH2CH3, NCH2C), 3.84 (s, 
3H, OCH3), 3.85 (s, 6H, OCH3), 3.87 (s, 3H, OCH3), 4.38 (d, J = 16.6 Hz, 1H, NCH2C), 4.64 
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(t, J = 5.2 Hz, 1H, CH(OCH2CH3)2), 6.74 (m, 3H, CHarom), 6.86 (dd, J = 1.7 Hz, J = 8.4 Hz, 
1H, NCHCCHCH), 6.96 (d, J = 1.7 Hz, 1H, NCHCCHCOCH3) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 15.32 (C-1), 36.15 (C-14), 50.82 (C-5), 55.81, 55.90 (C-10/C-19/C-21), 56.34 (C-4), 
60.16 (C-8), 61.46 (C-2), 62.24 (C-2'), 63.57 (C-15), 102.44 (C-3), 110.82, 120.26, 123.32 
(Carom), 127.65, 128.88 (C-6/C-13), 135.27 (C-16), 145.28, 148.18, 149.07, 150.32 (C-7/C-
9/C-18/C-20) ppm. (the missing peaks were hidden by other peaks). 
 
MS (EI):  
m/z (%) = 445 (M●+, 6), 400 (12), 399 (11), 343 (32), 342 (M●+−CH(OCH2CH3)2, 100), 329 
(13), 314 (20), 313 (50). 
 
IR (in CHCl3): 
ν = 2973 (vs), 2933 (vs), 2903 (vs), 2835 (s), 1594 (m), 1497 (vs), 1460 (vs), 1423 (s), 1373 
(m), 1341 (w), 1265 (vs), 1236 (vs), 1138 (vs), 1085 (vs), 1058 (vs), 1030 (vs), 988 (s), 865 
(w), 803 (m), 757 (vs), 665 (w). 
 
Elementary analysis: 
Anal. Calcd. for C25H35NO6:  C = 67.39 H = 7.92 N = 3.14 
Found:     C = 67.22 H = 7.90 N = 2.94 
 
(3S)-2-(2’,2’-Diethoxy-ethyl)-3-(3’’,4’’-dimethoxy-phenyl)-7,8-dimethoxy-1,2,3,4-
tetrahydroisoquinoline [(S)-141c] 
 
N
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MeO
OMe
OMe
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In a 10 mL flask bromoacetaldehyde diethyl acetal (71 µL, 0.47 mmol) was added to a 
suspension of tetrahydroisoquinoline (S)-142 (0.129 g, 0.39 mmol), K2CO3 (0.060 g, 
0.43 mmol) and KI (0.078 g, 0.47 mmol) in anhydrous DMF (5 mL). The reaction mixture 
was heated to 110 °C for 24 h and diluted with H2O. The organic phase was kept and the 
aqueous phase was extracted 4 times with Et2O. The combined organic phases were dried 
over MgSO4, filtered and concentrated under reduced pressure. The resulting crude mixture 
was purified by column chromatography (n-pentane/Et2O = 1/3) to give (S)-141c as a yellow 
syrup. 
 
Yield:   m = 0.111 g (0.25 mmol)  64% 
Optical rotation: [α]D23.5 = −51.8   (c = 0.64, CHCl3) 
ee:   = 99%     (Chiralpak AD; n-heptane/i-PrOH  
= 9/1; Rt = 14.13 min; λ = 230 nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-141c. 
 
(13aR)-2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]-quinolizin-5-ol 
[(R)-162] 
 
N
OMe
MeO
OMe
OMe
OH
H
1
23
45
6
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In a 10 mL flask a solution of acetal (R)-141c (0.105 g, 0.24 mmol) in acetone (2.6 mL) was 
cooled to 0 °C. Conc. aqueous HCl (86 µL) was added dropwise and the temperature was 
increased slowly to room temperature. After 2 h 30 the cooling bath was removed and the 
reaction mixture was stirred for further 14 h. The temperature was decreased to 0 °C and 1 N 
aqueous NaOH was carefully added till pH 10. The reaction mixture was extracted 4 times 
with CH2Cl2 and the combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting crude mixture was purified by column 
chromatography (Et2O/MeOH = 60/1) providing (R)-162 as a yellow solid. 
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Yield:   m = 0.077 g (0.21 mmol)  88% 
HPLC:  (min.) Rt = 18.33 min   (Chiralcel OD; n-heptane/i-PrOH  
= 8/2; λ = 230 nm) 
   (maj.) Rt = 23.72 min   (Chiralcel OD; n-heptane/i-PrOH  
= 8/2; λ = 230 nm) 
TLC:   Rf = 0.38    (Et2O/MeOH = 60/1) 
mp:   n. d. 
dr:   44/56     (Chiralcel OD; n-heptane/i-PrOH  
= 8/2; λ = 230 nm) 
 
1H-NMR (400 MHz, CDCl3, mixture of diastereomers): 
δ = 2.49 (dd, J = 8.1 Hz, J = 11.0 Hz, 1H, NCH2CHOH (min.)), 2.72-2.85 (m, 3H, 
NCH2CHOH (maj.), NCHCH2 (maj.), NCHCH2 (min.)), 3.12 (dd, J = 4.0 Hz, J = 16.1 Hz, 
1H, NCHCH2 (min.)), 3.24-3.30 (m, 2H, NCH2CHOH (maj.), NCHCH2 (maj.)), 3.33 (dd, J = 
4.9 Hz, J = 11.0 Hz, 1H, NCH2CHOH (min.)), 3.52 (dd, J = 3.9 Hz, J = 11.2 Hz, 1H, NCH 
(maj.)), 3.58 (d, J = 15.9 Hz, 1H, NCH2C (maj.)), 3.64 (dd, J = 4.0 Hz, J = 11.8 Hz, 1H, NCH 
(min.)), 3.69 (d, J = 16.8 Hz, 1H, NCH2C (min.)), 3.84 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 
3.86 (s, 3H, OCH3), 3.87 (s, 6H, OCH3), 3.89 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.91 (s, 3H, 
OCH3), 4.15 (d, J = 16.5 Hz, 1H, NCH2C (min.)), 4.19 (d, J = 16.8 Hz, 1H, NCH2C (maj.)), 
4.53 (s, 1H, NCH2CHOH (maj.)), 4.86 (dd, J = 4.9 Hz, J = 8.1 Hz, 1H, NCH2CHOH (min.)), 
6.69 (s, 1H, NCHCCH (min.)), 6.74 (s, 1H, NCHCCH (maj.)), 6.78 (d, J = 8.2 Hz, 1H, 
NCHCH2CCHCH (maj.)), 6.81 (d, J = 8.5 Hz, 1H, NCHCH2CCHCH (min.)), 6.84 (d, J = 8.5 
Hz, 1H, NCHCH2CCH (min.)), 6.87 (d, J = 8.2 Hz, 1H, NCHCH2CCH (maj.)), 6.89 (s, 1H, 
NCH2CH(OH)CCH (min.)), 7.06 (s, 1H, NCH2CH(OH)CCH (maj.)) ppm. 
 
13C-NMR (100 MHz, CDCl3, mixture of diastereomers): 
δ = 34.55 (C-12 (min.)), 36.22 (C-12 (maj.)), 52.97 (C-3 (min.)), 53.47 (C-3 (maj.)), 55.79, 
55.82, 55.95 (C-8/C-17/C-19), 58.06 (C-2 (min.)), 58.45 (C-13 (min.)), 58.66 (C-2 (maj.)), 
59.06 (C-13 (maj.)), 60.11 (C-6), 66.53 (C-1), 107.81 (C-15 (maj.)), 109.06 (C-15 (min.)), 
110.83 (C-9/C-20 (min.)), 110.95 (C-9/C-20 (maj.)), 111.71 (C-9/C-20), 123.60 (C-10 
(maj.)), 123.65 (C-10 (min.)), 126.98 (C-4/C-11/C-14/C-21 (min.)), 127.07 (C-4/C-11/C-
14/C-21 (maj.)), 127.94 (C-4/C-11/C-14/C-21 (min.)), 128.24 (C-4/C-11/C-14/C-21 (maj.)), 
128.67 (C-4/C-11/C-14/C-21 (min.)), 129.77, 130.02 (C-4/C-11/C-14/C-21 (maj.)), 130.07 
(C-4/C-11/C-14/C-21 (min.)), 144.79 (C-7 (maj.)), 144.97 (C-7 (min.)), 147.77 (C-16/C-18), 
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148.21 (C-16/C-18 (min.)), 148.84 (C-16/C-18), 150.11 (C-5 (maj.)), 150.15 (C-5 (min.)) 
ppm. (the missing peaks were covered by the other signals). 
 
MS (EI):  
m/z (%) = 371 (M●+, 41), 370 (13), 355 (10), 354 (47), 165 (32), 164 ((CH3O)2C6H3(C2H2)+, 
100), 163 (16), 150 (13), 149 (69), 121 (11). 
 
IR (in CHCl3): 
ν = 3016 (w), 2937 (w), 2362 (w), 2335 (w), 1612 (w), 1514 (s), 1497 (s), 1460 (m), 1326 
(w), 1278 (m), 1261 (m), 1218 (m), 1148 (m), 1106 (w), 1085 (w), 1035 (w), 861 (w), 755 
(vs), 667 (w). 
 
HRMS: 
m/z Calcd. for C21H25NO5 (M●+):  371.1733 
Found:     371.1733 
 
(13aS)-2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]-quinolizin-5-ol 
[(S)-162] 
 
N
OMe
MeO
OMe
OMe
OH
H
1
23
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
16
 
 
In a 10 mL flask a solution of acetal (S)-141c (0.105 g, 0.24 mmol) in acetone (2.6 mL) was 
cooled to 0 °C. Conc. aqueous HCl (86 µL) was added dropwise and the temperature was 
increased slowly to room temperature. After 2 h 30 the cooling bath was removed and the 
reaction mixture was stirred for further 14 h. The temperature was decreased to 0 °C and 1 N 
aqueous NaOH was carefully added until pH 10. The reaction mixture was extracted 4 times 
with CH2Cl2 and the combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The resulting crude mixture was purified by column 
chromatography (Et2O/MeOH = 60/1) to yield (S)-162 as a yellow solid. 
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Yield:   m = 0.076 g (0.20 mmol)  83% 
dr:   = 63/37    (Chiralcel OD; n-heptane/i-PrOH  
= 8/2; λ = 230 nm) 
 
All other analytical data correspond to those of the other mixture of diastereoisomers. 
 
(13aR)-2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; 
(R)-(+)-tetrahydropalmatine [(R)-(+)-59] 
 
N
OMe
MeO
H
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OMe
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
1
23
16
 
 
In a 5 mL flask under argon, a solution of alcohol (R)-162 (43 mg, 0.116 mmol) in abs. 
CH2Cl2 (1.5 mL) was cooled to −78 °C. BF3·OEt2 (37 µL, 0.289 mmol) and Et3SiH (46 µL, 
0.289 mmol) were successively added. After 2 h at −78 °C the temperature was increased to 
room temperature and the reaction mixture was stirred for further 5 h. The solution was then 
neutralised with sat. aqueous NaHCO3 (~ 0.5-1 mL). The organic phase was kept and the 
aqueous phase was extracted 4 times with CH2Cl2. The combined organic phase were dried 
over MgSO4, filtered and concentrated under reduced pressure. The resulting crude mixture 
was purified by column chromatography (n-pentane/Et2O = 1/1 + 5% Et3N) to yield (R)-59 as 
a light yellow solid. 
 
Yield:   m = 16 mg (0.044 mmol)  38% 
GC:   Rt = 15.47 min   (Sil-8, 160-10-300) 
TLC:   Rf = 0.33    (n-pentane/Et2O = 1/2 + 5% Et3N) 
Optical rotation: [α]D24.5 = +387.6   (c = 0.17, CHCl3) (Lit.136 [α]D20 = 
+280 (c = 1.16, CHCl3)) 
ee:   = 98%     (Chiralpak AD; n-heptane/i-PrOH  
= 8/2; Rt = 9.81 min; λ = 230 nm) 
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1H-NMR (400 MHz, CDCl3): 
δ = 2.61-2.71 (m, 2H, NCH2CH2), 2.83 (dd, J = 11.4 Hz, J = 15.8 Hz, 1H, NCHCH2), 3.10-
3.24 (m, 2H, NCH2CH2), 3.27 (dd, J = 3.7 Hz, J = 15.8 Hz, 1H, NCHCH2), 3.51-3.58 (m, 2H, 
NCH2C, NCHCH2), 3.56 (s, 6H, OCH3), 3.87 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 4.25 (d, J = 
15.9 Hz, 1H, NCH2C), 6.62 (s, 1H, CH2CH2CCH), 6.74 (s, 1H, NCHCCH), 6.79 (d, J = 8.2 
Hz, 1H, NCHCH2CCHCH), 6.88 (d, J = 8.2 Hz, 1H, NCHCH2CCH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 29.10 (C-1), 36.33 (C-12), 51.46 (C-2), 53.95 (C-3), 55.77, 55.80, 56.00 (C-8/C-17/C-19), 
59.25 (C-13), 60.10 (C-6), 108.42 (C-15), 110.76, 111.17 (C-9/C-20), 123.68 (C-10), 126.63 
(C-21), 127.57 (C-4), 128.54 (C-11), 129.53 (C-14), 144.86 (C-7), 147.21, 147.25 (C-16/C-
18), 150.05 (C-5) ppm. 
 
MS (EI):  
m/z (%) = 356 (20), 355 (M●+, 100), 354 (90), 324 (18), 190 (16), 165 (11), 164 (37), 149 
(31). 
 
IR (KBr): 
ν = 3464 (vs), 2929 (vs), 2866 (w), 2833 (m), 2800 (w), 2745 (w), 2361 (s), 2338 (s), 1734 
(w), 1719 (w), 1652 (m), 1613 (s), 1559 (w), 1514 (vs), 1458 (vs), 1386 (s), 1359 (m), 1335 
(s), 1278 (vs), 1259 (vs), 1230 (vs), 1141 (s), 1108 (s), 1083 (vs), 1056 (m), 1025 (s), 858 (s), 
823 (w), 786 (m), 500 (w). 
 
Elementary analysis: 
Anal. Calcd. for C21H25NO4:  C = 70.96 H = 7.09 N = 3.94 
Found:     C = 70.61 H = 7.67 N = 3.56 
 
All analytical data correspond to those reported in the literature.45,137
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(13aS)-2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; 
(S)-(−)-tetrahydropalmatine [(S)-(−)-59] 
 
N
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Method A: 
In a 25 mL flask under argon, Raney-nickel W2 (2 spatulas) was added to a solution of crude 
sulfide (S)-157 (max. 0.26 mmol) in anhydrous EtOH (10 mL). The argon atmosphere was 
removed under high vacuum until the EtOH started to bubble and hydrogen gas was added. 
This operation was repeated 2 times and the reaction mixture was heated to reflux for 22 h. 
The suspension was then filtered with CH2Cl2 over a pad of Celite. After evaporation of the 
solvents the residue was purified by column chromatography (n-pentane/Et2O = 1/2 to 1/1 + 
5% Et3N) to give (S)-59 as a light yellow solid. 
 
Yield:   m = 0.029 g (0.08 mmol)  31% (over 2 steps) 
ee:   = 90%     (Chiralpak AD; n-heptane/i-PrOH  
= 8/2; Rt = 13.74 min; λ = 230 nm) 
 
Method B: 
In a 5 mL flask a solution of alcohol (S)-162 (60 mg, 0.162 mmol) in abs. CH2Cl2 (3 mL) was 
cooled to −78 °C. BF3·OEt2 (0.10 mL, 0.808 mmol) and Et3SiH (0.13 mL, 0.808 mmol) were 
successively added. After 1 h at −78 °C the temperature was increased to room temperature 
and the reaction mixture was stirred for further 18 h. The solution was then neutralised with 
sat. aqueous NaHCO3 (~ 1-2 mL). The organic phase was kept and the aqueous phase was 
extracted 4 times with CH2Cl2. The combined organic phase were dried over MgSO4, filtered 
and concentrated under reduced pressure. The resulting crude mixture was purified by column 
chromatography (n-pentane/Et2O = 1/1 + 5% Et3N) providing (S)-59 as a light yellow solid. 
 
Yield:   m = 53 mg (0.149 mmol)  92% 
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mp:   138 °C     (Lit.138 140 °C) 
Optical rotation: [α]D24.5 = −268.5   (c = 0.8, CHCl3, ee = 98%) (Lit.139  
[α]D20 = −269 (c = 0.8, CHCl3)) 
ee:   = 98%     (Chiralpak AD; n-heptane/i-PrOH  
= 8/2; Rt = 13.74 min; λ = 230 nm) 
 
All other analytical data correspond to those of the other enantiomer (R)-59. 
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7. ABBREVIATIONS 
 
abs. absolute 
Ac acetate 
Ar aryl 
bp boiling point 
br broad 
BuLi butyllithium 
Bz benzyl 
calcd. calculated 
CI chemical ionisation 
conc. concentrated 
d doublet 
∆ reflux 
de diastereoisomeric excess 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
ee enantiomeric excess 
EI electron ionisation 
Et ethyl 
Et2O diethylether 
EtOH ethanol 
eq equivalent(s) 
GC gas chromatography 
GP general procedure 
HMPA hexamethylphosphoramide 
HPLC High Performance Liquid Chromatography 
HRMS High Resolution Mass Spectroscopy 
i- iso- 
IR infrared 
J coupling constant 
LDA lithium diisopropylamide 
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m multiplet 
m- meta- 
m-CPBA 3-chloroperbenzoic acid 
MHz Mega-Hertz 
M molecular mass 
M●+ molecule radical ion 
M molar 
max. maximum 
Me methyl 
MeOH methanol 
min minute(s) 
MMPP magnesium monoperoxyphthalate hexahydrate 
mp melting point 
Ms methanesulfonyl 
MS Mass spectroscopy, mass spectrum 
MS molecular sieves 
N normal 
n- normal- (linear) 
n. d. not determined 
NMP 1-methyl-2-pyrrolidinone  
NMR Nuclear Magnetic Resonance 
o- ortho- 
p- para- 
PCC pyridinium chlorochromate 
ppm Parts Per Million 
p-TsOH para-toluenesulfonic acid monohydrate 
Ph phenyl 
PhMe toluene 
Pr propyl 
q quartet 
quant. quantitative 
R organic rest 
RAMP (R)-1-amino-2-methoxymethyl-pyrrolidin 
Rf ratio of fronts (TLC) 
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Rt retention time (GC) 
rt room temperature 
s singulet 
s- sec- (secondary) 
SAMP (S)-1-amino-2-methoxymethyl-pyrrolidin 
sat. saturated 
SMP (S)-2-methoxymethyl-pyrrolidin 
t triplet 
t- tert- (tertiary) 
T transmission 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofurane 
TLC Thin Layer Chromatography 
TMEDA N,N,N’,N’-tetramethylethylenediamine 
UV ultraviolet 
* symbol for a stereogenic centre 
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8. APPENDIX 
 
8.1 STRUCTURE REPORT TO THE X-RAY ANALYSIS 
 
8.1.1 (3R)-3-PHENYL-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE [(R)-79a] 
 
O
N
H13
H6
H12
H11
H5
H4
H3 H1
H8b
H15
H8a
H9
C15
C1
C7
C6C5
C4
C3 C2
C14
C12C11C9
C10C8
H14
C13
 
 
Single colorless crystals of (R)-79a were obtained by recrystallisation from Et2O. The 
compound (irregular crystal of about 0.3×0.3×0.3 mm3) crystallizes in monoclinic space 
group P21 (Nr. 4) with two symmetrically independent molecules in the asymmetric unit 
(2×C15H13NO, Mr = 446.55). The cell dimensions are a = 9.087(1), b = 6.126(1), c = 
20.915(3) Å, and β = 91.176(5)°. A cell volume of V = 1164.0(3) Å3 and Z = 2 result in a 
calculated density of dcal = 1.274 gcm-3. 4959 reflections have been collected in the ω/2Θ 
mode at T = 298 K on an Enraf-Nonius CAD4 diffractometer employing graphite-
monochromated CuKα-radiation (λ = 1.54179 Å). Data collection covered the range -
11≤h≤11, -7≤k≤7, and -25≤l≤25 (Friedel pairs) up to Θmax = 72.77°. µ = 0.63 mm-1, no 
absorption correction. The structure has been solved by directs methods as implemented in the 
Xtal3.7 suite of crystallographic routines140 where GENSIN has been used to generate the 
structure-invariant relationships and GENTAN for the general tangent phasing procedure. 
3771 observed reflections (I>2σ(I)) have been included in the final full matrix least-squares 
refinement on F involving 316 parameters and converging at R(Rw) = 0.089 (0.11, w = 
1/[18.0σ2(F)], S = 1.277, and a residual electron density of -0.36/0.50 eÅ-3. Due to a large 
standard deviation the result of an attempted determination of the absolute configuration using 
Flack's method100 turned out to be insignificant. However, based on chemical evidence the 
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absolute configuration of the molecule could be assigned as shown in Figure 19. The 
nitrogen-bonded hydrogen atoms could be located and have been refined isotropically. All 
other hydrogen positions have been calculated in idealized positions, and their Us have been 
fixed at 1.5 times U of the relevant heavy atom without refinement of any parameters. 
The crystal structure of (R)-79a has been deposited as supplementary publication no. CCDC-
236862 at the Cambridge Crystallographic Data Centre. Copies of the data can be obtained 
free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-
1223-336033; e-mail: deposit@ccdc.cam.ac.uk, or http//www.ccdc.cam.ac.uk). 
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Fractional atomic positional and isotropic displacement parameters (U). Equivalents 
isotropic parameters (Ueq) for anisotropic refined atoms (shown with *) 
Atom X/a Y/b Z/x Ueq/Å2
O 0.6327(4) −0.191(2) 0.1994(2) * 0.060(2) 
N 0.4611(4) 0.069(2) 0.1786(2) * 0.050(2) 
C1 0.5823(5) −0.051(2) 0.1639(2) * 0.047(3) 
C2 0.6541(5) 0.010(2) 0.1044(2) * 0.046(3) 
C3 0.7609(5) −0.128(2) 0.0790(3) * 0.057(3) 
C4 0.8316(5) −0.070(3) 0.0243(3) * 0.069(4) 
C5 0.7994(5) 0.125(3) −0.0071(2) * 0.066(4) 
C6 0.6936(5) 0.262(3) 0.0178(3) * 0.062(3) 
C7 0.6204(5) 0.205(3) 0.0724(2) * 0.050(3) 
C8 0.5016(6) 0.349(2) 0.1001(3) * 0.061(3) 
C9 0.3865(5) 0.205(2) 0.1314(2) * 0.050(3) 
C10 0.2572(5) 0.331(3) 0.1572(2) * 0.047(3) 
C11 0.2769(5) 0.524(3) 0.1909(3) * 0.057(3) 
C12 0.1542(6) 0.645(2) 0.2082(3) * 0.067(4) 
C13 0.0159(6) 0.579(2) 0.1913(3) * 0.066(4) 
C14 −0.0047(5) 0.391(3) 0.1587(3) * 0.068(4) 
C15 0.1159(5) 0.264(2) 0.1419(2) * 0.057(3) 
H1 0.433(4) 0.05(1) 0.215(2) 0.04(1) 
H8a 0.5400(-) 0.4528(-) 0.1264(-) * 0.067(-) 
H8b 0.4515(-) 0.4264(-) 0.0627(-) * 0.067(-) 
H3 0.7906(-) −0.2652(-) 0.0993(-) * 0.060(-) 
H4 0.9060(-) −0.1741(-) 0.0061(-) * 0.079(-) 
H5 0.8515(-) 0.1534(-) −0.0465(-) * 0.078(-) 
H11 0.3775(-) 0.5675(-) 0.2086(-) * 0.060(-) 
H6 0.6751(-) 0.4031(-) −0.0053(-) * 0.070(-) 
H13 −0.0695(-) 0.6753(-) 0.1982(-) * 0.070(-) 
H9 0.3483(-) 0.1009(-) 0.1000(-) * 0.060(-) 
H12 0.1612(-) 0.7838(-) 0.2314(-) * 0.083(-) 
H14 −0.1041(-) 0.3314(-) 0.1512(-) * 0.065(-) 
H15 0.1004(-) 0.1309(-) 0.1158(-) * 0.062(-) 
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Atomic displacement parameters 
Atom U11 U22 U33 U12 U13 U23
O 0.070(2) 0.049(2) 0.062(2) 0.017(2) 0.007(2) 0.012(2) 
N 0.054(2) 0.047(3) 0.048(2) 0.005(2) 0.008(2) 0.001(2) 
C1 0.047(2) 0.044(3) 0.050(3) 0.000(3) −0.002(2) −0.004(3) 
C2 0.040(2) 0.048(3) 0.051(3) 0.001(2) −0.006(2) −0.006(3) 
C3 0.054(3) 0.057(4) 0.060(3) 0.011(3) 0.003(2) −0.003(3) 
C4 0.053(3) 0.086(5) 0.069(4) 0.017(4) 0.003(3) −0.012(4) 
C5 0.051(3) 0.092(5) 0.056(3) −0.011(3) 0.011(2) −0.005(4) 
C6 0.060(3) 0.060(4) 0.065(3) −0.001(3) 0.011(2) 0.008(3) 
C7 0.043(2) 0.051(3) 0.056(3) −0.001(3) 0.002(2) 0.002(3) 
C8 0.066(3) 0.047(3) 0.071(3) 0.007(3) 0.014(3) 0.010(3) 
C9 0.051(2) 0.047(3) 0.051(3) −0.000(2) 0.003(2) −0.003(3) 
C10 0.046(2) 0.048(3) 0.047(3) 0.005(3) 0.000(2) 0.006(3) 
C11 0.050(2) 0.057(4) 0.063(3) −0.003(3) −0.003(2) −0.009(3) 
C12 0.071(3) 0.054(4) 0.077(4) 0.002(3) 0.008(3) −0.011(3) 
C13 0.055(3) 0.076(5) 0.069(4) 0.020(3) 0.000(3) 0.002(4) 
C14 0.043(3) 0.083(5) 0.079(4) −0.001(3) 0.000(2) 0.000(4) 
C15 0.052(3) 0.055(4) 0.064(3) −0.007(3) 0.001(2) −0.010(3) 
H1 0.04(1)      
H8a 0.067(-) 0.067(-) 0.067(-) 0.000(-) 0.001(-) 0.000(-) 
H8b 0.067(-) 0.067(-) 0.067(-) 0.000(-) 0.001(-) 0.000(-) 
H3 0.060(-) 0.060(-) 0.060(-) 0.000(-) 0.001(-) 0.000(-) 
H4 0.079(-) 0.079(-) 0.079(-) 0.000(-) 0.002(-) 0.000(-) 
H5 0.078(-) 0.078(-) 0.078(-) 0.000(-) 0.002(-) 0.000(-) 
H11 0.060(-) 0.060(-) 0.060(-) 0.000(-) 0.001(-) 0.000(-) 
H6 0.070(-) 0.070(-) 0.070(-) 0.000(-) 0.001(-) 0.000(-) 
H13 0.070(-) 0.070(-) 0.070(-) 0.000(-) 0.001(-) 0.000(-) 
H9 0.060(-) 0.060(-) 0.060(-) 0.000(-) 0.001(-) 0.000(-) 
H12 0.083(-) 0.083(-) 0.083(-) 0.000(-) 0.002(-) 0.000(-) 
H14 0.065(-) 0.065(-) 0.065(-) 0.000(-) 0.001(-) 0.000(-) 
H15 0.062(-) 0.062(-) 0.062(-) 0.000(-) 0.001(-) 0.000(-) 
 
182 
APPENDIX 
Bond distances (Å) 
Bond Distance Bond Distance 
C2-C7 1.40(2) C5-H5 0.974(6) 
C2-C3 1.40(1) C5-C6 1.38(1) 
C2-C1 1.466(8) C11-H11 1.016(6) 
N-H1 0.81(4) C11-C12 1.39(1) 
N-C1 1.36(1) C11-C10 1.38(2) 
N-C9 1.45(1) C6-H6 1.00(1) 
C1-O 1.22(2) C10-C15 1.378(9) 
C7-C6 1.378(9) C10-C9 1.52(1) 
C7-C8 1.51(1) C13-H13 0.99(1) 
C8-H8b 1.016(8) C13-C12 1.36(1) 
C8-H8a 0.91(1) C13-C14 1.35(2) 
C8-C9 1.53(1) C9-H9 0.97(1) 
C3-H3 0.98(1) C12-H12 0.98(1) 
C3-C4 1.370(9) C14-H14 0.983(8) 
C4-H4 1.01(1) C14-C15 1.39(1) 
C4-C5 1.39(2) C15-H15 0.99(1) 
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Bond angles (º) 
Bond Angle Bond Angle 
C7-C2-C3 118.7(6) H11-C11-C12 119(1) 
C7-C2-C1 121.7(9) H11-C11-C10 121(1) 
C3-C2-C1 120(1) C12-C11-C10 119.5(7) 
H1-N-C1 114(4) H6-C6-C7 122(1) 
H1-N-C9 125(3) H6-C6-C5 116.9(7) 
C1-N-C9 121.7(5) C7-C6-C5 121(1) 
O-C1-N 122.6(6) C11-C10-C15 118.7(9) 
O-C1-C2 121.9(7) C11-C10-C9 121.6(6) 
N-C1-C2 115(1) C15-C10-C9 119(1) 
C6-C7-C2 120.3(9) H13-C13-C12 121(1) 
C6-C7-C8 122(1) H13-C13-C14 118.8(7) 
C2-C7-C8 117.6(6) C12-C13-C14 120.1(9) 
H8b-C8-H8a 107(1) H9-C9-N 104(1) 
H8b-C8-C9 107.5(5) H9-C9-C8 109.1(5) 
H8b-C8-C7 106.8(5) H9-C9-C10 107.8(5) 
H8a-C8-C9 113.9(6) N-C9-C8 108.0(5) 
H8a-C8-C7 111.8(6) N-C9-C10 114.0(5) 
C9-C8-C7 109(1) C8-C9-C10 114(1) 
H3-C3-C4 117.1(9) H12-C12-C13 115.8(9) 
H3-C3-C2 122.7(7) H12-C12-C11 123.2(8) 
C4-C3-C2 120(1) C13-C12-C11 121(1) 
H4-C4-C3 119(1) H14-C14-C15 119(1) 
H4-C4-C5 120.0(7) H14-C14-C13 120.9(9) 
C3-C4-C5 121(1) C15-C14-C13 120.0(7) 
H5-C5-C4 117(1) H15-C15-C14 119.6(6) 
H5-C5-C6 124(1) H15-C15-C10 119.6(9) 
C4-C5-C6 118.9(7) C14-C15-C10 121(1) 
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Dihedral angles (º) 
Bond Angle Bond Angle 
C7-C2-C1-N 13(1) C2-C3-C4-H4 −178.2(8) 
C7-C2-C1-O −163(1) H3-C3-C4-C5 −178.4(8) 
C3-C2-C1-N −167.8(9) H3-C3-C4-H4 3(1) 
C3-C2-C1-O 16(2) C3-C4-C5-C6 0(1) 
C1-C2-C7-C8 −3(1) C3-C4-C5-H5 −178.0(8) 
C1-C2-C7-C6 177.7(8) H4-C4-C5-C6 178.0(8) 
C3-C2-C7-C8 178.5(7) H4-C4-C5-H5 0(1) 
C3-C2-C7-C6 −1(1) C4-C5-C6-C7 0(1) 
C1-C2-C3-C4 −178.3(8) C4-C5-C6-H6 178.3(8) 
C1-C2-C3-H3 0(1) H5-C5-C6-C7 177.2(9) 
C7-C2-C3-C4 0(1) H5-C5-C6-H6 −4(1) 
C7-C2-C3-H3 179.0(8) C12-C11-C10-C9 173.7(8) 
C9-N-C1-C2 16(2) C12-C11-C10-C15 0(1) 
C9-N-C1-O −168(1) H11-C11-C10-C9 −15(1) 
H1-N-C1-C2 −168(4) H11-C11-C10-C15 171.2(8) 
H1-N-C1-O 8(4) C10-C11-C12-C13 −1(1) 
C1-N-C9-C8 −51(1) C10-C11-C12-H12 −178.9(9) 
C1-N-C9-C10 −178(1) H11-C11-C12-C13 −172.9(9) 
C1-N-C9-H9 65(1) H11-C11-C12-H12 9(2) 
H1-N-C9-C8 134(5) C11-C10-C9-N 81(1) 
H1-N-C9-C10 6(5) C11-C10-C9-C8 −43.5(9) 
H1-N-C9-H9 −111(5) C11-C10-C9-H9 −164.4(9) 
C2-C7-C8-C9 147.2(8) C15-C10-C9-N −105(1) 
C2-C7-C8-H8a 94(1) C15-C10-C9-C8 130.5(9) 
C2-C7-C8-H8b −148.5(9) C15-C10-C9-H9 10(1) 
C6-C7-C8-C9 −32.6(8) C11-C10-C15-C14 1(1) 
C6-C7-C8-H8a −86(1) C11-C10-C15-H15 176.8(9) 
C6-C7-C8-H8b 31(1) C9-C10-C15-C14 −172.7(9) 
C2-C7-C6-C5 1(1) C9-C10-C15-H15 3(1) 
C2-C7-C6-H6 −177.5(8) C14-C13-C12-C11 2(1) 
C8-C7-C6-C5 −178.6(8) C14-C13-C12-H12 179.6(9) 
C8-C7-C6-H6 3(1) H13-C13-C12-C11 −171.3(8) 
C7-C8-C9-N 56.1(9) H13-C13-C12-H12 7(1) 
C7-C8-C9-C10 −176.5(4) C12-C13-C14-C15 0(1) 
C7-C8-C9-H9 −56.2(9) C12-C13-C14-H14 172.0(9) 
H8a-C8-C9-N −70(1) H13-C13-C14-C15 172.6(8) 
H8a-C8-C9-C10 58(1) H13-C13-C14-H14 −15(2) 
H8a-C8-C9-H9 178.1(9) C13-C14-C15-C10 0(1) 
H8b-C8-C9-N 171.7(9) C13-C14-C15-H15 −176.4(9) 
H8b-C8-C9-C10 −61(1) H14-C14-C15-C10 −173.7(8) 
H8b-C8-C9-H9 59(1) H14-C14-C15-H15 11(1) 
C2-C3-C4-C5 0(1)   
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